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Abstract 
 
ADVANCED APPLICATIONS OF CARDIAC COMPUTED TOMOGRAPHY FOR THE 
DIFFICULT-TO-IMAGE PATIENT 
 
BENJAMIN JAMES CLAYTON 
 
Throughout the development of computed tomographic (CT) imaging the challenges of 
capturing the heart, with its perpetual, vigorous motion, and in particular the tiny 
detail within the coronary arteries, has driven technological progress. Today, CT is a 
widely used and rapidly growing modality for the investigation of coronary artery 
disease, as well as other cardiac pathology. However, limitations remain and particular 
patient groups present a significant challenge to the CT operator. 
 
This thesis adds new knowledge to the assessment of these difficult-to-image patients. 
It considers patients with artefact from coronary artery calcification or stents, 
examining the remarkable diagnostic performance of high definition scanning, as well 
as material subtraction techniques using dual energy CT, alongside ways in which 
current technology might be revisited and refined with the use of alternative image 
reconstruction methods. Patients with challenging heart rate or rhythm abnormalities 
are considered in three studies; how to achieve diagnostic image quality in atrial 
fibrillation, the safety of an aggressive approach to intravenous beta-blocker use prior 
to coronary imaging, and the development of patient information to address anxiety as 
a source of tachycardia and motion artefact. Finally, the novel application of a single 
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source, dual energy CT scanner to additional cardiac information is considered, with 
studies of myocardial perfusion CT and delayed iodine enhancement imaging, to 
identify ways in which non-coronary imaging might be exploited to more thoroughly 
evaluate a patient’s coronary artery status. 
 
These findings are presented in the context of developing technology and together 
offer a range of potential options for operators of cardiac CT when faced with a 
difficult-to-image patient. 
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1. Introduction 
At his Nobel Lecture in 1979 Sir Godfrey Hounsfield, the British inventor of computed 
tomography (CT) remarked on experiments performed in which detectors had 
traversed the heart in cardiac diastole, synchronised by an electrocardiograph. He 
alluded to the “special conditions of scanning” which might make it possible, one day, 
to image the coronary arteries.[1] Cardiac, and particularly coronary, CT imaging has 
always been one of the most challenging applications of this modality, with the 
requirement to accurately visualise tiny abnormalities within structures just a few 
millimetres across in the only perpetually moving organ in the human body. 
 
Although cardiac imaging developed with electron beam CT (EBCT) it was the 
introduction of multi-detector row CT in the late 1990s that began the rapid 
development of cardiac-capable CT scanners.[2] Over the last twenty years technology 
has developed at an astonishing pace, such that coronary arteries which were barely 
visible on early multi-slice CT systems can now be readily and accurately analysed, 
down to the composition of plaque within the arterial wall. Indeed, most modern 
developments in CT technology have been driven by the unique challenges presented 
by imaging the heart. 
 
This chapter is not intended to be a textbook on the principles of cardiac CT. However 
there are some particularly important principles which have guided the development 
of modern CT technology – CT needs to balance image quality with radiation dose, 
optimising diagnostic performance whilst maintaining acceptable safety. The drive to 
reduce the dose of radiation to which a patient is exposed has driven many of the 
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advances in cardiac CT to date, and the importance of dose will remain for further 
advances in the foreseeable future. It therefore seems prudent to outline the major 
issues with both radiation safety and image quality relevant to cardiac CT. 
1.1 Electrocardiographic gating 
To achieve diagnostic image quality, cardiac motion must be minimised, capitalising on 
moments of relative cardiac standstill, usually in mid-diastole or, at higher heart rates, 
end systole. Cardiac CT therefore uses electrocardiographic (ECG) triggering, or ‘gating’ 
(Figure 1). Early multi-detector CT used retrospective gating, whereby imaging is 
performed continuously over multiple cardiac cycles (Figure 1A). The required phases 
of the cardiac cycle are subsequently extracted for analysis to ensure that only the 
periods of interest are examined but, for most studies, the remainder is not required. 
In other words, over 3 or 4 heartbeats lasting a number of seconds only a few 
milliseconds of data are used. Dose modulation, where radiation exposure is reduced 
during the phases of the cardiac cycle least likely to be useful but maximised during 
the diagnostic phases, (Figure 1B) can reduce the radiation dose from standard 
retrospective CT by half.[3] 
 
Subsequent development led to the introduction of prospective gating. Here, the 
scanner uses a ‘step and shoot’ approach, acquiring a single volume through the heart 
in one cardiac cycle, using the next one or more cycles to move the patient through 
the scanner, before taking the next volume in another cycle. This is repeated until the 
entire volume is acquired, which is then ‘reassembled’ by the scanner (Figure 1C). 
While this requires good heart rate and rhythm control, to ensure that imaging occurs 
at the same point in the cardiac cycle for each volume, it exposes the patient to 
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significantly less radiation. The impact of gating techniques on radiation dose is 
discussed further below. 
 
 
Figure 1   
Electrocardiographic gating. The grey bars represent the delivery of radiation to the 
patient. A – retrospective gating without dose modulation, B – retrospective gating 
with modulation, C – prospective gating. 
 
 
With the new generation CT scanners comes a further development in gating 
technology which somewhat hybridises the existing methods.[4] High-pitch 
retrospective gating is one such technology. Standard retrospective scanning uses a 
very low pitch – the ratio of the table speed to detector width – to ensure complete 
data capture, which results in significant oversampling.[5] With dual-source scanners, 
which have two x-ray sources within a single gantry, the whole heart can be examined 
in half the time. This means that, if cardiac diastole is long enough, an entire heart 
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volume can be acquired in a single cardiac cycle. This dramatically reduces the 
radiation exposure to the patient while maintaining resolution.[6] 
 
1.2 Resolution 
Achieving optimal image resolution is key to maintaining diagnostic image quality. For 
general CT this includes spatial resolution and contrast resolution. 
 
Spatial resolution is the ability of the scanner to distinguish substances of different 
sizes. It is determined by factors such as the number of samples, the image 
reconstruction method, and reconstruction field of view. With helical scanning, the 
pitch is also important. The recommended detector size for cardiac CT is 0.625 mm or 
less.[4] It is easier to achieve resolution in the x-y axis (the axial plane) but z-axis 
resolution, in the craniocaudal or longitudinal direction is more challenging and is 
significantly influenced by the detector size and geometry.[7] The term isotropic 
resolution describes the situation where x-y and z-axis resolution are both equal and is 
important to allow three-dimensional visualisation in any plane without loss of spatial 
resolution. Spatial resolution is measured either in line pairs per centimetre, which 
reflects the number of pairs of equally sized lines that can be discriminated from each 
other within a one centimetre region of interest, or as MTF, or modulation transfer 
function. The latter concept describes the degradation in performance of a scanner as 
the spatial frequency (e.g.: number of line pairs per centimetre) increases. At the time 
of writing the current recommended minimum spatial resolution is 12.5 line pairs per 
centimetre at 10% MTF.[4] 
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Contrast resolution is the ability to discriminate between an object and its background 
or other objects. In cardiac CT these features are particularly important, to evaluate 
sub-millimetre structures such as coronary lumen and atheromatous plaque, and to 
distinguish between tissue densities or intravascular contrast. Contrast resolution 
improves with increasing tube current (and therefore radiation dose) but can also be 
influenced by reconstruction methods, patient habitus and detector sensitivity. All of 
these affect noise, which ultimately detracts from contrast resolution.[8] 
 
The challenge specific to cardiac CT is the addition of temporal resolution – the ability 
to ‘freeze’ cardiac motion to ensure imaging free from artefact. While ECG gating is 
important to identify the periods of least cardiac motion, it is still challenging to 
achieve image acquisition during these phases. The length of diastole varies in a non-
linear fashion according to heart rate[9] and shortens rapidly as heart rate rises. To 
achieve diagnostic image quality across multiple phases of the cardiac cycle the 
temporal resolution should be around 50 ms.[8] Fluoroscopy, used for invasive 
coronary angiography, has a temporal resolution in the order of 10 milliseconds or 
less. 
 
Temporal resolution with CT is limited predominantly by gantry rotation time. By using 
partial scan reconstruction scanners only require data from a 180° rotation (plus the 
fan beam angle) – a half-scan – but resolution is still dependent on the time taken for 
this to occur. Various methods have been used to improve this further. When 
retrospective gating it utilised, with helical scanning throughout multiple cardiac cycles 
and low pitch (resulting in slice overlap) multi-segment reconstruction becomes 
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possible. Small amounts of data can be utilised from each cardiac cycle until sufficient 
data is available to create a half-scan.[10] 
 
Another alternative to reduce the time taken to complete a half-scan is to increase the 
number of x-ray tubes. By using two x-ray sources only a quarter of a rotation is 
required, and thus one new generation CT scanner employs this approach (Somatom 
Definition, Siemens Medical Solutions, Forchheim, Germany), such that with a rotation 
time of 330 ms it can achieve an effective temporal resolution as short as 83 ms.[11] 
 
1.3 Radiation 
A recurring issue considered in the previous section is the balance between improved 
resolution and radiation dose. The rapid growth in the use of CT, both for cardiac and 
general imaging examinations, has contributed to an increase in the use of ionising 
radiation. Technological developments, the need for surveillance of established 
disease, and wider appreciation of the merits of detailed, cross-sectional imaging from 
both clinicians and patients have driven this demand,[12]such that the United States 
saw a sixfold increase in medical radiation exposures over the 25 years to 2006.[13] 
Since a seminal report in 2001[14], further, large scale analyses have demonstrated 
the potential long term risk of radiation, particularly in children[15,16] and a multitude 
of similar studies are expected in the next few years[17]. 
 
When therapeutic radiotherapy is excluded, somewhere between 19 and 40% of, 
medical radiation exposure is due to cardiological diagnosis or therapeutics.[18,19] The 
risk from cardiac computed tomography (CT) has been of particular interest and 
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concern – radiation exposures from cardiac CT have traditionally been considered 
significant,[18] leading to criticism of the technique[20] and, in line with the overall 
growth of this modality[19], the volume of cardiac CT scans has also increased 
dramatically in recent years.[18] 
 
In fact the dose of radiation a patient receives from an individual exposure has fallen 
substantially in recent years,[19] but this may not always be reflected in discussions 
about the risk from CT imaging.[12] A recent position paper from the European Society 
of Cardiology (ESC) suggested that prescribers and practitioners of imaging techniques 
may lack awareness or understanding about radiation, potentially threatening longer 
term public health.[19] 
 
Broadly, there are two effects on biological tissues from ionising radiation. 
Deterministic effects are localised tissue reactions, which arise due to serious cell 
damage or death, and generally occur predictably beyond a given dose threshold.[21] 
Examples of these effects include cutaneous erythema, desquamation or ulceration, 
hair loss, or cataract formation, and their severity increases proportionally to the dose 
received. Although rare for most diagnostic imaging procedures, they may occur 
during fluoroscopically-guided interventional procedures, or poorly planned 
radiotherapy. One highly publicised example from the United States highlighted 
cerebral CT perfusion studies which left patients with a circumferential band of hair 
loss.[22] 
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While clearly alarming for patients it is perhaps the other sequelae, stochastic effects, 
which are the most concerning public health issue.[18] These increase the future 
likelihood of adverse events, rather than the severity of a particular occurrence. Arising 
due to radiation-induced mutation, they are binary in nature – they will either occur or 
they will not – and may increase the risk of malignancy in later life. There is a lag of five 
to 10 years before the development of most solid tumours and at least 2 years for 
leukaemias,[18] making direct causal attribution challenging. The stochastic effects of 
radiation are described as ‘linear no-threshold’ (LNT), implying that, in contrast to 
deterministic effects, the risk increases continuously, in a linear fashion, but without a 
clear dose threshold or safe lower limit.[23] Theoretically, genetic mutation may also 
affect the progeny of the index patient. The risk of any genetic disease has been 
estimated at 0.3-0.5% per Gray for each first-generation offspring[21], although these 
assessments are based on extensive experimental, rather than direct, in-vivo, 
evidence.[18] This is notably different from in-utero exposure, where epidemiological 
data supports the proposition of an increased rate of childhood cancer.[24] 
 
Ironically, radiation also increases the risk of developing cardiovascular disease. Higher 
rates of stroke are seen following radical radiotherapy for head and neck cancers,[25] 
while breast cancer therapy appears to confer a significant, long-term risk of 
cardiovascular mortality.[26] Radiation appears to promote atherosclerosis, with lipid 
accumulation and plaque rupture both possible,[27] possibly due to tissue injury and 
repair. 
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Measurement of radiation dose 
The quantification of radiation dose is not altogether straightforward. A plethora of 
terms exist to describe the way radiation is generated and disseminated, its 
absorption, and its effect on biological tissue. The term ‘radiation exposure’ may have 
colloquial interpretations but, strictly, means the amount of ionisation created in air, 
measured as the total charge of positive or negative ions produced by radiation in 1kg 
of dry air.[21] 
 
To estimate the potential risk of an imaging investigation to patients, the absorbed 
dose – the amount of energy delivered to tissues – must be established. Absorbed 
dose from CT is measured using the CT dose index (CTDI). This describes the dose 
delivered in a single axial slice, dividing the total absorbed dose by the width of the x-
ray beam. This is less meaningful in a clinical scan, which often involves a series of 
slices of a given thickness, often with overlaps or gaps and therefore for practical 
application the volume CTDI (CTDIvol) is preferred. This provides an estimate of the 
dose in a given volume by a particular scan protocol and, importantly, facilitates 
comparison of the performance of a centre or individual with recognised standards[28] 
or other institutions. 
 
Neither parameter considers the length of the scan in the longitudinal plain (or z axis); 
clearly important when considering the total patient dose. The dose-length product 
(DLP) is the CTDIvol multiplied by the scan length in centimetres. It more closely 
resembles the dose received by an individual patient, although it is important to 
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appreciate that it is still computationally derived from standardised phantom sizes and 
measurements, mathematical assumptions and calculations[21]. 
 
Estimating the potential risk of harm requires further consideration. Tissues vary 
considerably in their propensity for malignant transformation and some tissues are 
more sensitive to radiation than others. The same radiation dose applied to a brain has 
far less potential to induce carcinogenesis than that absorbed by breast tissue. To 
accommodate this, conversion factors are utilised to ‘normalise’ localised irradiation 
relative to whole body exposure[29] and facilitate comparison between examinations. 
This measurement, the effective dose (E), can be calculated through Monte Carlo 
simulations, or estimated as the product of a surrogate conversion factor (k) and the 
DLP[30], and is measured in milliSieverts (1 Sv = 1 J/kg). 
 
There are advantages to using effective dose to describe potential risk: it is relatively 
simple,[28] accounts for tissue sensitivity, and allows comparison to a variety of non-
medical radiation exposures, and between imaging modalities.[31] This last benefit 
may be particularly useful when explaining risk to laypersons. Unfortunately effective 
dose also has significant limitations, ignoring important patient-specific factors such as 
obesity,[28] age and gender and still relying on numerous statistical assumptions. The 
same is true of the tissue weightings themselves, which are broad approximations, 
averaged for age and gender.[18] Thus the actual dose received by a patient may be 
three times higher or lower than the estimated E value.[32] Experts recommend that E 
should therefore be retained for broad estimates of dose for populations, based on the 
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order of magnitude, rather than assuming it to be a precise measure of an individual’s 
risk. 
 
There are specific issues with effective dose and cardiac CT. New generation scanners 
increasingly employed for cardiac CT utilise novel image acquisition techniques, which 
have not been calculated into the standard dose models. Changes in scatter, coverage 
and other factors may need to be re-evaluated, and meanwhile the use of effective 
dose calculations and conversion factors is questionable.[33] In addition, there is 
concern about the most widely used conversion factor for cardiac CT. The International 
Commission on Radiological Protection (ICRP) currently recommend the ‘chest’ 
conversion factor of 0.014 to calculate the effective dose from the DLP. However in 
addition to the heart, the organs receiving the highest doses with cardiac CT are the 
breasts, part of the lungs, liver, and oesophagus[21] and breast tissue in particular is 
highly sensitive to radiation. Furthermore, considering the thoracic volume as the 
whole chest does not accurately depict the coverage of cardiac CT, which covers the 
mid-chest to the upper abdomen.[34] For these reasons, the chest factor significantly 
underestimates the dose from cardiac CT[33,35] and analyses suggest doubling this (to 
0.028) to achieve a more representative assessment.[36] 
 
Estimation of risk 
Estimation of the risk of radiation stems largely from the Life Span Study (LSS), a cohort 
of around 100 000 survivors of the Hiroshima and Nagasaki atomic bombs[37]. This 
study estimated the likely radiation exposure to individuals and has subsequently 
observed them for more than 50 years. The incidence of cancer and other pathology 
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has been extensively studied, providing statistical expectations of an individual’s risk 
following a given exposure and assessing tissue sensitivity from which ICRP weightings 
are derived.[29] 
 
The appropriateness of these extrapolations is not without controversy. Unlike 
patients, who usually experience repeated, low-dose radiation exposures, targeted to 
limited anatomy, over days or even years, participants in the LSS received an initial, 
high, whole-body dose, over a few seconds, with subsequent exposure over days to 
months. The radiation is heterogeneous, and confounders such as toxins and 
carcinogens from blast debris exist.[38] That said, large epidemiological studies,[14] 
including recent work[16,39] demonstrate remarkable parity with LSS predictions. 
 
Further debate arises from the extrapolation of LSS data to ‘linear no-threshold’ (LNT) 
principle described above. LNT was conceived as a tool for occupational radiation 
protection, rather than to predict biological harm in patients and some authors claim 
that there is insufficient data to support its use in this fashion.[40] A number of 
studies, in a range of environments, have considered whether lower dose radiation 
carries a risk of carcinogenesis at all, or may even be hormetic. These include patients 
with occupational, radiographic or therapeutic exposure, as well as patients from the 
Japanese atomic bomb and Chernobyl disasters[38]. It is proposed that where 
radiation causes the production of oxidative free radicals, known to induce 
malignancy, at a rate similar to biological processes then they present very little risk, 
and that only when very high doses of radiation are encountered are immune defence 
mechanisms overwhelmed. 
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Controversy arises from projections of mathematical data, difficulty attributing 
causality and the need for long-term, confounder-free follow up, not entirely 
achievable from the Life Span Study or other registries. Furthermore, as the risks of 
radiation reduce in a population with an already high level of cancer, greater numbers 
of participants are required for follow-up, in order to identify additional events with 
statistical confidence[41]. While the issue remains contentious, with some major 
organisations declaring safety at even quite moderate doses[42], most international 
advisory boards persist with the LNT principle, acknowledging its limitations[18,43], 
until such a time that further evidence is forthcoming[23]. Meanwhile it may at least 
draw attention to the need for careful radiation protection measures[44]. 
 
The disagreements about LNT are fundamental to the debate about the risks of 
medical radiation. The vast majority of medical exposures are considered to be low, or 
ultra-low dose (less than 50mSv in a single examination), particularly in comparison to 
the very large doses experienced by the atomic bomb survivors. There is little evidence 
specifically considering small exposures, not least because of the aforementioned 
study design challenges, and so risk has to be based on extrapolation and 
inference.[18] Most studies which do analyse medical exposures consider much higher 
radiation doses than current practice would confer,[18] and due to the latency period 
between exposure and sequelae even very recent analyses can overestimate the risk 
of modern practice. That said, recent, large studies appear to suggest a link between 
medical radiation and future cancer risk. So far these have mainly been in 
children,[15,16] unreflective of the majority of patients undergoing cardiological 
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investigation or treatment. One analysis has considered the radiation exposure from 
cardiac examinations in adults admitted to hospital with myocardial infarction,[45] 
approximating exposure based on the type and number of cardiac procedures for each 
patient. Using subsequent health insurance claims, the authors suggested an increased 
risk of 3% for every 10 mSv exposure, but the study was hampered by a number of 
methodological limitations,[18] including failing to adjust for important confounders, 
reliance on insurance claims databases as a sole source of subsequent diagnoses and a 
lack of detail regarding both patient baseline and outcomes. They also ignored the risk 
of not undertaking investigation or treatment. 
 
Justification of risk 
One major concern of proponents of imaging irrespective of dose is the potential 
failure to diagnose important pathology.[46] For many conditions the risk of death 
from missed diagnosis is greater than the potential harm from imaging[47] and with 
cardiovascular disease the leading cause of death worldwide[48] this is particularly 
relevant to cardiac imaging. 
 
The roles of imaging are to confirm, refine or refute the clinical diagnosis, add to risk 
stratification, guide or facilitate therapy, and evaluate disease progression or 
treatment. Investigations should be targeted to the individual patient[49] according to 
the diagnostic or therapeutic goal. Selecting an investigation using ionising radiation 
should only occur if there is no other suitable test to adequately answer the clinical 
question and after “thoughtful consideration of the patient”.[50] Clinicians might also 
consider local expertise, previous investigations and the likely investigative yield[49]. 
38 
 
The risk of not undertaking a test may be sufficiently low to justify an alternative 
strategy, but might equally make it clear that the radiation risk is justified.[51] One 
clear example would be the exposure to radiation from fluoroscopy of a patient 
suffering an ST-elevation myocardial infarction – in this case, the need to undertake 
diagnosis and treatment of the occluded coronary artery is justifiable on the basis that 
failure to revascularise the myocardium is likely to lead to death or permanent 
disability and other therapies are less effective. Appropriate use guidance is available 
from specialist bodies,[52] but ultimately the risk assessment needs to be dynamic,[19] 
adjusted to the individual situation. It has been estimated that between one-fifth and 
half of all CT requests could be changed for a test without radiation or simply 
cancelled.[53] 
 
One further consideration is non-transferability of risk. This means that one patient’s 
risk from an exposure cannot transfer the potential risk of future malignancy to 
another. This is relevant in the reporting of population statistics, such as at the start of 
this chapter, commenting on the increased use of medical imaging. Such increases 
should only be averaged over the number of patients being imaged, and not an entire 
population. These groups may differ – imaged patients may be sicker and older than 
the general population –  thereby altering the balance of risk, [51] although this, too, is 
contentious.[45] 
 
As with all medical procedures, discussion with the patient is key to the appropriate 
selection of investigations. Patients can guide the choice[49], and may have their own 
opinion as to what constitutes acceptable risk to them. Furthermore, through the 
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process of providing clear information to patients, clinicians may further explore their 
own rationale for choosing a particular test. There are risks associated with most tests, 
all of which need to be considered, along with the patient, for the ‘least worst’, and 
most suitable, test to be selected. 
 
Optimising technique to reduce dose 
Justifying patient exposure to ionising radiation is only half of the consideration, simply 
deciding if it is an appropriate means of achieving the clinical goal, in the context of the 
individual patient and with knowledge of the risks, benefits and alternatives. The next 
step is to ensure that the procedure is optimised, using the smallest amount of 
radiation that provides diagnostic image quality.[40] The historically high radiation 
exposure from cardiac CT[18] has led to great radiation awareness in the cardiac 
imaging community[40] and demand for radiation reduction strategies has led to a 
number of technological developments. 
 
Acquisition techniques 
Major progress was made in terms of radiation reduction with the developments in 
ECG gating which were discussed earlier. The introduction of dose modulation reduced 
the then-high doses of radiation by half.[3] Most current scanners employ prospective 
gating, where the scanner predicts the relevant cardiac phase based on the ECG and 
acquires data only at those points (Figure 1C). This method requires good heart rate 
control, to ensure that the optimal phases of the cycle are sufficiently long and 
consistent, and it is therefore unsurprising that the administration of beta-blockers to 
patients prior to CT can facilitate dose-reducing techniques.[54] 
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Further dose reduction can be achieved by modifying the tube energy (kV). Modern 
cardiac CT techniques use 100 kV for most patients, sparing the traditional 120 kV for 
patients with a larger body habitus. Some centres use 80 kV for sleight patients. 
Radiation dose is proportional to the tube voltage, squared,[21] and introduction of a 
reduced tube energy protocol reduces radiation dose by half again.[34,55] 
 
Combined, these changes can facilitate an 80% dose reduction compared to un-
modulated, retrospective techniques (Figure 2).[3] Retrospective studies do retain a 
role, particularly where cardiac motion is vigorous or unpredictable, such as in patients 
with tachycardia or arrhythmia.[52] Even here, however, improvements are being 
made and the latest generation of cardiac-capable scanners can obtain images very 
rapidly, achieving doses as low as 14% of standard scans, even in patients with higher 
heart rates.[56] New generation technologies also confer improved dose efficiency, 
with larger detectors requiring fewer rotations for each acquisition, and thus less 
wasted penumbra. 
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Figure 2 
CT coronary angiography in a young adult to exclude vasculitic complications. The 
patient’s body mass index was 22 kg/m2. The entire scan was undertaken using 80 kV, 
250 mA on a prospective protocol with ‘zero padding’, with a dose length product of 26 
mGy·cm. 
 
 
Reconstruction 
The major limitation of reducing tube energies to save dose is the subsequent increase 
in noise[57] – lower energy photons are less likely to penetrate tissue, instead being 
scattered. Noise is also an issue inherent to the process of image reconstruction using 
the original method of filtered back projection. With this technique, the passage of x-
rays through a structure creates attenuation profiles called ray sums, a process known 
as forward projection. These profiles are then projected back across the image space. 
This cycle is repeated at a number of different angles to create the composite, back 
projected, image. In the course of this image construction significant artefact is 
introduced and this needs to be removed using a filter, or kernel. The filters are 
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mathematically modelled on the CT process and, for computational simplicity, include 
many simplified assumptions about the scanning process, for example the size and 
shape of the x-ray beam and focal spot, which are assumed to be infinitely small 
points. This makes data processing easier at the expense of accuracy, and introduces 
noise. Recently, novel reconstruction techniques have been developed with more 
sophisticated mathematical modelling, performed repeatedly on the filtered data via a 
series of iterations. These iterative reconstruction (IR) processes result in fewer 
assumptions and less noise and while this does not reduce dose directly, it facilitates 
the use of lower tube energies while maintaining an acceptable level of image noise, 
because the noise from the reconstruction process has been reduced.[34] IR also 
improves tissue analysis characteristics, particularly the reduction of artefact, so image 
quality may even improve despite the reduced dose.[57] The introduction of IR into 
cardiac CT imaging has facilitated a halving of the radiation dose.[34] 
 
The next logical development is to attempt to accurately model the entire CT 
acquisition process. Model-based reconstruction is computationally demanding, 
making no assumptions about the scanner or physical characteristics of the scan, but 
instead modelling each detail of the optics of the CT system accurately, with the 
promise of dramatically improved image quality for even less dose. Early work applying 
these techniques to thoracic imaging have suggested that some CT procedures may be 
achievable for a radiation dose comparable to a plain chest radiograph[58] and may 
improve the visualisation of coronary plaque.[59] 
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Service evaluation 
With even controversial evidence of potential harm but various options to mitigate 
this, scrutiny of cardiac imaging providers is an essential component of both safety and 
quality improvement programmes.[53] As postulated, dose reduction cannot be at the 
expense of diagnosis, as this would render the investigation futile, but ensuring doses 
are kept as low as reasonably possible is vital. Radiation doses for particular 
examinations vary considerably between centres[60] and the landmark PROTECTION 1 
study confirmed that cardiac CT was no different.[61] The investigators identified a 6-
fold difference in dose between sites, according to the available technology and image 
acquisition protocols. Centres embarking on active quality improvement programmes 
can derive significant reductions in dose.[62] Together, these findings suggest that 
significant improvements in both technique and dose optimisation could be made, and 
the move by national authorities to survey and report on the undertakings of their 
members[63] will begin to facilitate this. A programme of education, for providers and 
patients, multi-professional collaboration, audit and further research into the effects 
of radiation and techniques to optimise safety are required.[40] 
 
1.4 Dual energy CT 
The arrival of dual-energy computed tomography has provided a plethora of novel CT 
applications, not least for cardiac imaging. The ability to simultaneously interrogate 
the same structures with two x-ray energies simultaneously not only improves the 
assessment of solid state materials such as coronary plaque or myocardial scar but, by 
exploiting the properties of contrast, also makes feasible the assessment of perfusion 
and blood flow characteristics.   
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Conventional multidetector CT generates a continuous stream of polychromatic 
Bremsstrahlung from the rotating anode.[64] The programmed tube voltage selected 
by the operator refers to the maximum energy of the photons produced, below which 
there is a spectrum of lower energies. The use of filters can enable further refinement 
of the x-ray beam, but this remains polychromatic, with the average x-ray energy of 
the beam approximately one-third of the maximal tube voltage (kVp). 
 
The passage of x-rays through tissue depends on both the energy of the photons and 
the interaction thereof. The photoelectric effect, which increases with the atomic 
number of a material, is of little consequence traversing most intrathoracic structures, 
but in dense calcification or intravascular contrast, significantly increases photon 
absorption. This effect is exploited by the use of substances exhibiting the maximal 
photoelectric influence (up to that of caesium, due to its electron shell configuration) 
with the use of contrast materials containing iodine or barium. While the photoelectric 
effect with calcium is less than these heavier metals, due to an emptier electron K 
shell, it remains greater than that of organic material, nitrogen or oxygen. 
 
Of course the varying attenuation properties of different materials are what provide 
the delineation between tissue structures required to make CT imaging feasible. 
However, the lower energy photons required to maximise the contrast between 
materials are absorbed by heavier substances such as calcium and iodine, such that the 
x-ray beam is ‘hardened’. This reduces the tissue contrast beyond the structure and 
may also change the apparent overall material property; creating artefacts overlying 
the soft tissue which hinder accurate analysis. 
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Dual energy CT (DECT), or spectral imaging, uses two distinct photon spectra in an 
attempt to better interrogate tissues, gaining the benefits of contrast at lower energy 
and of overcoming artefact with higher energy. The use of 80 and 140 kilovoltage 
peaks (kVp) provides maximal difference and least overlap between spectra, within 
clinically useful and technically achievable parameters. Below 80 kVp most spectra will 
be excessively absorbed and technological limitations currently prohibit routine use of 
greater energies than 140 kVp. 
 
Image acquisition techniques 
Current systems generate images using the entire profile of detector fluorescence 
created by photon arrival. There is no clinically available technology to identify the 
energy of these photons as they arrive at the detector, although this may be available 
in future,[64][65] for example by using multi-layer detectors. This means that at 
present scanners must either use two distinct x-ray sources with paired detectors, or 
vary the timing of generation and detection of particular spectra in order to distinguish 
between them. 
 
This is of particular relevance to cardiac CT, where temporal resolution is of prime 
importance. The near-constant motion of the cardiac structures requires almost 
simultaneous acquisition of data at the respective energies to ensure a consistent 
region is accurately imaged. This prohibits the application of sequential imaging to 
cardiac CT, whereby a scan is undertaken twice, at different tube energies. 
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Both alternative methods are currently employed in DECT scanners. Dual source 
imaging uses the two-source/two-detector approach. With rapid gantry rotation, two 
energy spectra can be used simultaneously, although the precise accuracy of this is 
theoretically questionable, as the orientation of image acquisition or timing thereof, 
must be distinct.[66] Furthermore, the need to fit two sources and detectors into the 
gantry requires miniaturisation of the second system, which significantly limits the 
potential field of view. One further limitation of this approach to dual-energy imaging 
is the risk of scatter, with the potential for photons from one detector to be received 
by that of the other. Modern scanner iterations employ computing technologies to 
recognise and compensate for this phenomenon. 
 
It is possible to image the body using a single source and still achieve dual energy 
analysis. X-ray tubes are capable of rapid oscillation between energy spectra,[67] the 
timing of which can be analysed so that detected photons can be appropriately 
attributed. Traditionally, this meant that the gantry rotation speed had to be slowed to 
permit sufficient time for data acquisition. Newer detector materials permit acquisition 
with kVp alternating at 5 kHz,[67] reducing the temporal resolution so important to 
cardiac imaging. This method may incur a greater dose penalty, due to its inability to 
utilise dose reduction features such as tube current modulation or optimal 
filtration.[64] 
 
Monochromatic imaging & material decomposition 
Two major outputs from dual energy CT have been utilised for a wide range of clinical 
applications. Images can be produced as if they were generated from a pure, 
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monochromatic beam of photons of a single energy (keV), rather than from the reality 
of a polychromatic beam with a designated peak energy (kVp). Virtual monochromatic 
images can be synthesised at a range of keV values, which can reduce beam hardening 
artefact and improve the measurement of attenuation.[66] Clinically, high keV images 
can be used for reducing artefact from metal implants, calcification or pools of 
contrast, while lower keV datasets improve soft tissue contrast to allow visualisation of 
soft tissue[68] or atheroma. 
 
Basis material decomposition has been explored for almost 40 years.[69] This 
technique exploits the different attenuation coefficients of substances at differing 
photon energies and, by referencing the attenuation effects of known substances, for 
example iodine and water, is able to model other materials. This permits the 
identification of particular materials such as bone, or vascular calcium, which can then 
be subtracted from the image[70], or may facilitate the identification of the 
composition of stones[71], or even the characteristics of tumours.[72] By subtracting 
iodine it is possible to generate both an enhanced and a ‘virtual’ non-enhanced 
dataset from a single contrast acquisition.[66] 
 
In systems using rapid energy switching, basis material decomposition is performed in 
the projection domain, but with dual source systems, where the two datasets are not 
as closely temporally aligned, this occurs in the image domain.[66] While 
reconstruction of the raw data generally confers better image quality, it relies on 
precisely aligned datasets, which are not always achievable with dual source 
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technology.[73] To date there has been little research comparing what, if any, impact 
these differences have on the clinical application of these technologies. 
 
1.5 Calcium 
The presence of coronary calcium is a well established marker of the potential for 
intraluminal coronary atheroma, but it is also a major limiting factor for cardiac CT. 
Increasing awareness of coronary calcium among radiologists has led to its presence 
being reported in non-cardiac investigations (Figure 3), particularly in smokers or those 
with dyspnoea undergoing thoracic CT. It presence and distribution are now crucial to 
image quality with modern cardiac CT, particularly for coronary imaging. Its relevance 
to clinical practice and its influence on technological developments are fundamental to 
this thesis and so a brief overview of coronary calcification will be outlined here. 
 
Various studies have examined the relationship between the calcium score and both 
radiological[74] and histological[75] measures of atherosclerotic plaque burden, 
including at invasive coronary angiography.[76,77] The location of plaque does not 
necessarily correspond directly to clinically relevant stenosis, due to compensatory 
remodelling of affected arteries[78] (Figure 4). In addition, most acute coronary events 
occur due to soft plaque rupture rather than stenosis, which is less likely in calcified 
artery, but there is evidence that calcified plaques colocalise with the more rupture-
prone atheroma.[79] This is particularly important for the negative predictive value of 
calcium scoring. Because calcification occurs late in the healing phase of 
atherosclerosis, non-calcified plaque and stenosis may be present in patients without 
coronary calcium. In particular, younger or diabetic populations,[80] where this 
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process may not have yet occurred or occur slowly due to poor healing, may have rates 
of significant atheroma as high as 20%.[81] 
 
 
Figure 3 
Incidental coronary calcification. Image from an ungated CT pulmonary angiogram 
demonstrating the incidental presence of extensive calcification of the left main stem, 
left anterior descending and proximal circumflex arteries 
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Figure 4 
Expansile remodelling of calcified coronary atheroma (arrow). Despite a large plaque 
there is little impingement on the coronary artery lumen. 
 
The presence of coronary calcium is therefore reflective of overall vascular health 
rather than demonstrating specific culprit lesions. Measurement of the burden of 
arterial calcium is utilised widely in the assessment of patients presenting with chest 
pain of potential cardiac origin, and features in international guidelines for this 
purpose.[82,83] There is also evidence supporting its use for prognostication in 
asymptomatic patients. The presence of any coronary calcium is associated with a 
significantly higher rate of death, myocardial infarction or need for coronary 
revascularisation than having none,[84,85] and the degree of risk correlates with the 
overall arterial burden.[86][87] 
 
The most widely used method of quantifying coronary calcium is the Agatston score, 
using a standardised, ECG-gated, non-contrast acquisition, which has been in use for 
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over 20 years.[88] Although based on evidence from electron-beam CT (EBCT) its 
validity has broadly been accepted in modern multi-slice scanners[82,89] despite only 
limited evidence[90] and a lack of robust clinical trials. Most CT technology employs 
semi-automated software to calculate the Agatston score with minimal effort to 
provide a numerical value. 
 
Artefact from calcification 
As previously mentioned, the landmark study examining the utility of 64-multidetector 
row CT was ACCURACY (Assessment by Coronary Computed Tomographic Angiography 
of Individuals Undergoing Invasive Coronary Angiography).[91] A subgroup analysis of 
patients with severe coronary artery calcification (Agatston score more than 400 units) 
demonstrated significant drop off of the accuracy of CT, a phenomenon which has 
been replicated repeatedly. One large systematic review and meta analysis found that 
for patients with an Agatston score between 400 and 1000 the per-patient sensitivity 
of CT to detect significant atheroma was 0.99 but the specificity was 0.84. With 
Agatston scores above 1000 sensitivity was maintained at 0.98 but the specificity fell 
to 0.51. 
 
The reason that CT performance falls in the presence of calcium is the metal’s density 
and the artefacts that it creates. Recalling the explanation of dual energy CT above, 
lower energy x-rays are important to help differentiate between different materials 
but are readily absorbed by dense structures, including calcium. This has the effect of 
‘hardening’, or increasing the energy of, the x-ray beam. This reduces the available 
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contrast in the tissues surrounding the calcium and creates image artefacts that can be 
misinterpreted or can obscure the area of interest. 
 
The other major limitation is partial volume artefact, where tissues of markedly 
differing density are projected onto the same voxel. The scanner is unable to 
differentiate between the structures and the image created depicts the highest density 
material. This can lead to overestimation of the volume of calcium present, known as 
‘blooming’ artefact (Figure 5). Partial volume artefacts have been reduced in general 
CT with improved spatial resolution, but cardiac imaging requires such resolution at 
the very limits of scanner technology and the small structures and measurements 
involved means that blooming artefact remains a problem, particularly with 
conventional scanner technology. 
 
 
Figure 5 
Schematic representation of the principles of partial volume, or blooming, artefact. A 
highly dense object is scanned (A) and the CT scanner creates an image in a series of 
voxels (B). If each voxel represents the smallest volume that the scanner can distinguish 
then voxels which only partially contain high density material may be misinterpreted as 
entirely containing high density material (C). Even if filtering is applied, the result is a 
much larger image than the object itself (D). 
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1.5 Current uses of cardiac CT 
The use of cardiac CT is increasingly widespread and the breadth of indications is also 
expanding. At the time of writing there are two sets of international appropriate use 
criteria in existence; from the United States[92] and Korea[93] (Tables 1 and 2). 
Written in 2006 and 2015, respectively, they reflect the rapid progress in CT 
technology over that 9 year period.  
 
The predominant application of cardiac CT is for non-invasive coronary angiography. 
There is currently no other modality which can achieve sufficient image resolution in a 
non-invasive manner and the risks of coronary angiography are increasingly apparent 
and do not appear reducible.[94] The risk in patients with coronary artery bypass 
grafts are higher still.[95] CT is also significantly cheaper than invasive 
angiography.[96] 
 
There is not universal agreement on the patients who should undergo a CT angiogram. 
Both international appropriate use guidelines recommend its use in patients of 
intermediate risk[92,93] – that is to say, those patients in whom the clinical history and 
risk factor profile place them in an intermediate pre-test stratum for the risk of 
obstructive coronary artery disease.[97] In the United Kingdom, NICE Clinical Guideline 
95 recommends CT for use only in patients deemed at low clinical risk.[82] This is 
mainly due to the limited positive predictive value of CT in patients in the higher risk 
groups, due in turn to the high prevalence of severe coronary calcification in this 
cohort. This is particularly relevant as NICE Diagnostics Guideline 3, recommending the 
use of new generation CT scanners for the difficult to image patient, did not revisit 
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these criteria and therefore the recommended use of new technology for challenging 
patients is limited to coronary artery assessment in this low risk group.[98]  
 
 
American 2006 Guideline[92] 
Coronary artery assessment 
 Chest pain, with intermediate pre-test probability 
 Chest pain, with equivocal stress test 
 Assessment of coronary anomalies 
 
? Chest pain syndromes in patients who have previously undergone coronary 
artery bypass grafting or percutaneous coronary intervention 
? Chest pain with low pre-test probability, or intermediate probability and 
unsuitable for exercise tolerance test 
? High-risk, asymptomatic patients 
 
 Asymptomatic patients of low or intermediate risk 
Cardiac anatomy 
 Pulmonary vein anatomy prior to ablation for atrial fibrillation 
 Cardiac venous anatomy prior to biventricular pacing  
 Repeat cardiothoracic surgery – to assess access and risk of iatrogenic injury 
 Complex or vascular congenital heart disease 
 Evaluation of cardiac masses (as a second line investigation) 
 Anatomical assessment of the pericardium (as a second line investigation) 
Cardiac (myocardial and valvular) function 
? Left ventricular in the context of heart failure or coronary artery disease (as a 
second line investigation) 
? Native and prosthetic valvular function (as a second line investigation) 
Table 1 
Abbreviated summary of the ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 
Appropriateness Criteria for Cardiac Computed Tomography.  - Appropriate 
indication; ? – Uncertain appropriateness;  - Inappropriate indication. 
 
 
  
55 
 
Korean 2015 Guideline[93] 
Coronary artery assessment 
 Chest pain, with low to intermediate pre-test probability 
 Chest pain syndromes in patients who have previously undergone coronary 
artery bypass grafting 
 Chest pain syndromes in patients who have previous undergone percutaneous 
coronary intervention to the left main stem, or other major artery more than 
3 mm diameter 
 Chest pain syndromes with normal coronary arteries at invasive angiography 
 Chest pain requiring triple rule out* 
 Chest pain following equivocal or discordant stress testing 
 Assessment of heart failure (if low risk of coronary artery disease) 
 Screening prior to non-coronary cardiac surgery 
 Prior to complex percutaneous coronary intervention, including chronic total 
occlusions 
 History of Kawasaki’s disease 
 
? Screening of asymptomatic individuals if intermediate risk  
? Investigation of ventricular tachycardia 
? Investigation of syncope 
 
 Chest pain, with high pre-test probability 
 Inappropriate for the assessment of the aetiology of new atrial fibrillation 
Cardiac anatomy 
 Pulmonary vein anatomy prior to ablation for atrial fibrillation 
 Cardiac venous anatomy prior to biventricular pacing  
 Other percutaneous cardiac procedures (such as device closure), to confirm 
anatomy 
 Repeat cardiothoracic surgery – to assess access and risk of iatrogenic injury 
 Complex or vascular congenital heart disease 
 Evaluation of cardiac masses 
 Anatomical assessment of the pericardium 
Cardiac (myocardial and valvular) function 
 Left ventricular function where other imaging modalities are unsuitable 
 Right ventricular function 
 Valvular function (as a second line investigation) 
 Prosthetic valve dysfunction  
 
? Left ventricular function as a first line test in the context of heart failure or 
coronary artery disease 
? Myocardial viability where other modalities are not suitable 
*Triple rule out: the exclusion of obstructive coronary artery disease, acute aortic 
syndrome and pulmonary emboli in a single examination 
Table 2 
Abbreviated summary of the Korean Guidelines for the Appropriate Use of Cardiac CT. 
 - Appropriate indication; ? – Uncertain appropriateness;  - Inappropriate indication. 
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While assessment of coronary artery disease remains the major application for cardiac 
CT,[99] its use is of course not restricted to arterial pathology. Playing to its strengths, 
CT is therefore commonly used to rule out ischaemic heart disease as a cause of 
cardiomyopathy, either with calcium scoring[100] or, considering the limited sensitivity 
of calcium scoring due to the wide slice thickness used, lower prevalence of calcific 
disease in young and diabetic patients[80] particularly, and its inability to confirm 
stenotic coronary disease, CT coronary angiography. Both 16-slice[101] and 64-slice 
CT[102,103] can discriminate between ischaemic and non-ischaemic causes in patients 
with a dilated cardiomyopathy phenotype, with one meta-analysis suggesting a pooled 
summary estimate of 98% sensitivity and 97% specificity for the diagnosis of ischaemic 
cardiomyopathy using CTCA.[104] The gross morphology is non-specific, with 
ventricular dilatation and dysfunction, myocardial thinning and, although less 
commonly, intramyocardial fat, and so can make this distinction otherwise 
challenging.[105] 
 
The widespread use of both contrast angiography and unenhanced imaging for 
coronary assessment means that there is extensive work examining the consequences 
of ischaemia and infarction with CT. Rudimentary blood flow imaging, simply observing 
myocardial density following contrast delivery, can be achieved with standard CT[106] 
and areas of hypoattenuation can often be seen in patients with significant CAD. This is 
not entirely straightforward as apparent hypoperfusion may be the result of beam-
hardening artefact, which is best refuted using multiphase examination, but doing this 
increases the radiation exposure. Further evaluation of ischaemic sequelae can be 
achieved by undertaking deferred scanning, at an interval following contrast 
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administration. Delayed enhancement can be identified in a similar manner to late 
gadolinium enhancement with cardiac MRI. In combination with CTCA, the presence of 
scar adds additional accuracy to the diagnosis of ischaemic cardiomyopathy.[103] At 
present, assessment of myocardial viability with CT is predominantly a research tool 
and there is uncertainty about recommending its use in clinical settings. 
 
In 2010 an expert panel of the American College of Cardiology also outlined potentially 
emerging uses for CT.[7] These included improved assessment of coronary atheroma, 
both in terms of the overall vascular burden of atherosclerotic plaque and the 
identification of ‘vulnerable’ plaque, which may be at greater risk of rupture. It also 
suggested myocardial assessment for hypoenhacement following myocardial 
infarction, which has just been described. Finally the statement acknowledged that 
there remained a lack of consensus about the use of CT for screening asymptomatic 
patients with a high pre-test probability of coronary stenosis, and the use of the triple 
rule out test, a single-examination assessment for coronary artery disease, acute aortic 
syndrome and pulmonary emboli. 
  
1.6 Approaching the ‘difficult-to-image’ patient 
The ‘difficult-to-image’ patient was a concept illustrated by the National Institute of 
Health and Clinical Excellence (NICE) in its 2013 technology appraisal of ‘new 
generation’ scanners.[98] The development of scanners had, to this point, been largely 
comparable between manufacturers with each iteration of scanner offering additional 
detector rows or image slices.[107] The range of new generation scanners has seen 
notable diversity in technology including novel detector materials, improved spatial 
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resolution, improved temporal resolution and wider detector coverage to address 
previous technological limitations.[98] 
 
It is an interesting concept as it suggests two somewhat paradoxical ideas about the 
current capabilities of cardiac CT – that it is so advanced as to make its widespread use 
conventional, and yet it is insufficiently advanced as to allow its unrestricted 
application to all patients and situations. In practice of course this simply reflects the 
development of the technology, but it might be argued that the fact that NICE has 
identified a small group of patients in which imaging with CT remains challenging is in 
fact illustrative of just how far CT has been developed and how widely it can be used. 
 
 In particular NICE identified spatial resolution, low contrast detection, noise artefacts 
and higher levels of radiation to be the major shortfalls of conventional scanners and 
reflected this in its list of the patients in whom imaging with conventional scanners has 
been demonstrated to be challenging. These include: 
 obesity  
 high levels of coronary calcium (calcium score greater than 400)  
 arrhythmias  
 high heart rates 
 stents  
 previous coronary artery bypass grafts 
 
These can be further grouped into broad themes or difficulties and it is useful to 
combine the technological limitation with its in vivo challenges in order to understand 
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the clinical importance of these issues. The difficulties of coronary calcification, due to 
limited spatial resolution, beam hardening artefact and partial voluming (or blooming) 
have been discussed previously. The same issues arise in patients with previous bypass 
grafts, where evaluation of both the surgical grafts and the native coronary arteries is 
required. In fact, the former are generally well visualised with conventional CT[108–
111] but the native vessels tend to be heavily calcified, limiting the diagnostic 
performance of CT in this cohort. Stents present similar challenges, in that the high-
density materials used to construct them leads to significant beam hardening and 
blooming artefacts which prohibit satisfactory visualisation of the coronary lumen, 
particularly in smaller stents.[112] The consideration of all such artefact and its 
detriment to coronary visualisation will be considered. 
 
High heart rates and arrhythmia may also be linked in terms of the technological 
challenges they present. These are generally motion artefact and misregistration 
artefact. The former is encountered in patients with relative tachyarrhythmias where 
the heart rate cannot be suitably controlled – such clinical scenarios may include 
patients in whom beta-receptor antagonist drugs (beta-blockers) are contraindicated, 
patients with atrial fibrillation where the high heart rate may be relatively refractory to 
pharmacotherapy or situations where it is difficult to isolate part of the cardiac cycle 
where cardiac motion is minimised. This last issue is one reason that retrospective 
gating may be preferred in some patients with tachycardia, despite its higher radiation 
burden, as phase selection can be achieved more reliably. The issue of misregistration 
artefact arises due to the need to image an entire organ with detectors that do not 
fully cover it, instead relying on accurate imaging in ‘slabs’ through the heart over a 
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number of cardiac cycles which are then digitally assembled to create a whole heart 
reconstruction. Again, atrial fibrillation can be challenging as it is difficult to predict the 
timing of cardiac motion in such an irregular, chaotic arrhythmia. 
 
Obesity presents a number of challenges for CT operators. Image quality is 
impaired[113] due to increased photon attenuation and scatter by fat, which leads to 
increased image noise. As discussed in chapter 1.2 above, reducing noise in this 
context requires an increase in photons reaching the detector, which can be achieved 
by increasing the tube energies. This in turn increases the radiation exposure to the 
patient. Furthermore, by improving the penetration power of photons (by increasing 
the kVp) the effects of beam hardening are accentuated.[114] 
 
In addition to identifying solutions to these specific problems, an alternative approach 
would be to change the way in which we use CT. The use of CT to examine the heart 
beyond the coronary arteries has already been outlined and assessment of the 
myocardium can give clues about the underlying coronary vessels. For example, the 
identification of abnormal myocardium due to scarring following infarction, or the 
abnormal uptake of contrast medium due to impaired downstream tissue perfusion 
can both highlight problems with coronary artery patency. Following on from this, it 
may be possible to generate so-called functional information, that is to say information 
about the working of the heart and its blood supply rather than its anatomical 
appearance, from CT images. 
 
This thesis will consider initial explorations into all of these approaches. 
61 
 
 
 
 
 
 
 
Section 2 – Artefact from high-density material 
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2. High-definition CT 
2.1 Introduction 
 
By rapidly altering the x-ray focal spot in the horizontal, or z axis, (a technique referred 
to as focal spot ‘wobble’), the high definition scanner can acquire significantly more 
data with each gantry rotation, thereby improving spatial resolution. The use of novel 
image reconstruction methods, now widely recognised to facilitate a reduction in the 
ionising radiation requirements of CT,[115] can be incorporated into high-definition CT 
(HDCT) scanning to offset the otherwise increased dose necessitated by higher tube 
energies. Furthermore such iterative reconstruction algorithms also reduce image 
noise compared to traditional filtered-back projection (FBP) techniques (see Chapter 
1), which may provide additional image quality optimisation. 
 
While appealing, these concepts have not been widely explored in clinical practice. 
This study therefore aimed to investigate the diagnostic performance of HDCT with 
dose optimisation and iterative reconstruction in the evaluation of significant coronary 
artery disease, using invasive coronary angiography (ICA) as the reference standard. 
 
2.2 The study 
Materials and methods 
Patients and design 
This study was a prospective, diagnostic accuracy trial, conducted at a single, high-
volume, tertiary cardiothoracic centre (Derriford Hospital, Plymouth, UK). Consecutive 
patients undergoing invasive coronary angiography, with a high pre-test risk of 
coronary artery disease (as assessed by a consultant cardiologist), previously treated 
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(percutaneously or surgically) coronary disease, or stable patients admitted with an 
acute coronary syndrome were screened and enrolled. Exclusion criteria were patient 
under 40 years old, those requiring immediate percutaneous coronary intervention, 
elevated serum creatinine (>135 mmol/L) or estimated glomerular filtration rate 
<30ml/min/1.73m2, contrast induced nephropathy, permanent or persistent atrial 
fibrillation, New York Heart Association class III or IV heart failure, severe aortic 
stenosis, contraindication to beta-blockade, pregnancy or body mass index >33/m2. 
Patients unable to hear or understand English were also excluded. 
 
The study was undertaken in accordance with the Declaration of Helsinki and approved 
by our instutitional research and development team and a committee of the UK 
National Research Ethics Service, and was registered as a clinical trial (NCT01946737). 
Patients provided informed, written consent. 
 
Blinding 
Following the clinical reporting of both investigations, the images were anonymised, 
assigned study numbers and stored digitally offline for investigative reporting. ICA 
images were reported by two experienced, independent readers. HDCT images were 
reported by two other, independent readers with extensive CTCA experience. 
Discrepancies were resolved by consensus. 
 
Procedures 
ICA was undertaken in accordance with standard clinical practice (Allura XPer FD10, 
Philips Healthcare, Best, Netherlands). Each coronary artery was visualised in at least 
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two orthogonal planes using standard projections, with additional views undertaken 
for overlapping segments or unusual anatomy. Stenosis assessment was facilitated 
with proprietary quantitative coronary analysis software (View Plus, Sanders Data 
Systems, California, USA). 
 
All patients underwent two sequential CT acquisitions (coronary artery calcium scoring 
and coronary angiography) within 28 days of ICA with a 64-slice high definition scanner 
(Discovery HD-750, GE Healthcare, Milwaukee, USA). Patients with a heart rate greater 
than 60 beats per minute received intravenous metoprolol, in 2.5 – 5 mg aliquots to a 
maximum of 60 mg, to achieve a target heart rate of less than 60 beats per minute. 
Calcium scoring was performed using prospective ECG gating in 3-4 sets of non-
overlapping, axial slices with 4 cm z-axis coverage, 80, 100, or 120 kV tube voltage 
according to body mass index and 300 mAs tube current. CTCA was performed in high 
definition mode using prospective ECG gating, 350 ms gantry rotation speed, 64 x 
0.625 mm slice collimation, 100 kV tube voltage, and fixed tube current according to 
body mass index (BMI < 22.5 kg/m2: 450 mA,  BMI 22.5 – 24.9 kg/m2: 500 mA, BMI 
25.0 – 27.4 kg/m2: 600 mA, BMI 27.5 – 30 kg/m2: 700 mA, BMI >30 kg/m2: 800 mA). 
Additional tube-on time (padding) of up to 200 ms was used at the discretion of the 
supervising clinician for patients with heart rate variability, according to standard 
departmental protocol, with 100 ms added for heart rate variability or 200 ms for 
heart rate 60 – 65 bpm despite beta blockade. A multi-phase contrast injection 
protocol was used with 100 ml (125 ml for patients with coronary bypass grafts) of 
Optiray 350 (Ioversol, Mallinkrodt Inc, MO, USA), initially at 6.5 ml/sec reducing to 5.5 
ml/sec over 17 seconds, followed by 70 ml of saline flush at 5.5 ml/sec, using a 
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standardised protocol. Raw CT data was reconstructed using a combination of 40% 
Adaptive Statistical Iterative Reconstruction (ASIR) and 60% filtered back projection. 
 
Assessment was undertaking using the standardised, American Heart Association 
coronary model in both modalities.[116] All coronary artery segments larger than 1.5 
mm diameter were evaluated for stenoses which were graded using an ordinal scale 
(normal, < 50% stenosis [mild], 50 to 70% stenosis [moderate], greater than 70% 
stenosis [severe] and absence of opacification [occluded]). Segments with more than 
one stenosis were graded according to the greatest stenosis. Segments distal to an 
occlusion were excluded from the analysis. Inter-reader differences in stenosis 
assessment were resolved by a third expert in the relevant modality.  
 
On CT, all coronary artery segments were assessed for image quality using a 4-point 
Likert scale: 4 = good image quality, no artefacts; 3 = adequate image quality; 2 = 
suboptimal image quality; 1 = non-diagnostic). All segments of non-diagnostic image 
quality were labelled as significantly stenosed on an intention-to-diagnose basis. 
 
The primary outcome was the diagnostic accuracy of the high definition CT protocol to 
detect moderate stenoses (>50%) as defined by invasive angiography, which is the 
general degree of accuracy assessed by most diagnostic coronary imaging studies. 
Further analyses evaluated the diagnostic accuracy for severe stenosis (>70%, which 
may be more specific for functionally significance, although it is now widely accepted 
that stenosis alone is a poor predictor of functional significance[117]) and the radiation 
dose. The radiation dose was recorded from the scanner dose report, expressed as 
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dose-length product (DLP) in milligray-centimetres. The effective dose was calculated 
using a cardiac-specific conversion factor in accordance with previously published data 
from our institution.[36] 
 
Statistical analysis 
Patient demographics were assessed graphically for distribution and presented using 
means or medians as appropriate. Mortality was compared using Fisher’s exact test. 
Diagnostic accuracy was calculated for four groups: all stented segments (per-
segment), for all patients with stents (per-patient), for all native segments in patients 
with previous bypass grafts (per-segment), and for all patients with previous grafts 
(per-patient). Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were all calculated with 95% confidence intervals. Two-tailed P 
values <0.05 were considered significant. Cohen’s kappa was used to compare 
intermodality agreement, and interobserver agreement for CTCA. Statistical analysis 
was performed using MedCalc (v13.2, MedCalc Software, Belgium). 
 
Patient follow-up 
Clinical outcomes were evaluated at one year, using the hospital admissions system 
and the patient’s clinical notes. 
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Results 
Of 486 patients screened for inclusion in the study, 350 patients were eligible 
according to the study criteria. 48 patients did not consent and two patients, who 
were excluded due to dysrhythmia on the day of the CTCA, withdrew consent. Thus 
300 patients were included in the final analysis. No patient was excluded due to 
suboptimal CTCA scan, on an intention to diagnose basis. 
 
Table 3 illustrates the baseline characteristics of the patients included in the study. The 
prevalence of significant coronary artery disease, defined by the presence of at least 
one stenosis of > 50%, was 69%. 215 (72%) patients had a high pre-test probability of 
significant coronary disease and 85 (28%) patients had established coronary artery 
disease which was previously treated either percutaneously or surgically (62 patients 
had stents, 20 had coronary bypass grafts and three had both). 
 
The median time between CTCA and ICA was 12 days (range 1 – 28). There were no 
serious adverse events and all patients completed the study protocol, undergoing 
unenhanced, low-dose calcium score scanning and prospectively-gated CTCA. This 
required aggressive heart rate control with 206 (69%) patients requiring intravenous 
metoprolol prior to the scan and 49 patients (16%) receiving more than 30 mg. A small 
proportion (10%) of scans required additional tube-on time (padding), to enable 
evaluation of multiphase dataset, reducing the number of non-diagnostic studies due 
to beat-to-beat heart rate variability during image acquisition. Full CTCA characteristics 
are described in Table 4. 
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Patient baseline characteristics Value 
Age in years – median (interquartile range) 66 (60-73) 
Gender – Male (%) / Female (%) 
225 (75%) / 75 
(25%) 
Body mass index - median (interquartile range) 
< 20 – n (%) 
20-24.9 – n (%) 
25-29.9 – n (%) 
>30 – n (%) 
27 (25-28) 
7 (2%) 
79 (26%) 
176 (59%) 
38 (13%) 
Chest pain 
Unstable angina - n (%) 
Stable or single episode - n (%) 
 
24 (8%) 
276 (92%) 
Hypertension - n (%) 278 (93%) 
Diabetes - n (%) 35 (12%) 
Hypercholesterolemia - n (%) 248 (83%) 
Smoking 
Current - n (%) 
Past history - n (%) 
Non-smoker - n (%) 
 
123 (41%) 
102 (34%) 
75 (25%) 
Family history of CAD - n (%) 85 (28%) 
NYHA Status 
Class I – n (%) 
Class II – n (%) 
 
227 (76%) 
73 (24%) 
Previous heart failure – n (%) 15 (5%) 
Previous stroke – n (%) 3 (1%) 
Previous myocardial infarction – n (%) 44 (15%) 
Previous percutaneous intervention – n (%) 65 (22%) 
Previous Coronary bypass grafting – n (%) 23 (8%) 
Table 3 
Baseline characteristics of patients included in the study of high definition CT coronary 
angiography.  
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CTCA characteristics Value 
Time from ICA to CTCA in days – median (interquartile range) 12 (1-24) 
Heart rate 
Baseline – median (interquartile range) 
Acquisition – median (interquartile range) 
Beat-to-beat variability at acquisition – n (%) 
 
65 (58-74) 
57 (52-60) 
37 (12%) 
Beta-blocker 
Previous oral – n (%) 
Intravenous – n (%) 
 
119 (40%) 
206 (69%) 
Beta-blocker dose – median (interquartile range) 
<10 mg – n (%) 
11-30 mg – n (%) 
>30 mg – n (%) 
9 (0-21) 
88 (29%) 
69 (23%) 
49 (16%) 
Agatston calcium score – median (interquartile range) 
<400 - n (%) 
400-999 - n (%) 
>1000 - n (%) 
587 (110-1435) 
121 (40%) 
71 (24%) 
108 (36%) 
Tube current – mA – median (interquartile range) 800 (740-800) 
Padding – median (interquartile range) 
None – n (%) 
100 msec – n (%) 
200 msec – n (%) 
 
269 (90%) 
1 
31 (10%) 
Dose length product – milligray-centimetre (mGy·cm) 151 (150-253) 
Effective dose – milliSieverts (mSv) 4.2 (4.2-7.1) 
Table 4 
Characteristics of acquisitions for high definition CT coronary angiograms 
 
 
The median radiation dose for CTCA was 151 mGy-cm (IQR 150-253) which translated 
to a median effective dose of 4.2 mSv (IQR 4.2-7.1) using a CTCA specific conversion 
factor (k = 0.028 mSv/mGy·cm). 
 
For the primary outcome measure data was analysed on patient, coronary vessel and 
coronary segment levels. The image quality was excellent in a majority of coronary 
artery segments. 4248 coronary artery segments were analysed on both ICA and CTCA. 
4116 (96.9%) segments demonstrated diagnostic quality on CTCA, while 132 (3.1%) 
segments were considered non-diagnostic. The diagnostic performance of CTCA on a 
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per-patient and per-vessel basis is detailed in Tables 5 and 6. For 50% stenosis the per-
vessel sensitivity of HDCT was 96.1% (95% confidence interval 93.8 – 97.7), specificity 
98.8% (97.8 – 99.5), positive predictive value 97.9% (96.0 – 99.0) and negative 
predictive value 97.8% (96.5 – 98.7). 
 
Patient Level 50% stenosis  70% stenosis 
 Value 95% CI  Value 95% CI 
Sensitivity 97.0 93.8 – 98.9  98.9 96.0 – 99.8 
Specificity 97.9 92.5 – 99.7  93.4 87.5 – 97.1 
PPV 99.0 96.4 – 99.8  96.6 91.6 – 98.1 
NPV 93.9 87.1 – 97.7  98.3 93.9 – 99.7 
Table 5 
Accuracy of high definition CT coronary angiography on a per-patient basis. 
 
 
Vessel Level 50% stenosis  70% stenosis 
 Value 95% CI  Value 95% CI 
Sensitivity 96.1 93.8 – 97.7  98.8 96.9 – 99.7 
Specificity 98.8 97.8 – 99.5  96 94.4 – 97.2 
PPV 97.9 96.0 – 99.0  90.2 86.6 – 93.0 
NPV 97.8 96.5 – 98.7  99.5 98.8 – 99.9 
Table 6 
Accuracy of high definition CT coronary angiography on a per-vessel basis. The vessels 
have been assessed as left main stem, left anterior descending, circumflex and right 
coronary arteries. Branch vessels are included in the main vessel analysis. 
 
The weighted Kappa value for agreement between two independent readers on high-
definition CTCA was 0.99. 
2.3 Discussion 
This study demonstrates that with high definition technology, CT coronary angiography 
is a highly accurate diagnostic test, comparable to invasive coronary angiography, with 
sensitivity and specificity greater than 95% for 50% stenosis at both patient and vessel 
level.  
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Furthermore, HDCT maintains its accuracy across a range of vessel stenoses. 
Differentiating between moderate and severe lesions is frequently challenging in 
clinical practice, but the sensitivity and specificity remain above 95% for all four levels 
of stenosis (mild, moderate, severe, occluded) on a per-vessel analysis. Importantly, 
this accuracy has persisted despite evaluating patients with extensive coronary 
disease, a cohort previously considered less suitable for CTCA due to vessel artefact 
from calcification or stents[91,118] where international guidelines are unable to make 
firm recommendations.[92] 
 
The advantages of CTCA to the interventional cardiologist are clear. In patients with a 
low pre-test probability of coronary artery disease, CTCA has been shown to provide 
safe and rapid exclusion of disease, avoiding the risks of unnecessary interventional 
procedures. Now, for high-risk patients, therapy can be pre-planned and targeted. The 
same is true for patients with coronary bypass grafts where decisions can be made 
prospectively regarding the need to intervene percutaneously on grafts or native 
arteries, and assistance gained with locating or avoiding particular vessels.  
 
One of the major limitations in the uptake of CT as a mainstream investigative 
modality has been its limited positive predictive performance and, consequentially, its 
use in patients with a high pre-test probability of significant coronary artery disease 
has not been recommended.[119–121] This does influence the risk-benefit ratio of CT, 
as the diagnostic yield in lower risk populations is less. Of course, assessing the 
accuracy of CT in a cohort with a high, a priori risk of coronary artery disease is not 
directly comparable to assessing the same technology in a cohort with a lower 
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prevalence of disease because of the effect on the positive predictive value, but the 
maintenance of a high negative predictive value in this setting is extremely reassuring. 
 
Radiation exposure remains the main disadvantage to CT, as discussed in the earlier 
chapters. The median dose-length product (DLP) in our study was 150.8 (interquartile 
range 150.0 – 252.5). This equates to a median effective dose of 4.2 mSv (4.2 – 7.1), 
which is comparable to previously published studies using 64-slice scanners.[122][118] 
The effective dose is not as low as those published in several recent studies[123,124] 
due to the use of a more appropriate conversion factor, validated at our institution 
previously.[36] This is comparable to a median effective dose of 6.3 mSv (4.2 – 8.2) for 
ICA at our institution, which is likely to underestimate exposure during graft studies. It 
should be noted that our department already utilises aggressive dose-reduction 
strategies, including widespread use of prospective gating, patient-adjusted tube 
energy and heart-rate reduction, which may contribute to this modest dose range. In 
the Prospective Multicentre Study on Radiation Dose Estimates of Cardiac CT 
Angiography in Daily Practice I (PROTECTION I) study, the median radiation dose was 
12 mSv and prospective ECG-gating and 100-kV tube voltage were used in 6% and 5% 
of patients, respectively.[125] In the ACCURACY trial examining dose reduction 
strategies, the median dose fell from 21 to 10 mSv, with prospective ECG-gating and 
100 kV tube voltage used in 0% and 43% of patients, respectively.[122] In contrast in 
our study all scans (100%) were performed using prospective ECG gating and 296 
(99%) at 100 kV tube voltage.  
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It is possible that the upper limit on body-mass index of 33 kg/m2 may also have 
reduced the radiation dose of our cohort. The mean BMI in the ACCURACY study was 
31.4 kg/m2 which is clearly higher than the median average of 27 kg/m2 in our study 
(Table 3). Nonetheless, comparison to the later PROTECTION I study is favourable, with 
a median BMI in the prospectively gated arm of 28.5 kg/m2, suggesting that BMI alone 
is unlikely to be the sole factor in radiation reducing. 
  
This study has a few limitations. Overall the patient recruitment is largely reflective of 
real-world requirements and our exclusion criteria align with common 
contraindications to CTCA. Furthermore, no patient was excluded on the basis of a 
suboptimal scan or non-diagnostic coronary segment. However, patient selection 
remains an important consideration for successful CTCA. Heart rate and variability are 
important factors and while diagnosis is possible despite rate-controlled AF and other 
dysrhythmias such patients were excluded from this study, as were patients where 
heart rate control would be challenging due to beta-blocker intolerance. 
 
The study was conducted in a high-volume, tertiary centre and the CTCA reporters 
have extensive experience with cardiac CT. While this does not diminish the accuracy 
of the technique, it should be considered when developing new services elsewhere. 
That said, the intra-observer agreement in this study was very high (weighted kappa 
0.99). Along with the very low proportion of non-diagnostic coronary segments (3.1%) 
this suggests that the technique should be highly reproducible. 
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The use of ICA as the reference standard also begets difficulty. ICA is not a ‘gold 
standard’ test as it has its own limitations. It cannot evaluate extra-luminal disease, 
including expansile remodelling, coronary segments are not always fully imaged and 
visual assessment of stenoses can be somewhat subjective. The use of QCA attempts 
to mitigate this but still ignores features such as serial stenoses or long segments of 
disease. Of course anatomical stenosis does not correlate perfectly with 
haemodynamic significance, as demonstrated by the FAME trial,[117] and as yet CT 
cannot provide robust perfusion analysis, although this is under development. 
 
This is the first study to comprehensively evaluate the accuracy of HDCT in a clinical 
population. The findings support the wider use of CTCA for the evaluation of coronary 
artery disease and may question the use of ICA as a first-line diagnostic modality 
where contemporaneous intervention is not being planned. 
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Subset analysis – patients who have undergone prior revascularisation 
2.4 Introduction 
As previously considered, patients who have previously undergone coronary 
revascularisation are particularly challenging to image with CT, with artefact, from 
stent metal or heavy calcification in the native vessels of patients who have undergone 
coronary artery bypass grafting (CABG), impairing image quality. Current guidance 
from the European Society of Cardiology highlights both the potential utility of CTCA 
for the evaluation of patients following revascularisation, as well as its weaknesses, 
notably pronounced coronary calcification.[126] 
 
In the United Kingdom, the National Institute of Health and Care Excellence (NICE) now 
recommends the use of new generation CT scanners “for first-line evaluation of 
disease progression, to establish the need for revascularisation, in people with known 
coronary artery disease in whom imaging with earlier generation CT scanners is 
difficult”.[98] While the performance of conventional multidetector-row CT has been 
extensively evaluated, there are relatively few studies examining the accuracy of new 
generation technology for the assessment of revascularised patients. The aim of this 
study was therefore to assess the accuracy of high-definition CT in patients who have 
previously undergone coronary revascularisation, in a subset of the previously 
described study. 
 
Materials and methods 
The methodology has been described earlier in this chapter. This prospective study 
was approved by the UK National Research Ethics Service and was conducted in a 
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single, high-volume, tertiary teaching hospital. All patients gave informed, written 
consent. The methodology has been described previously. Of this study population, 66 
patients had undergone prior revascularisation, 41 with percutaneous coronary 
intervention (PCI) and 21 with CABG and 4 with both. 
 
The ICA and CTCA images were pseudonymised and reported on a segment-by-
segment basis, using the American Heart Association 17-segment coronary model, by 
two independent experts for each modality (each with over 5 years’ experience), 
blinded to the other imaging results. Discrepancies were resolved by a third, 
independent expert. Contiguous stents were considered as a single entity, and all 
segments containing stents were analysed (e.g.: two, adjoining stents crossing the first 
diagonal would be recorded as a single stent but analysed for both proximal and mid-
left anterior descending segments). Segments beyond an occlusion were not assessed. 
Significant disease was defined as the presence of moderate (≥50%) or severe (≥70%) 
stenosis. All non-diagnostic segments were labelled as significantly stenosed on an 
intention-to-diagnose basis. No segment was excluded on the basis of size or image 
quality. 
 
Results 
Demographics 
All recruited patients completed the study, undergoing both imaging techniques. Sixty-
six patients with prior revascularisation were identified. Fifty-three (80%) were male 
and the median age was 67 years (range 43 – 82). The mean body mass index was 26 
kg/m2 (standard deviation 3.3). The median Agatston calcium score in patients without 
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coronary stents was 1628 (interquartile range 373 – 2800). The median dose-length 
product was 192 mGy.cm (IQR 150.5 – 247.9) giving an effective dose of 5.4 (IQR 4.2 – 
6.9) using a cardiac-specific conversion factor of 0.028.[31] The smallest stent was 2.5 
mm in diameter. 
 
Accuracy 
Eighty-three stented, and 244 native, vessel segments were analysed. The prevalence 
of moderate stenosis (>50%) was 9.6% in the stent group, 43.6% in the native coronary 
group and 34.9% combined. The prevalence of severe stenosis (>70%) was 4.8%, 39.4% 
and 30.6% respectively. The accuracy of CTCA to detect moderate or severe stenosis, 
for each method of revascularisation and combined, was very high (Table 7). The per-
patient sensitivity, specificity, PPV and NPV, for all patients, were all 100% for severe 
stenosis and 97.2%, 100%, 100% and 94.7% respectively for moderate stenosis. 
Agreement between high-definition CT and invasive angiography was very good 
(combined kappa 0.95, weighted kappa 0.97). 
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 Per segment Per patient 
 50% stenosis 70% stenosis 50% stenosis 70% stenosis 
Stent 
assessment  
   
Sensitivity 87.5% 
(47.4 – 97.9) 
75%  
(20.3 – 95.9) 
96.4% 
(81.6 - 99.4) 
100% 
(86.2 - 100) 
Specificity 100% 
(95.2 – 100) 
98.7% 
(93.1 – 99.8) 
100% 
(80.3 - 100) 
100% 
(83.0 - 100) 
PPV 100% 
(58.9 – 100) 
75%  
(20.3 – 95.9) 
100% 
(87.1 - 100) 
100% 
(86.2 - 100) 
NPV 98.7% 
(92.9-99.8) 
98.7%  
(93.1 – 99.8) 
94.4% 
(72.6 - 99.1) 
100% 
(83.0 - 100) 
Native vessels     
Sensitivity 99.1% 
(94.8 – 99.8) 
100% 
(96.2 - 100) 
100% 
(85.6 - 100) 
100% 
(85.6 - 100) 
Specificity 97.8% 
(93.7 – 99.6) 
96.6% 
(92.2 - 98.9) 
100% 
(16.5 - 100) 
100% 
(16.5 - 100) 
PPV 97.2% 
(92.1 – 99.4) 
95.1% 
(88.9 - 98.4) 
100% 
(85.6 - 100) 
100% 
(85.6 - 100) 
NPV 99.3% 
(95.9 – 99.9) 
100% 
(97.4 - 100) 
100% 
(16.5 - 100) 
100% 
(16.5 - 100) 
Combined     
Sensitivity 98.3%  
(93.8 – 99.7) 
99.0% 
(94.6 – 99.8) 
97.2% 
(88.9 - 99.7) 
100% 
(92.1 - 100) 
Specificity 98.6% 
(95.9 – 99.7) 
97.3% 
(94.3 – 99.0) 
100% 
(81.3 - 100) 
100% 
(83.8 - 100) 
PPV 97.4% 
(92.6 – 99.4) 
94.3% 
(88.1 – 97.9) 
100% 
(92.4 - 100) 
100% 
(92.1 - 100) 
NPV 99.1%  
(96.6 – 99.9) 
99.6% 
(97.5 – 99.9) 
94.7% 
(73.9 - 99.1) 
100% 
(83.8 - 100) 
Table 7 
Accuracy of high definition CT coronary angiography in patients who have had previous 
coronary revascularisation, expressed as percentages, with 95% confidence intervals. 
PPV – positive predictive value, NPV – negative predictive value 
 
The weighted kappa for interobserver agreement between the expert CT readers was 
0.99 for the entire study population. 
 
Clinical follow-up 
At one year, 79% of patients had been managed medically, comprising 73% of patients 
with existing stents and 92% of patients who had undergone previous CABG (Table 8). 
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Mortality in previously revascularised patients was 6%, compared to 3.6% for the total 
study population (p = 0.28). One from each group (stents and bypass grafts) had died 
from metastatic malignancy and another in the group with previous bypass grafts died 
following diverticular perforation. All three were receiving medical management. One 
patient in the stent group died post-operatively following CABG with mitral valve 
repair. 
 
Strategy All Previous stent Previous 
CABG 
Further revascularisation 19.7% (13) 24.4% (11) 8.0% (2) 
Medical management 78.8% (52) 73.3% (33) 92.0% (23) 
Table 8 
Onward management of all patients who had previously undergone coronary 
revascularisation, following their subsequent investigation. Data for one patient with a 
stent unavailable 
 
2.5 Discussion 
This subset analysis suggests that high-definition CT is highly accurate in the 
assessment of patients who have undergone previous coronary revascularisation who 
present with chest pain. The combined, per-segment sensitivity, specificity, PPV and 
NPV for 70% stenosis are 99.0%, 97.3%, 94.3% and 99.6% respectively, and are all 
100% on a per-patient basis. The median dose-length product of 192 is considerably 
less than the benchmark from standard 64-multidetector row CT identified in one 
major, multicentre study.[61] 
 
High-definition CT is a new generation technology[98] which utilises both novel 
hardware and image reconstruction methods, to improve image quality and diagnostic 
accuracy. It uses a ‘flying focal spot’, which increases the data sampling with each 
gantry rotation, thereby providing more data for image reconstruction and greatly 
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improved spatial resolution. Image reconstruction is performed using enhanced 
mathematical modelling of the scan process, undertaking recurrent adjustments to 
filtered-back project data in an iterative fashion (Adaptive Statistical Iterative 
Reconstruction). This results in reduced image noise and blooming artefact, which also 
permits radiation dose reduction.[36,127,128] 
 
CTCA versus ICA 
It is important to consider the justification for referring patients to CT rather than ICA. 
Previous presumption has been that the likelihood of recurrent disease is so high as to 
warrant an invasive strategy, where revascularisation can be attempted at the same 
sitting if appropriate. Our data suggest that, in fact, the vast majority of patients do 
not require further revascularisation with 79% of our cohort, and 92% of those with 
bypass grafts, receiving medical management. Even in patients with stents, where 
repeat revascularisation is more likely, slightly fewer than one in four required such 
intervention. An important caveat is that patients presenting acutely who required 
immediate PCI were excluded from the study. These conclusions should therefore only 
be applied to patients investigated in an elective, outpatient fashion. 
 
This low rate of intervention alters the perceived risk-benefit ratio of invasive 
angiography. Drug-eluting coronary stents have significantly reduced the frequency of 
restenosis, with major trials suggesting a prevalence of 5-10%[129,130] and a ‘rule-out’ 
approach, utilised so successfully in patients without known CAD, may therefore be 
appropriate. This is reflected in studies of clinical populations being investigated for in-
stent restenosis, where the prevalence of significant disease is in the order of 13-26% 
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(Figure 6).[112] The use of CT for ‘rule-out’ assessment is already incorporated into 
international guidelines for the evaluation of left main stem stents.[126] Conventional 
CT and even alternative, new-generation technology, has been limited in this group, 
with reasonable negative predictive, but poor positive predictive, values in the order of 
100% and 67% respectively with a 16-slice scanner,[131] and 83-100% and 12.5-23% 
respectively using dual-source techniques.[132,133] 
 
 
Figure 6 
Normal appearances of coronary stents. The left hand image is a modern, platinum-
chromium, drug eluting stent (‘Promus Element’, Boston Scientific, Marlborough, MA, 
USA). The right hand image is an older, stainless steel, bare metal stent (‘Teneo’, 
Biotronik, Berlin, Germany). Both are free of intimal hyperplasia or in-stent restenosis. 
 
Graft studies may also be best suited to CT. Invasively these can be challenging and 
prolonged and the risk of iatrogenic stroke from ICA is three times higher in patients 
with previous CABG than those without.[95] Conversely, there is a wealth of evidence 
demonstrating excellent diagnostic accuracy in bypass graft assessment using CT.[108–
111] CT also positively impacts on downstream care, with demonstrable benefit to 
surgical procedure time, rates of peri-operative myocardial infarction and intensive 
care stay, in patients undergoing repeat cardiac surgery.[134] 
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Other new generation technology 
Although NICE has recommended new-generation technology for the assessment of all 
difficult to image patients they may not be equal. Indeed, the guideline acknowledges 
that differences in the technological advances with each new generation scanner may 
provide different benefits, depending on the reasons for imaging being difficult.[98] 
 
Dual-source CT scanners and those with wide detector arrays[135] can both achieve 
rapid image acquisition, and so logically reduce artefact due to misregistration or 
cardiac motion. This is important in graft studies where large volume acquisition is 
required. However, assessment of the grafts alone does not provide the whole story 
and the ESC guidelines recommend evaluation of the native coronary arteries 
also.[126] There are few studies to have considered this, but wide-bore detectors 
appear to struggle with sensitivity, specificity, NPV and PPV for non-grafted vessels just 
83%, 77%, 77% and 83% respectively in one large study.[135] DSCT appears to fare 
better, with one study demonstrating 99%, 96%, 94 and 99% respectively.[136] To our 
knowledge, no previous study has examined the use of high-definition CT in this 
population, and overall there is very little prior evidence for firm conclusions to be 
drawn about any technology in this group.[96] 
 
The existing evidence base is somewhat larger for stent assessment, comprising over 
30 single-centre studies and at least two meta-analyses. As with conventional CT 
indications, most studies demonstrate reasonable negative predictive value with 
limited positive prediction. Pooled sensitivity, specificity, PPV and NPV has been 
estimated at 87%, 84%, 68%, and 98% respectively.[137] As with native arteries in 
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post-CABG patients, large bore detectors do not appear to add significant benefit, with 
the positive predictive value remaining low, between 54 and 77%,[138–140] with 
sensitivity as low as 59%.[138] Dual-source scanners again seem to perform somewhat 
better, achieving sensitivity and positive predictive values approaching, and up to, 
100% in recent studies.[141–145] Nonetheless, the positive predictive values in these 
studies remain poor, between 14 and 89%. One previous study has examined the use 
of high-definition CT in comparison to both a conventional scanner and ICA.[123] 
While no significant difference could be identified between scanners, the authors 
acknowledge that their study was underpowered, and the performance of high-
definition CT compared to ICA was very good, with per-stent sensitivity, specificity, 
positive and negative predictive values of 96, 95, 90 and 98% respectively. Importantly 
in this study, all stents were included irrespective of image quality. 
 
Limitations 
This study has a number of limitations, some in addition to the main analysis described 
previously. The sample size is relatively small. Furthermore, the low prevalence of 
recurrent disease in the stent group makes firm conclusions as to the positive 
predictive value of CTCA difficult (as evidenced by the broad confidence intervals in the 
per-stented segment group), although its ability to exclude significant disease is 
apparent. Similarly, the very high rate of significant disease in the native vessels of 
patients who have undergone CABG somewhat limits comprehensive assessment of 
the negative predictive value of high-definition CT in this group. Nonetheless, the 
samples are comparable to previous similar studies, and this cohort represents the first 
evaluation of native vessels in patients with prior CABG to use high-definition imaging. 
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The study uses an anatomical measure, invasive coronary angiography, as its gold 
standard. There is now widespread acknowledgement of the limitations of anatomical 
testing[146] and fractional flow reserve is a more robust method for decision making 
regarding revascularisation, with patient outcome data to support this approach.[117] 
However, CT is presently an anatomical test and it is therefore appropriate to compare 
this to the current anatomical gold standard. 
 
While our exclusion criteria were reflective of real world requirements and limitations 
of CTCA, and are commensurate with current clinical practice, current limitations of CT 
technology necessitated the exclusion of patients with dysrhythmias, those where 
heart rate control was not possible, patients unable to breath-hold for at least 20 
seconds, and those with BMI >33 kg/m2. Importantly, however, no patient was 
excluded on the basis of suboptimal scan or non-diagnostic images. The study was 
undertaken in a single, high-volume, tertiary centre and by reporters with extensive 
cardiac CT experience. Although this does not diminish the accuracy of the technique, 
it should be considered when developing newer services in smaller volume centres. On 
the other hand, the inter-observer agreement in this study was very high (weighted 
kappa of 0.99) which may suggest that the technique is robust and highly reproducible.  
 
Conclusions 
Our results suggest that high definition CT offers exceptional diagnostic accuracy, 
comparable to ICA. This is a subset analysis and the small populations must be 
considered.  Nonetheless, high definition CTCA appears to be a promising tool for the 
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evaluation of patients who have undergone prior coronary revascularisation, and, 
given the low proportion of patients requiring further intervention, may obviate the 
need for ICA as a first-line diagnostic test. 
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3. Dual-energy CT for the subtraction of calcium 
3.1 Introduction 
To recap from chapter 1, dual-energy CT (DECT) is a novel technology currently being 
explored for use in cardiac imaging. The heart is interrogated using two x-ray spectra 
simultaneously, either from two x-ray sources or using novel detectors with a single 
source,[65] and the attenuation of each spectrum by particular materials is measured. 
The latter technique requires novel detectors, capable of distinguishing between 
different signals, 0.25 milliseconds apart, without artefact from the detector afterglow 
experienced with traditional materials, so that the two energy spectra can be emitted 
from a single anode almost simultaneously, using rapid tube voltage switching.[67] 
 
The datasets from each spectrum can then be compared to ensure that errors due to 
beam hardening are reduced. Processing the data in the projection domain, both peak 
kilovolt (kVp) projections are processed to generate measurements according to the 
density of two basis materials which would be required to produce the observed 
attenuation. Based on known mass attenuation coefficients of these materials, final 
image sets can be produced at simulated, monochromatic tube energies, that depict 
objects as if they have been subjected to a specified photon energy, rather than a 
polychromatic beam[147] (virtual monochromatic images). Lower keV images can be 
used to improve tissue differentiation or enhance intravascular contrast, while higher 
keV images can help to reduce blooming artefact. The purported improvement in a 
material’s identification, based on its attenuation coefficients, and transformation into 
a linear combination of the two basis materials (material decomposition), might also 
provide the opportunity for subtracting particular materials from each other, such as 
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calcium from iodine. The use of a single x-ray source may have theoretical advantages 
over dual-source systems, due to the improved temporal association of each dataset. 
 
To date, this technology has had relatively little evaluation in clinical practice. While 
the utility of monochromatic data analysis has been assessed in terms of noise and 
image quality,[147] the accuracy of images generated by single source, dual-energy CT 
has yet to be considered in a population with significant coronary calcification. We 
therefore undertook a feasibility study to examine the potential benefits and 
limitations of virtual monochromatic, and material decomposition (calcium 
subtraction), images for the assessment of patients with calcified coronary artery 
disease, and to assess their potential diagnostic accuracy in comparison to invasive 
angiography. 
 
3.2 The study 
Materials and methods 
This prospective study was approved by a committee of the UK National Research 
Ethics Service and registered as a clinical trial (NCT 01816750). All participants gave 
informed, written consent. Thirty patients were recruited at a single, high-volume, 
tertiary cardiothoracic centre from a population undergoing invasive coronary 
angiography (ICA) on clinical grounds. Only patients with evidence of coronary 
calcification, visible at angiography or on previous cross-sectional imaging, were 
included. The exclusion criteria were patients under 50 years old, body mass index 
>30kg/m2, allergy to iodinated contrast media, contraindication to intravenous beta-
blockade, estimated glomerular filtration rate <30ml/min, or pregnancy. Patients 
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requiring urgent revascularisation before CT scanning could take place were also 
excluded. Of all the patients approached (consecutively) six declined to participate. 
 
Reference standard 
The reference standard for the study was invasive, catheter angiography (ICA), which 
was performed as per standard clinical protocol using digital angiography (Allura XPer 
FD10, Philips Healthcare, Best, Netherlands). Each coronary artery was viewed in at 
least two orthogonal planes. Images were later reported by two angiographers (each 
with more than 5 years experience of ICA), blinded to the clinical data and CTCA 
results. Images were assessed according to the modified AHA 15-segment model[148] 
and each segment was scored based on the presence and degree of stenosis in this 
fashion: <50% (mild), 50<70% (moderate) or >70% (severe). Variations in results were 
resolved by a third, independent angiographer. 
 
CT protocol 
CTCA was performed using a single source, dual-energy scanner (Discovery CT750 HD, 
GE Healthcare, Milwaukee, WI). Patients with a resting, pre-scan heart rate of >65 
beats per minute received intravenous metoprolol (Betaloc, AstraZeneca, London, UK) 
in 5mg aliquots (up to 40mg) to achieve a heart rate of <65 beats per minute. A non-
enhanced scan was performed for the purposes of calcium scoring. Angiography was 
undertaken in dual-energy mode (rapid kV switching between 80 and 140 kV) using 
vendor-programmed tube settings according to the patient’s body mass index (Table 
9). Scans were acquired using prospective ECG gating, centred around 75% of the R-R 
interval. Where heart rate control remained inadequate despite beta-blockade up to 
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200 milliseconds of padding (additional ‘tube-on’ time, to cover more of the cardiac 
cycle) was utilised and the centre point was moved to 60% of the R-R interval, to 
acquire both systolic and diastolic phases. Iodinated contrast (Optiray 350, Covidien, 
MA, USA) was administered as a 100 ml, multiphase bolus at an initial rate of 6.5 ml/s, 
followed by a 50 ml saline flush and the scan was triggered manually upon 
opacification of the ascending aorta, with a seven second scan delay. 
 
 
BMI (kg/m2) Preset 
No.† 
Tube voltage 
(kV)* 
Tube current 
(mA)* 
Bowtie filter 
<20 – 22.9 62 108 600 Small cardiac 
23.0-26.9 65 112 640 Small cardiac 
27.0-30.0 64 112 640 Medium cardiac 
 
Table 9 
Tube parameters for dual energy presets (manufacturer-specified) and their use 
according to body mass index.BMI – body mass index. †Manufacturer programmed, 
non-modifiable tube parameters, selected by choosing the appropriate preset *These 
values are approximated as an average resulting from rapid switching between 80 kVp 
and 140 kVp.  
 
 
Image analysis 
Following the scan the images were reconstructed using 50% iterative reconstruction 
(Adaptive Statistical Iterative Reconstruction, GE Healthcare), as recommended by 
previous studies[147], and transferred to a workstation (Advantage Workstation 4.6, 
GE Healthcare). They were anonymised and subsequently reported by two 
independent experts (each with more than 10 years experience of CTCA), blinded to 
the clinical data and the results of the invasive angiogram, using the 15-segment model 
as before. Scans were analysed as virtual monochromatic datasets at 60, 100 and 120 
keV, and using ‘calcium subtraction’ (iodine-hydroxyapetate material density 
subtraction). Previous work has suggested that 65-75 keV confers highest image 
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quality[7], which also approximates to the mean photon energy of a 120 kVp 
polychromatic beam, while higher monochromatic energies may reduce blooming 
artefact from calcific deposits. Monochromatic and material density subtraction image 
sets were evaluated independently, with more than 6 weeks interval between each 
read. 
 
Lesions were graded using the same descriptions as for ICA and differences between 
the readers were resolved by consensus. The non-enhanced scan was used to calculate 
an Agatston calcium score using semi-automated software on the workstation. 
 
Statistical analysis 
Distributions in patient demographics and scan features were assessed graphically, 
with subsequent metric or parametric techniques selected accordingly. 
 
Descriptive statistics were used to describe the accuracy (including sensitivity, 
specificity, negative predictive value [NPV] and positive predictive value [PPV]) of CT 
versus ICA, with 95% confidence intervals for both moderate and severe stenoses. 
Comparisons were made on a per-segment, per-vessel and per-patient basis, the 
vessels comprising the left main stem, left anterior descending artery, circumflex 
artery, and right coronary artery. Branches of each vessel were included in the 
assessment of the major vessel from which they arose. Cohen’s kappa was calculated 
to describe the agreement between the two modalities. 
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Results 
All patients underwent CTCA, without complication or adverse incident, within three 
months (median 5.5 days) of ICA. One study was subject to significant motion blur due 
to contrast-induced tachycardia and respiratory motion, and was non-diagnostic. All 
the segments of all remaining patients were included in the analysis, irrespective of 
image quality. In total, 403 segments in 86 vessels were analysed.  
 
Eighty percent of the study subjects were male, with a mean age of 69.2 (range 53 – 
85) years and a mean body mass index of 28.6 (range 21.6 – 30) kg/m2. Calcified 
coronary plaque was identified in all patients and the median Agatston calcium score 
was 964 (interquartile range 304.5 – 1840.5) units. The mean volume CT dose index 
(CTDIvol) for the entire examination was 17.9, dose-length product 197 mGy cm
-1, 
giving an effective dose of 5.5 mSv (cardiac conversion factor 0.028[36]). 
 
The per-segment, per-vessel and per-patient prevalence of moderate stenosis was 
24%, 59% and 86%, and the prevalence of severe stenosis was 15%, 51% and 83%, 
respectively. 
 
The sensitivities, specificities, PPV and NPV of the virtual monochromatic image sets 
are illustrated in Table 10, with 95% confidence intervals. The accuracy of this 
technique for the identification of moderate and severe stenosis was 0.88 on a per-
segment basis, 0.84 and 0.86 respectively on a per-vessel basis, and 0.93 and 0.97 
respectively on a per-patient basis. The weighted kappa statistic between ICA and 
CTCA was 0.71, suggesting good agreement between the two methods. 
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 Per segment Per vessel Per patient 
>50% stenosis    
Sensitivity 0.76 (0.66 – 0.84) 0.78 (0.64 – 0.89) 0.93 (0.76 – 0.99) 
Specificity 0.92 (0.89 – 0.95) 0.93 (0.80 – 0.98) 1.00 (0.19 – 1.00) 
Positive predictive valve 0.76 (0.66 – 0.84) 0.92 (0.79 – 0.98) 1.00 (0.86 – 1.00) 
Negative predictive value 0.92 (0.89 – 0.95) 0.79 (0.65 – 0.90) 0.50 (0.08 – 0.92) 
    
>70% stenosis    
Sensitivity 0.73 (0.60 – 0.83) 0.78 (0.61 – 0.90) 1.00 (0.85 – 1.00) 
Specificity 0.91 (0.87 – 0.93) 0.94 (0.84 – 0.98) 0.83 (0.36 – 0.97) 
Positive predictive valve 0.58 (0.47 – 0.70) 0.90 (0.74 – 0.98) 0.96 (0.79 – 0.99) 
Negative predictive value 0.95 (0.92 – 0.97) 0.86 (0.74 – 0.94) 1.00 (0.48 – 1.00) 
Table 10 
Diagnostic accuracy of monochromatic imaging on per-segment, per-vessel and per-
patient level analyses for moderate (>50%) and severe (>70%) stenoses with 95% 
confidence intervals 
 
 
The per-segment sensitivity, specificity, PPV and NPV (and 95% confidence intervals) of 
the material decomposition image sets were 0.67 (0.57 – 0.76), 0.82 (0.77 – 0.86), 0.54 
(0.45 – 0.63) and 0.88 (0.84 – 0.92) respectively for moderate stenosis, and 0.70 (0.57 
– 0.80), 0.79 (0.75 – 0.83), 0.40 (0.31 – 0.49) and 0.93 (0.89 – 0.96) respectively for 
severe stenosis. The overall accuracy was 0.78 for both moderate and severe stenosis. 
 
3.3 Discussion 
This study demonstrates that the use of virtual monochromatic images from single 
source, dual-energy CTCA is feasible in patients with severe coronary calcification and 
further investigation of its diagnostic performance is merited. The use of calcium 
subtraction techniques from material decomposition image sets provided highly 
inconsistent calcium subtraction (Figures 7 & 8) and were not considered to be useful 
for further analysis, thus combined analysis using both techniques was not attempted. 
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The poor image quality appeared to be due to image noise, with resultant 
misidentification of calcium and excessive subtraction. 
 
 
 
Figure 7 
Dual energy assessment of the calcified lesion – 1. Example of the image set of a 
patient with a calcified stenosis of the proximal right coronary artery. Panel A 
illustrates the stenosis (beginning at the arrow) with comparative, invasive 
angiography. Panel B is the material decomposition (calcium-subtracted) image. Panel 
C is the same image reconstructed as a virtual monochromatic image at 60 keV 
(approximately equivalent to the mean energy of a 100 kVp polychromatic beam) and 
demonstrates greater calcium blooming than Panel D, which is reconstructed at 100 
keV. 
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Figure 8 
Dual energy assessment of the calcified lesion – 2. Severe stenosis of a proximal right 
coronary artery at invasive angiography (Panel A). The material decomposition image 
(Panel B) accurately subtracts the two small calcified deposits. With the low burden of 
calcific deposits there is no advantage of high keV images (Panel D) compared to low 
keV (Panel C), and the lower energy images improve intravascular contrast 
visualisation (C). 
 
 
Just six years ago the landmark ACCURACY study demonstrated the value of 64-
multidetector row CT (MDCT) with per-patient sensitivity, specificity, PPV and NPV of 
0.95, 0.83, 0.64, and 0.99 for the identification of moderate stenosis, and 0.94, 0.83, 
0.48, and 0.99, for severe stenosis[91]. In a subgroup of patients with severe coronary 
artery calcification (Agatston score >400 units), the specificity fell to 0.53. A more 
recent subgroup analysis from the CorE64 study, in patients with a calcium score >600, 
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found that the sensitivity, specificity, positive and negative predictive values were 
0.96, 0.56, 0.94 and 0.63 respectively,[119] limited due to blooming artefact, while a 
large systematic review gave pooled, per-patient sensitivity as 0.98 – 0.99 and 
specificity as 0.51 – 0.84 (two categories of Agatston score, 400-1000 and >1000) for 
64-MDCT.[149] 
 
The appeal of CT for the investigation of coronary artery disease is clear. Invasive 
angiography carries a small, but important, risk of mortality and morbidity[95], while 
CT is both cost effective[96] and convenient, and can demonstrate plaque composition 
both within and out of the vessel lumen. Even in the presence of severe coronary 
calcification, ascertaining the presence or absence of obstructive disease can predict 
the need for revascularisation and the likelihood of death. In one recent analysis only 
11% of patients with a calcium score >600 required revascularisation, and all of these 
had severe, underlying stenosis identified at CT.[150] However, conventional CTCA 
techniques have struggled to maintain their diagnostic performance in patients with 
extensive calcification.[119] This study adds to existing evidence that novel imaging 
methods may be able to overcome such difficulties, permitting access to non-invasive 
anatomical imaging to a wider patient group.[151] Importantly in this study, no patient 
was excluded on the basis of artefact from calcification.[152] 
 
Few studies of new-generation CT scanners have been undertaken to explore imaging 
in patients with extensive coronary calcification.[151] Initial exploration of dual source 
techniques was disappointing, with one of two studies from the same centre reporting 
“limited accuracy” with a PPV of just 70%,[153] and the second seeing an 
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overestimation of mild stenosis leading to a PPV of 61%, despite the per-vessel 
prevalence of moderate stenosis of just 17%.[154] One more promising study 
demonstrated sensitivity, specificity, PPV and NPV all above 90% on segment- and 
vessel-based analysis, but with a similarly low disease prevalence (19%) and having 
excluded segments where artefact from calcium impacted on image quality.[152] 
Results from studies of dual-source CT (DSCT) in the aforementioned systematic review 
suggested a pooled sensitivity and specificity of 0.96 – 0.97 and 50.0 – 84.0 
respectively, for calcium scores of 400-1000 and >1000.[149] 
 
There are some theoretical advantages of single-source over alternative dual-source 
techniques. With two sources located distinctly from each other there must be gantry 
rotation between each kVp acquisition. This reduces the temporal association of each 
kVp dataset. Furthermore, because this data is not entirely coincident it must be 
reconstructed in the image, rather than projection, domain which may impair image 
quality.[155] Whether these differences in technology translate into meaningful 
clinical discrepancies remains to be seen. 
 
Our study has some limitations. It included patients with heavy coronary calcification, 
who therefore had a high pre-test likelihood of significant coronary artery stenosis. 
The high positive predictive value of this test should be interpreted accordingly, 
although this does not detract from the potential benefits of this modality in such a 
patient group. This feature of our cohort also accounts for the apparently poor, per-
patient, NPV for moderate stenosis – only four patients had a ‘negative’ CT. The wide 
98 
 
confidence intervals at the per-patient level prohibit definitive conclusions being 
drawn about test accuracy.  
 
The radiation dose is significant. In order to ensure the feasibility of the technique we 
aimed to avoid noise limitation as a priority and so used tube presets with higher 
currents and fewer BMI strata than previous studies.[147] We used a cardiac-specific 
conversion factor[36] double that of most earlier studies, and when this variation is 
considered the dose is comparable to,[152] or less than,[156] other dual-energy 
studies and akin to contemporary practice,[36] particularly in the context of calcified 
disease. 
 
One patient was excluded from the analysis due to the occurrence of contrast-induced 
tachycardia, which rendered the images completely uninterpretable. Our study 
protocol did not permit repeat imaging and no meaningful estimation could be made 
of any coronary segment. This is an acquisition difficulty rather than one related to the 
novel technology. 
 
Finally, this remains a pilot study and, while demonstrating the ability to generate 
interpretable images with satisfactory patient tolerance at an acceptable radiation 
dose, firm conclusions as to the diagnostic abilities of this technology require further, 
large scale analyses. While we have attempted to make broad comparisons with 
existing technologies and previous studies, head-to-head comparison is required to 
confidently assess the diagnostic benefit of dual-energy techniques. 
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Overall this initial study suggests that the use of single-source, dual energy CT for the 
assessment of severely calcified coronary arteries is feasible, and demonstrates 
acceptable accuracy compared to conventional technology, which may be worthy of 
further evaluation in a clinical population. 
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4. Image reconstruction methods 
4.1 Introduction 
A range of novel technologies has been developed to improve the assessment of 
calcified coronary arteries, some of which have been explored in the preceding 
chapters. Iterative reconstruction (IR) is one further method which may improve 
diagnostic accuracy, using more complex mathematical processing of the statistical 
facets of image acquisition, combined with filtered back projection data, to minimise 
image noise (see chapter 1.3). The use of IR is becoming widespread, not least due to 
the apparent ability to keep noise constant, or even reduced, while also reducing 
radiation dose.[57] While these techniques improve image quality, their effect on 
diagnostic accuracy is less clear. Recent work in abdominal imaging has examined IR 
techniques with liver lesions, which are typically low density, and raised concerns that 
low-contrast detectability may be impaired when the radiation dose is also 
reduced.[157] Further studies with thoracic CT suggest similarly questionable results at 
very low radiation doses,[158] although this is inconsistent and IR does seem to 
provide acceptable results for some pathologies.[159] IR has been examined in small 
cohorts of patients to consider coronary stenosis assessment and plaque 
composition,[160] where it appears to reduce blooming artefact.[161] 
 
As of 2012, model-based iterative reconstruction (MBIR) techniques have also been 
developed. As previously discussed, these methods use more accurate modelling of 
the scanner system optics, avoiding assumptions about the scanner or the physical 
properties of the image acquisition process. By modelling these processes from scratch 
and thereby avoiding hybridisation with filtered back projection, which is inherently 
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flawed due to these mathematical assumptions, these purport less noise. They offer 
the possibility of ultra low-dose scanning, with some exploratory chest CT imaging 
reaching doses comparable to chest radiography.[58] As with statistically modelled 
reconstruction methods, the question remains one of accuracy and while there is a 
plethora of analysis considering image quality, there is a paucity of data examining the 
accuracy of these techniques. Some recent work in this area has evaluated the 
delineation of vessels[162,163] and the assessment of vascular diameter[164,165] with 
various types of iterative reconstruction. These studies have examined large, non-
calcified vessels. 
 
To date a single study has examined the application of MBIR to cardiac CT.[166] This in 
vivo work studied 42 patients using standard and ultra-low dose CT, the latter 
employing tube current of 150 – 210 mA and 80 – 100 kV dependent on body mass 
index. The mean dose length product was 14.9 mGy cm – a dose reduction of 82% - 
with no statistically significant difference in image quality. Because MBIR is not yet 
commercially available the scans needed to be reconstructed off-site with the 
manufacturer. Furthermore, only 48% of patients had coronary calcium and the 
median calcium score for the whole study population was 141. There was no 
assessment of the accuracy of the reconstruction algorithm. My preliminary 
investigations suggested a marked improvement in image quality using MBIR (Figure 
9). 
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Figure 9 
Preliminary examination of a single in vitro coronary artery phantom containing a 
drug-eluting stent. The same image has been reconstructed using iterative 
reconstruction (left) currently used in clinical practice (50% blending with filtered back 
projection) with a novel model-based iterative reconstruction method (right). 
 
 
Of interest, some recent work has also considered more straightforward options of 
improving accuracy in the context of calcified stenosis. CT scanners come with a variety 
of reconstruction algorithms, or ‘kernels’. These are the filters through which the back 
projected data is reconstructed and each one does this variably, to balance spatial and 
contrast resolution. They are generally classified according to the degree of 
‘smoothness’ they confer, and are useful for specific indications. Softer, smoothing 
kernels tend to facilitate the visualisation of low-contrast structures at the expense of 
spatial resolution, while sharper, edge-enhancing kernels are often used to identify 
high-contrast boundaries, for example between soft tissue and bone. These in 
particular appear to improve stent assessment, both in terms of visibility[167] and 
detection of in-stent re-stenosis.[168] Some kernels also adjust Hounsfield values of 
various tissues. As previously discussed, filtered back projection is far less 
computationally demanding (and therefore faster) than both iterative and model-
based reconstruction techniques, and optimisation of this process may be just as 
useful if appropriate kernels are selected.[169] 
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The optimal imaging strategy of the calcified coronary lesion has not been evaluated, 
despite its importance as the limiting factor for the accuracy of CT coronary 
angiography. In order to further consider the range of techniques available for 
coronary analysis we assessed the accuracy of existing reconstruction methods and a 
new model-based iterative reconstruction process at evaluating dense stenosis in 
coronary phantom models. 
 
4.2 The study 
Materials and methods 
Coronary phantoms 
Coronary segment phantoms (Fuyo Corporation, Tokyo, Japan) were constructed at 
2.5, 3.0 and 3.5 mm (+/- 0.02 mm) luminal diameter using acrylonitrile butadiene 
styrene (which has a density of 40 HU). Models of both concentric circular and 
irregular (crosshair) morphology were precision machined high density polyvinyl 
chloride (950 HU) to simulate calcified plaque, to create mild (25%), moderate (50%) 
and severe (75%) concentric luminal stenoses for each segment diameter. We 
measured the mean density of intraluminal contrast in 100 consecutive patients with 
calcified disease. The phantom segments were filled with intravenous contrast 
(Omnipaque 300, GE Healthcare AS, Oslo, Norway), diluted to a density of 
approximately 450 HU, to correlate with these clinical targets. In total, 18 variations of 
coronary anatomy were studied. 
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Imaging protocol 
Each coronary segment was placed into a 32 cm CTDI phantom to simulate 
surrounding tissue and were individually imaged longitudinally, parallel to the z-axis, 
using a standardised protocol (100 kV, 420 mA, pitch 0.2, 400 ms gantry rotation time) 
with a 64-MDCT scanner (Discovery CT750 HD, GE Healthcare, Milwaukee). This 
standardised protocol was selected as, at the time of investigation, model-based 
iterative reconstruction was not available for use in imaging protocols using ECG 
gating. The images were undertaken in both standard and high-definition modes and 
were not touched between these acquisitions. The images were then reconstructed 
using filtered back projection, iterative reconstruction (Adaptive Statistical Iterative 
Reconstruction, GE Healthcare), model-based iterative reconstruction (Veo, GE 
Healthcare), and with standard or edge-enhancing kernels (Bone, GE Healthcare), 
according to the reconstruction method. We reconstructed these in 0.625 mm 
thickness slices at 0.5 mm intervals. In all, 11 combinations of reconstruction 
techniques were assessed (Table 11). 
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Scan mode Reconstruction method Kernel 
Standard Filtered back projection Standard 
 Iterative reconstruction – 30% 
blending 
Standard 
 IR – 50% blending Standard 
 IR – 70% blending Standard 
 IR – 100% blending Standard 
 Filtered back projection Edge-enhancing 
 IR – 50% blending Edge-enhancing 
 IR – 100% blending Edge-enhancing 
 Model-based iterative 
reconstruction 
N/A 
High-definition IR – 50% blending Standard 
 IR – 50% blending Edge-enhancing 
Table 11 
Scanner parameters investigated using coronary artery phantoms 
 
 
Image analysis 
The circular concentric stenoses were analysed quantitatively for assessment of 
stenosis. The segment was examined in an axial plane to visualise the luminal cross 
section. This was bisected through the centre in a horizontal plane, parallel to the x-
axis, and measurements of the Hounsfield unit density were taken at 0.1 mm intervals 
along this line using the workstation software (Advantage Workstation 4.6, GE 
Healthcare). This allowed the construction of a graphical illustration of the cross-
section, plotting density against distance (Figure 10). Maximum and minimum luminal 
diameters were measured precisely from this graph, and the difference between these 
recorded, to give a quantitative measure of the clarity of the lumen. The degree of 
error was calculated as a proportion of the mean diameter at CT compared to the 
known manufactured diameter. 
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Figure 10.1 
Graphical cross section of the same coronary segment demonstrating densities 
reconstructed using model-based iterative reconstruction (black) and 50% Adaptive 
Statistical Iterative Reconstruction blending and a standard kernel. The peaks illustrate 
the high-density ‘plaque’ with the centre portion demarcating the contrast-filled lumen. 
The arrows show the maximum and minimum diameter of the lumen using each 
technique. 
 
Figure 10.2 
Illustrative diagram demonstrating the generation of Figure 10a from the image. The 
phamtom was bisected with density measurements every 0.1 mm. 
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The irregular stenoses underwent visual analysis by two experienced readers of CT 
coronary angiography each with more than 10 years experience of cardiac CT). Each 
image was rated using a Likert scale to describe the clarity of the lumen and estimation 
of stenosis: 1 – no lumen visible; 2 – lumen barely visible, impossible to establish 
shape; 3 – lumen visible, uncertainty about shape; 4 – lumen fairly clear, shape 
distinguishable but stenosis uncertain; 5 – lumen shape easily identifiable and stenosis 
assessable. Differences between the readers were aligned by consensus. 
 
Statistical analysis 
For the quantitative assessments, the degree of error was calculated for each 
parameter (reconstruction method or kernel) and the mean was derived. These were 
compared graphically in a boxplot and analysed using the Friedman test as a non-
parametric analysis of variance. As the Friedman test suggested that a significant 
difference was present a Wilcoxon signed-rank test for paired data was used to 
compare groups. Due to the sample size, and that the data does not look plausibly 
normal, a non-parametric Wilcox signed-rank test was employed. A full pairwise 
analysis was performed between each group, allowing for the multiple testing using a 
Benjamini and Hochberg correction. Two-tailed P values <0.05 were considered 
significant. 
 
We also analysed the data on an ‘as-scanned’ basis, comparing combinations of 
reconstruction method and kernel. These clinical combinations were also compared 
using the Freidman test, followed by pairwise analysis, again using a Benjamini and 
Hochberg correction. 
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Qualitative assessment was scored for each image (nine stenoses, 11 reconstruction 
methods). The mean scores were analysed using a non-parametric Wilcox signed-rank 
test and interobserver variability was assessed using Cohen’s kappa. 
 
Statistics were performed using R (version 3.0.1, R Foundation for Statistical 
Computing, Vienna, Austria). 
 
Results 
Nine coronary segments, comprising three vessel sizes (internal diameters of 2.5, 3.0 
and 3.5 mm) with three degrees of high density stenosis (mild, moderate, severe) were 
analysed. The segment with an internal diameter of 2.5 mm and severe stenosis 
(residual luminal diameter 1.3 mm) could not be assessed using the standard kernel as 
the lumen was completely obliterated by artefact (Figure 11). This segment was 
therefore excluded from the quantitative analysis. Of note, the error of all methods of 
reconstruction increased markedly in this segment, suggesting that structures this 
small may not be sufficiently visible using this technology. 
 
For the quantitative assessment, the error for each reconstruction method is detailed 
in Table 12. With regards to the qualitative assessment, the kappa statistic for 
interobserver agreement was 0.91 (weighted 0.95, confidence interval 0.86 – 0.98) 
suggesting excellent agreement. The image quality scores are presented in Table 13. 
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Figure 11 
Cross section through the 2.5mm coronary segment with severe stenosis. No lumen can 
be identified. Grey scale lines represent filtered back projection and various levels of 
iterative reconstruction blending (30%, 50%, 70% and 100%). 
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Reconstruction 
method 
Stenosis Vessel size Total 
Mode Recon Kernel Mild Moderate Severe 2.5 
mm 
3.0 
mm 
3.5 
mm 
Mean 
Std FBP Std 0.520 0.583 0.394 0.518 0.530 0.491 0.512 
Std IR 30% Std 0.531 0.581 0.394 0.492 0.549 0.497 0.516 
Std IR 50% Std 0.531 0.574 0.394 0.492 0.549 0.491 0.513 
Std IR 70% Std 0.567 0.565 0.394 0.524 0.549 0.496 0.514 
Std IR 
100%  
Std 0.532 0.577 0.394 0.518 0.536 0.490 0.515 
Std FBP Edge 0.238 0.234 0.367 0.482 0.218 0.140 0.280 
Std IR 50%  Edge 0.288 0.254 0.367 0.520 0.230 0.160 0.303 
Std IR 
100% 
Edge 0.244 0.204 0.329 0.416 0.215 0.147 0.259 
Std MBIR N/A 0.162 0.220 0.344 0.324 0.256 0.146 0.242 
HD IR 50%  Std 0.520 0.606 0.394 0.518 0.539 0.147 0.520 
HD IR 50%  Edge 0.253 0.241 0.301 0.420 0.229 0.146 0.265 
Table 12 
Summary of quantitative error for each reconstruction parameter, given by degree of 
stenosis, vessel size and total mean. Std – standard, HD – high-definition, Edge – edge-
enhancing kernel, FBP – filtered back projection, IR – iterative reconstruction (ASIR), 
MBIR – model-based iterative reconstruction, N/A – not applicable (kernels are not 
used for MBIR) 
 
 
 
Reconstruction method Image quality 
score Mode Recon Kernel 
Std FBP Std 1.8 
Std IR 30% Std 1.6 
Std IR 50% Std 1.6 
Std IR 70% Std 1.7 
Std IR 
100%  
Std 2.0 
Std FBP Edge 3.3 
Std IR 50%  Edge 3.4 
Std IR 
100% 
Edge 3.4 
Std MBIR N/A 4.0 
HD IR 50%  Std 1.6 
HD IR 50%  Edge 3.6 
Table 13 
Image quality for each reconstruction parameter. Std – standard, HD – high-definition, 
Edge – edge-enhancing kernel, FBP – filtered back projection, IR – iterative 
reconstruction (ASIR), MBIR – model-based iterative reconstruction 
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Kernels 
The mean error for the standard kernel across all other parameters was 0.524. The 
mean error for the edge enhancement kernel was 0.277. The edge enhancement 
kernel resulted in significantly less error than the standard kernel (p 0.012, figure 12). 
Kernels cannot currently be specified with MBIR, but overall this too was significantly 
more accurate than non-MBIR methods with standard kernels (error 0.242, p 0.012). 
The edge-enhancement kernel was not statistically significantly different to MBIR (p 
0.547). The range of measured densities appears higher using edge-enhancement 
kernels with high-definition scanning, but this did not affect edge definition or error. 
 
Figure 12 
Box plot comparing mean errors by kernel type, and with model-based iterative 
reconstruction 
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Subjective lumen visibility was also higher with both model-based iterative 
reconstruction (mean score 4) and edge-enhancement kernels (3.4) than with standard 
kernels (1.7). 
 
Reconstruction methods 
The mean errors for the each reconstruction method were: FBP – 0.389, ASIR – 0.432, 
MBIR – 0.242, demonstrating that there were significant differences between them (p 
= 0.0008). Pairwise testing suggested differences between all three groups (Figure 13), 
with MBIR significantly more accurate than both ASIR (p = 0.012) and FBP (p = 0.016), 
but also with FBP more accurate than ASIR (p = 0.012). 
 
Figure 13 
Box plot comparing image reconstruction methods. 
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MBIR was scored highest for lumen visibility with a mean of 4. FBP was better than all 
levels of ASIR combined (2.6 vs. 2.3) but similar to ASIR with 100% blending (2.6 vs. 
2.7). This suggests that there may be subtle differences between each level of ASIR, 
which is corroborated by the increasing visibility seen with increasing blending of ASIR 
(Table 14). 
 
% ASIR blend 0 (FBP) 30 50 70 100 
Mean score 1.8 1.6 1.6 1.7 2 
Table 14 
Mean lumen visibility score for levels of ASiR using standard reconstruction kernel 
 
 
  
115 
 
Scanning mode 
 
The mean error for high-definition scanning and standard scanning were 0.369 and 
0.372 respectively. There was no significant difference between these groups (p = 
0.476). This is reflected by the measured graphs (Figure 14) and the mean visibility 
score, which was 2.6 for high-definition acquisition and 2.5 for standard methods. 
 
 
Figure 14 
3.5mm vessel with severe stenosis comparing HD (white) with standard (black) 
acquisition, using edge-enhancement (smooth line) and standard (dotted line) kernels. 
There is no clear difference between HD and standard scan modes. 
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Clinical combinations 
Combining reconstruction techniques in a manner commensurate with routine clinical 
practice demonstrated similar results. At 5% significance there are statistically 
significant differences between the standard reconstruction kernel and both the edge-
enhancement kernel and MBIR (Figure 15, Table 15). 
 
Figure 15 
Box plot comparing clinical combinations of reconstruction method and kernels 
 
 
Reconstruction method  FBP FBP ASiR ASiR 
 Kernel Standard Bone Standard Bone 
FBP Standard -    
FBP Bone 0.013 -   
ASiR Standard 0.655 0.013 -  
ASiR Bone 0.013 0.655 0.013 - 
MBIR  0.013 0.673 0.013 0.638 
Table 15 
p values for error comparisons of clinical combinations of reconstruction methods. FBP 
– filtered back projection, ASIR – Adaptive Statistical Iterative Reconstruction 
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4.3 Discussion 
Arterial wall calcification represents a major challenge to successful, accurate CT 
coronary angiography. This phantom study suggests that model-based iterative 
reconstruction may prove to be of significant benefit in the assessment of calcified 
coronary arteries (Figure 16). Blooming artefact, caused by partial voluming at the 
interface between very high and much lower tissue densities, and beam hardening, 
appears to be reduced, resulting in greatly improved delineation of structures. This 
finding is consistent with previous work by others examining the accuracy of MBIR in 
larger, non-calcified vessels.[165] 
 
 
Figure 16 
3.5mm vessel with moderate, irregular stenosis reconstructed using MBIR. The smallest 
internal diameter of this vessel phantom is 0.48 mm. 
 
Our study also highlights the importance of reconstruction kernels and suggests that 
there may be a need to adjust these in light of findings for each patient. This rapid and 
widely available adjustment to reconstruction comes with no additional burden to the 
patient, in terms of either scans or radiation dose, and may improve the accuracy of 
the imaging when highly calcified vessels are encountered. This will need specific 
assessment in patients with mixed morphology plaque to ensure that the increase in 
noise does not adversely impact on the interpretation of the remainder of the image, 
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although the simplicity and aforementioned benefits of reconstruction kernels would 
readily permit an edge-enhanced image set to be produced alongside standard 
imaging.  
 
 
Figure 17 
The effect of ASIR and edge enhancing kernels. The same coronary segment 
reconstructed with (from left to right) FBP, 30% ASIR, 50% ASIR, 70% ASIR, 100% ASIR 
and using edge-enhancement (top) and standard (bottom) kernels. 
 
In this study, with our static x-ray dose (fixed mA protocol), the iterative reconstruction 
algorithm did not alter the diagnostic accuracy in this setting (Figure 17), and only high 
levels of iterative blending conferred any advantage in lumen visibility and assessment. 
Further work will be required to establish whether accuracy can be maintained using 
iterative reconstruction despite a reduction in dose. Although the use of novel 
reconstruction methods is touted as a method for improving image quality, in clinical 
practice it is often used to facilitate a reduction in radiation dose, while maintaining a 
particular image quality level. It will be important to evaluate whether IR offers 
superior maintenance of image quality in the face of reducing radiation dose, in 
comparison to conventional techniques. 
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Importantly, the study considers the accuracy of the various reconstruction methods, 
rather than just interpreting image quality. A plethora of studies have already 
confirmed that iterative reconstruction improves image quality, including in coronary 
imaging,[59] but far less work has been undertaken to consider its impact on diagnosis. 
The improvements in image quality with MBIR have been confirmed in a previous 
study at our institution investigating thoracic CT[170] and a small study examining its 
use in cardiac CT,[166] a finding which has also been seen in our analysis. While these 
previous studies confirmed the visually appealing nature of MBIR, it also suggested 
that the diagnostic acceptability of this method is high, which has been further 
corroborated by our work. 
 
This study does have a number of limitations which need to be considered. In order to 
ensure exact parity between acquisition and reconstruction techniques, and facilitate 
precise analysis, coronary segments with known dimensions and stenoses must be 
repeatedly scanned in the same position. Quite clearly this cannot be achieved in 
patients, not least due to the radiation dose, and cardiac and respiratory motion, and 
therefore this study relies on phantoms. The vessel and its composition do limit the 
direct applicability of these findings to a patient population. The use of a CTDI (CT dose 
index) phantom may also limit some of the findings. The coronary segments are 
surrounded by a thin layer of air inside cavities within the phantom. This adds an 
additional tissue interface which is not present in vivo, although of course the heart is 
surrounded by intrapulmonary air. Whether this has a significant impact on the 
reconstruction algorithms is not clear, but altering the surrounding soft tissue may 
introduce noise, which these techniques are intended to reduce. A further limitation is 
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that our scans were undertaken without ECG gating and using helical acquisition. This 
was essential to ensure compatibility with MBIR, which is not yet available for clinical 
use with ECG gating. At our centre the vast majority of clinical studies are carried out 
with prospective gating and this again somewhat limits our findings. That said, 
previous analyses have shown that prospective gating improves image quality,[171] 
and so we may have in fact underestimated the usefulness of MBIR, and the impact of 
gating is likely to affect all scanning and reconstruction techniques equally. Finally, 
despite attempts to make the assessment of the coronary lumen entirely objective, 
some element of subjectivity was present, particularly in segments where the image 
quality was poor (Figure 18). 
 
Figure 18 
Limitations of objectivity with assessment of phantom diameter. If the distance 
representing the lowest density is used then, strictly, the bottom arrow represents the 
measurement which should be taken. Applying some subjectivity one of the other two 
arrows is likely to be more representative. While these do vary the maximum variation 
is less than 0.4 mm which is unlikely to have a significant impact on the overall results. 
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The use of three decimal places may give a false impression of the accuracy of 
measurement. The Hounsfield unit density was measured at 0.1 mm intervals across 
the image and the degree of error was therefore calculated as a submillimeter 
proportion. Nonetheless, the image has been acquired by 0.625 mm detectors, with 
the reconstruction process creating variations below this interval and while these tiny 
alterations are the focus of this study it is unlikely that genuine differences at less than 
0.1 mm can be identified with this methodology. Furthermore the clinical relevance of 
any such variation is dubious. 
 
Despite these limitations, we have ensured that consistency is maintained with each 
scan acquisition. We have assumed a perfect environment, without cardiac motion and 
with presumed breath hold, while keeping scanner settings constant, in order to 
minimise confounding factors as much as possible. Furthermore, we have examined 
coronary segments simulating concentric calcification, which is a particularly 
challenging scenario for the current generation of CT scanners. The major residual 
limitation is undoubtedly the current clinical applicability of these findings. It is clear 
that further in vivo studies are required in patients to examine the effects of 
reconstruction kernels on diagnostic accuracy but at present model-based iterative 
reconstruction is not available for clinical use in cardiac CT studies.[166] 
 
Our study therefore raises a number of questions for future research. The effects of 
reducing radiation dose and increasing surrounding soft tissue need to be explored. 
Further reconstruction kernels should be examined in a clinical setting, ideally with 
correlation with reference standards, to identify the optimal choice, and patient-
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specific protocols may need to be considered. In particular the benefit of high-
definition scanning over standard acquisition with edge enhancement kernels may 
need to be established (Figure 19). Additional scan parameters, particularly tube 
energy (kV), should also be assessed, as well as cardiac motion, and studies are 
ongoing at our institution using a beating heart phantom for this purpose. Future 
studies should continue to explore the diagnostic accuracy of these techniques, in 
comparison to accepted CT methodology or (preferably) the reference standard of 
invasive coronary angiography, rather than just measurements of subjective visual 
appeal. 
 
Finally, this study has highlighted that current methods using standard algorithms may 
not be suitable for the analysis small, calcified vessels. Minimum vessel sizes may need 
to be stipulated for particular reconstruction techniques to ensure that diagnostic 
reliability can be maintained. 
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Figure 19 
The effect of high definition scanning and edge enhancement kernels. The same 
coronary segment imaged in high definition (left) and standard (right) modes and 
reconstructed using edge enhancement (top) and standard (bottom) kernels. 50% 
iterative reconstruction (ASIR) was used for all images. 
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Section 3 – Patients with poorly controlled heart rate or rhythm 
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5. Imaging patients with atrial fibrillation 
5.1 Introduction 
Patients with atrial fibrillation (AF) often have both R-R interval variation, and 
persistent relative tachycardia, making CT imaging challenging and degrading image 
quality. The prevalence of coronary artery disease in patients with AF is extremely 
high, particularly in those referred for CTCA, with estimates of more than 80% having 
any disease.[172] Furthermore, mortality in these patients is more than double that of 
patients without AF, predominantly due to underlying cardiac pathology.[172] 
Accurate coronary imaging is therefore of potentially great benefit. 
 
The conventional method for imaging patients with fast, or irregular, heartbeats is with 
retrospective ECG gating, where image acquisition occurs constantly throughout a 
number of cardiac cycles and suitable cycle phases are retrospectively extracted for 
image analysis.[173] While this allows the maximum flexibility, to overcome variation 
in the length of R-R interval and facilitate assessment of the phases with the least 
motion blur, the cost in terms of radiation exposure is high.  In patients in sinus 
rhythm, prospective gating, where the x-ray tube is turned on for a brief moment at a 
predetermined phase of the cardiac cycle, results in better image quality with a 
radiation dose reduction of more than 75%.[174] The usual preference is to image in 
diastole, where coronary motion is at its least, but the unpredictable R-R interval and 
shorter duration of diastole in tachycardia make this difficult in AF. 
 
Some studies have considered acquisition of images earlier in the cardiac cycle. End-
systole (or more precisely, the period of isovolumetric relaxation which immediately 
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follows) offers a small window of relative cardiac and coronary stability, which has 
been exploited to image both the aorta[175] and the coronary arteries in patients with 
AF.[176,177] This seems intuitive, due to the reduced time from detection of the R 
wave to scanning which, in combination with aggressive heart rate control,[178] would 
minimise the opportunity for interruption by the next ventricular contraction. Studies 
of ‘systolic triggering’ have been limited, demonstrating improvement in both image 
quality and radiation dose but still with only moderate image quality in more than one-
third of patients.[177] 
 
This study examined the transition from retrospectively gated scanning to 
prospectively gated, systolic triggering as our default method of acquisition for 
patients in atrial fibrillation. Analysis was undertaken to examine CTCAs before and 
after the introduction of this technique, with the primary outcome measure being 
radiation dose and the secondary measure being diagnostic confidence. 
 
5.2 The study 
Materials and methods 
Study methods and ethical review 
All CT scans were undertaken at a single, tertiary referral centre. The study was 
reviewed by our institutional Research & Development board and registered locally as 
a clinical service evaluation. Further ethical review was waived due to the 
retrospective nature of the study and informed consent was not required. 
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Patient selection 
We reviewed the Clinical Radiology Information System to retrieve image sets on two 
groups of 25 consecutive patients with atrial fibrillation undergoing cardiac CT. One 
group was selected from patients immediately prior to September 2013, when we 
began prospective gating in AF, and the second group comprised 25 patients 
immediately after this change. Patients were excluded where image quality was 
suboptimal for reasons other than heart rate or rhythm (failure to breath-hold, 
contrast timing error, etc.). Demographic information and scan acquisition data were 
extracted from the clinical report, which is recorded contemporaneously at the time of 
image acquisition, and the scanner data sheet. 
 
Image acquisition and reconstruction 
The CT acquisition protocol was as follows. Patients with a minimum heart rate of >50 
beats per minute and a maximum heart rate of >60 beats per minute received 
intravenous metoprolol, titrated in 5 mg aliquots.[178] Imaging was performed on a 
64-detector row CT scanner (Discovery CT750, GE Healthcare, USA), with either 
prospective or retrospective gating. For prospective ECG gating with systolic triggering 
(45% R-R interval), 100 milliseconds of padding (additional tube-on time either side of 
the R-R interval) were applied, as per standard departmental protocol when imaging 
patients with heart rate variability. 0.625mm slices were taken at 0.5mm intervals to 
cover the cardiac volume. Retrospectively gated acquisition was undertaken without 
dose modulation with the pitch set to 0.2. In both cases tube parameters were 
adjusted according to patient BMI, with the same parameters selected regardless of 
gating mode. 100ml ioversol (Opivist 350, Covidien, Dublin) was administered (125ml 
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for bypass graft studies) at a reducing rate, commencing at 6.5ml/sec, followed by a 
saline bolus. Aside from the gating mode, all other acquisition parameters were 
consistent between the groups. 
 
Images were reconstructed in a standard fashion, using a 50/50 blend of filtered back 
projection (FBP) and iterative reconstruction (Adaptive Statistical Iterative 
Reconstruction, GE Healthcare) and standard kernel, at 5% phase intervals, including 
the 45% (of the R-R interval) phase. 
 
Image analysis 
The images were anonymised in a random fashion and reviewed, blinded, by two 
expert readers, each with more than 10 years experience of cardiac CT. These were 
reviewed for stenosis assessment and diagnostic confidence. The latter was recorded 
on a 5-point Likert scale for each coronary segment, thus: 5 – excellent image quality 
with minimal motion artefact, not affecting diagnosis, 4 – mild motion artefact but 
diagnostic confidence maintained, 3 – moderate artefact with little diagnostic doubt, 2 
– significant motion artefact with diagnostic uncertainty, correlative imaging essential, 
1 – study uninterpretable due to motion artefact. Segments graded 3 or greater were 
considered to be diagnostic for the purposes of the study. 
 
Outcome measures 
The outcome measures were image quality by gating method and total study radiation 
dose. The secondary outcomes were diagnostic confidence by patient and artery. 
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Statistical analysis 
Statistical analysis was performed using SPSS Statistics 21 (IBM Corp., New York). Chi 
squares were performed for categorical variables and Mann Whitney U testing for 
continuous variables, with a significance level of 0.05. Image quality scores were 
analysed on a per-patient and per-vessel basis, both by lowest image quality score and 
by mean image quality score, tested with the Kruskal-Wallace Test for independent 
samples. Post-hoc power was estimated using G*Power 3.1.9.2 .[179] 
 
Results 
Fifty patients were identified, having excluded three for non-AF reasons (two failed to 
breath-hold, one poor contrast timing due to contrast pump failure). The patient 
demographics are presented in table 16. There was no significant difference in gender, 
BMI, heart rate (absolute or degree of variability) or calcium score between the two 
groups. 
 
 Prospective Retrospective p value 
Mean age (years) 66 (SD 43 – 88) 62 (SD 43 – 82) 0.11 
Male 80% 68% 0.18 
Bypass graft studies (n) 1 1 0.31 
Median calcium score 113 (IQR 31 - 287) 25 (IQR 0 – 129) 0.41 
Mean BMI (kg/m2) 28 (SD 19 – 38) 29 (SD 17 – 40) 0.74 
Mean high heart rate (bpm) 89 (SD 47 – 130) 90 (SD 52 – 129) 0.73 
Mean low heart rate (bpm) 61 (SD 29 – 93) 62 (SD 39 – 83) 0.50 
Heart rate variation 30% 30% 0.65 
 
Table 16 
Baseline demographics for patients in the AF study. SD –standard deviation from the 
mean, IQR – interquartile range 
 
 
The radiation dose was significantly higher for patients in the retrospectively gated 
group than those being scanned using prospective gating. The mean CTDIvol was 17.58 
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in the prospectively acquired group and 50.82 in the retrospectively acquired group (p 
<0.01). The mean dose-length product was 212 mGy.cm  compared with 761 mGy.cm 
respectively (approximately 2.9 mSv versus 21 mSv using a 0.028 cardiac-specific 
conversion factor[36]). 
 
Seven hundred and fifty seven coronary artery segments were evaluated for image 
quality (373 in the prospectively gated group and 384 in the retrospectively gated 
group). The proportion of diagnostic segments was 85% and 63% respectively (p 
<0.001). At a patient level, image quality was better in the prospectively gated group 
than the retrospectively gated group regardless of whether it was based on a mean of 
every analysed segment (3.78 versus 3.09, p = 0.02), or the lowest rated segment 
within each patient (2.36 versus 1.64, p = 0.01). Image quality was better in the 
prospective group for analysis of each major coronary vessel.  
 
We undertook a post-hoc estimation of power for the primary outcome of radiation 
dose. This was calculated assuming an α-error probability of 0.05 and a calculated 
effect size of 2.2. The power of the study was calculated at 1.0. 
 
5.3 Discussion 
This study demonstrates that the use of end-systolic, prospective gating can 
significantly reduce the radiation exposure for patients in AF undergoing CT coronary 
angiography, and that image quality is at least comparable to retrospectively gated 
studies. Importantly this can be achieved using standard CT technology without the 
need for dual-source or wide detector array scanners. 
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The use of CT in patients with AF is expanding considerably. In addition to the 
identification of CAD, which is highly prevalent in this cohort,[172] CT is increasingly 
used for the evaluation of the heart prior to AF procedures, to identify left atrial or 
pulmonary venous abnormalities,[180] the proximity of at-risk structures,[181] or for 
fusion with intraprocedural, electrophysiological maps.[182] The exclusion of coronary 
disease is important where class Ic antiarrhythmic drugs are being considered.[183] 
Finally, patients with paroxysmal AF may be referred in good faith due to sinus rhythm 
at the time of consultation, but arrive for their CTCA in AF. 
 
Various methods have been employed to facilitate coronary imaging in AF. Reducing 
average heart rate and heart rate variability in patients with atrial fibrillation improves 
image quality[184] and some authors have even considered inducing short periods of 
asystole for fluoroscopic imaging.[185] In recent years a number of technological 
advances have improved the temporal resolution of CT, helping overcome the 
difficulties of heart rate variability while maintaining radiation dose reduction. Wide-
detector scanners can image the heart in a single heartbeat, although the appropriate 
phase of the cardiac cycle must still be decided.[186] This either has to be accurately 
chosen, or else the entire cardiac cycle must be imaged, which adds to the x-ray 
exposure time and therefore radiation dose.[187] The ability to dose-modulate for 
more than one target phase is being tested[188], but again the phases must be chosen 
prospectively to benefit maximally from radiation reducing techniques. The improved 
temporal resolution of dual-source scanners should also be of benefit when imaging 
patients with a tachyarrhythmia[189] and the diagnostic accuracy of these scanners 
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appears promising when compared to ICA, even without attempts at heart rate 
control[190] but results are variable[191] radiation dose remains a significant 
issue[190,192] and the technology has not always been compared to conventional 
scanners.[188,191]  
 
This study is limited by its retrospective nature. The patient and scan information, 
including scanner settings and radiation dose, is all collected prospectively but given 
the clinical nature of the decision to scan there may well be some selection bias. Some 
patients may not have been scanned at the operator’s discretion. However, there is no 
reason for the decision making threshold to have varied following the switch to 
prospective gating and the remarkable similarity in patient demographics suggests that 
the impact of selection bias is likely to be very small. Furthermore, there may be 
limitations due to the inability to completely blind the image analysis to the gating 
method. This is inherently discernible to any experienced reader from a single phase 
examination, even before multiple phases are used (there will be more phases 
available from retrospective acquisition). Firm conclusions about the superiority of the 
diagnostic confidence of prospectively gated studies may therefore be questionable. 
 
Due to limitations in our scanner technology it was not possible to prospectively select 
the timing of acquisition using the time from the R peak. Instead, the scan was 
triggered at a specified phase of the R-R interval, based on the scanner’s calculation of 
preceding R-R intervals. In atrial fibrillation, where there is significant R-R variation, 
this approach may be less accurate. Furthermore it cannot be adjusted in cases where 
the activation time is prolonged, such as with bundle branch block or extrinsic pacing. 
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While we reconstructed images based on absolute time from the R wave, acquisition in 
this fashion would be preferable, as utilised in other studies.[191] 
 
In summary, although CT diagnosis is highly achievable in atrial fibrillation, the 
radiation dose remains high.[193] Because such patients are difficult to image, most 
major literature has excluded those without rate-controlled sinus rhythm, resulting in 
a relative paucity of data for such groups, and their exclusion from clinical access to 
this useful modality. For patients in sinus rhythm image quality is superior with 
prospectively gated studies[174] and the routine use of prospective gating in AF 
therefore offers the potential for both dose reduction and improved diagnostic 
accuracy. 
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6. The use of beta-blockers for cardiac CT 
6.1 Introduction 
The use of beta-blockers to facilitate high image quality remains pertinent to cardiac 
CT. The use of these drugs is important in atrial fibrillation, as discussed in the previous 
chapter, and in sinus rhythm. We have now explained the use of systolic data 
acquisition in atrial fibrillation but in sinus rhythm this usually occurs during cardiac 
diastole, when cardiac motion is minimised or briefly ceased, and lower heart rates 
prolong this phase, which reduces image artefacts. Slower heart rates also facilitate 
the use of optimal radiation-reducing techniques;[173] for example at higher heart 
rates, the scanning time is increased to include more of the cardiac cycle in order to 
identify an optimally motion-free phase, or to allow the analysis of multiple phases, to 
overcome the otherwise limited image quality. 
 
The use of beta-blockers to achieve heart rate control is well established, most 
commonly with metoprolol,[194] although centres vary widely in their choice of agent, 
administration route, and dose. Although recent European data suggests a trend 
towards increasingly aggressive use of beta-blockade,[194] there is little literature 
documenting the safety of this approach, and guidelines for practitioners have 
recommended conservative dosing regimens.[54,195] While defensively safe, such 
protocols result in a substantial proportion of patients failing to meet the target heart 
rate,[54,196] with the potential implications of poorer image quality and greater 
radiation exposure. 
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We pursue aggressive heart rate control with intravenous metoprolol tartrate (Betaloc, 
AstraZeneca UK Ltd., Luton), in an off-label fashion, due to its favourable 
pharmacological characteristics, including rapid onset, predictability and short half-life 
(average 3.5 hours, range 1 – 9 hours)[197] compared to alternative agents. To 
evaluate the safety of our practice, a retrospective data analysis was performed. 
 
6.2 The study 
Materials and methods 
The study was reviewed by the Research & Development department at our institution 
and registered locally as a clinical audit. Further review and the need for informed 
consent were waived. 
 
The records of all patients undergoing CT coronary angiography on clinical grounds 
over a 3 year period (July 2010 – June 2013) at our tertiary cardiothoracic centre were 
examined to establish beta-blocker usage and the occurrence of immediate 
complications. Patients undergoing non-coronary assessment, and those referred from 
outside the hospital catchment area, were excluded. All adverse incidents where 
treatment or monitoring is required (such as contrast allergy) are recorded in the 
clinical report, produced contemporaneously to the scan. We reviewed all clinical 
reports and the hospital admissions database was interrogated for readmissions within 
48 hours. 
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Beta-blocker administration 
The decision to administer intravenous metoprolol is taken by the supervising 
physician at the time of the scan, and administered by them. Advanced life support 
facilities are immediately available. The target heart rate is <65 beats per minute, and 
ideally <60 beats per minute[2], during a breath-hold (which provides physiological 
augmentation to bradycardia in most patients) with no pre-defined, maximum dose; 
metoprolol is administered in 5mg boluses at one-minute intervals and titration is 
continued provided an observable impact on heart rate is being achieved. While the 
patient’s three-lead electrocardiogram is continuously monitored throughout 
administration we do not routinely record or monitor the patient’s blood pressure. 
 
Most standard contraindications are observed,[197] including: allergy to the drug or its 
excipients, high-grade atrioventricular block (first degree block with a PR interval >260 
milliseconds, any second or third degree block), severe or decompensated heart 
failure, or severe peripheral vascular disease. We also exclude patients with severe 
aortic stenosis. We treat the concomitant use of verapamil as an absolute 
contraindication to intravenous metoprolol, but not diltiazem, and we will administer a 
modest dose of metoprolol (up to 10 – 20 mg), cautiously with the latter. The use of 
oral beta-blockers is not considered when deciding to use intravenous beta-blockers, 
other than as reassurance of the patient’s likely tolerance. 
 
Patients with asthma are counselled about the potential risk, but are offered beta-
blockers if they are not using high-dose inhaled beta2-agonists, have not required 
corticosteroid therapy within the last year, and have no other indications of poor 
140 
 
control or risk factors for severe exacerbation (e.g.: previous critical care admission). 
Chronic obstructive pulmonary disease is not a contraindication to the use of beta-
blockade, although we avoid intravenous administration where patients have a 
significant bronchospastic component, requiring regular, high-dose bronchodilator 
therapy. Patients with such a relative contraindication or caution are offered an 
informed choice, comprising careful use of metoprolol, scanning with increased 
radiation dose, or an alternative imaging modality. Inpatients with acute illness, such 
as sepsis or potential pulmonary embolus, do not undergo rate-control. 
 
Following the scan patients are observed for at least 20 minutes prior to discharge 
(i.e.: beyond the time to peak onset). Vital signs are not routinely monitored. 
 
Results 
We identified 3098 consecutive patients meeting the inclusion criteria. In 68 cases the 
use or dosage of beta-blockers could not be verified. 1159 patients (37%) did not 
receive beta-blockers due to satisfactory baseline heart rate, or contraindication. 1871 
patients received intravenous metoprolol with a dose range of 2.5 – 70 mg (median 
dose 15 mg, interquartile range 10 – 25) (Figure 20). 901 (29%) patients received more 
than the licensed dose of 15 mg (noting that there is no formal licence for the use of 
metoprolol for cardiac CT). 129 patients received intravenous metoprolol despite a 
resting heart rate <65 bpm, with a median dose of 6mg (interquartile range 5 – 10). No 
complications or adverse incidents were reported in this cohort. There were no 
unplanned hospital admissions within 48 hours of the CT. 
 
141 
 
 
Figure 20 
Administration of intravenous metoprolol. Number of patients within each dose range 
of IV beta-blocker. 
 
Out of all 1871 patients there was one adverse incident. Brief loss of consciousness 
occurred, without sequelae, in an outpatient under investigation for atypical chest pain 
and syncope, who had received 15 mg metoprolol prior to CT. The patient fully 
recovered and was discharged from hospital following a short period of cardiac 
monitoring, ultimately being diagnosed with reflex syncope. No other complications or 
adverse incidents occurred and no other patients required any medical treatment. 
 
6.3 Discussion 
Our data, comprising the largest analysis of real-world practice in this setting, suggest 
that the off-label use of intravenous beta-blockers to facilitate cardiac CT is safe. 
Complications are rare, provided that due consideration and appropriate patient 
assessment is undertaken, on an individual basis. We have also demonstrated, in a 
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small subset, that beta-blockers can be used at doses above that currently 
recommended for other indications[7] in selected patients. As cardiac CT becomes 
increasingly widespread, the ability to achieve safe heart rate control has important 
implications for both image quality, and potentially therefore for the need for 
additional downstream testing, and for radiation exposure. 
 
The low rate of complications and side effects compared to the expected frequencies 
seen in clinical trials and surveillance needs careful consideration. This is a 
retrospective analysis and therefore there is an inherent risk of reporting bias, 
although the data has been collected prospectively for clinical purposes and so recall 
bias has been reduced. Most of the common side effects of metoprolol are minor, such 
as dizziness, headache or nausea, which patients may not report or may attribute to 
the iodinated contrast media administered during the final phase of imaging. The use 
of a single dose of metoprolol is also likely to be relevant, with side effect profiles 
being generated from patients taking longer term, generally oral, therapy and side-
effects such as weight loss and fatigue are much less relevant. While bradycardia will 
be reported as an adverse incident in the context of arrhythmia or myocardial 
infarction (and occurs commonly), relative bradycardia is of course the objective when 
using metoprolol for cardiac CT. Perhaps the significance in this analysis is the absence 
of any patients requiring intervention for profound, symptomatic or compromising 
bradycardia. 
 
Our judicious use of beta-blockers in patients with bronchospastic disease, and 
avoidance in acutely unwell patients also avoids many of the other side effects we 
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would expect to see in such cohorts, whereas intravenous metoprolol is generally used 
for patients suffering acute myocardial infarction or arrhythmia, both of which can 
cause significant clinical instability and even death – we experienced no complications 
in any of these groups. Finally, postural disorders are also considered to be a common 
side effect of intravenous metoprolol, although with syncope occurring rarely.[197] 
Even with our single adverse event, the rate of postural symptoms is low. This is likely 
to be due to a combination of mild or self-limiting symptoms not being reported by 
patients and not requiring medical intervention, the use of a one-off dose, and 
mitigation by the use of intravenous contrast which provides a 100 – 125ml fluid bolus 
and may contribute to intravascular volume expansion. 
 
The majority of other side effects are considered to be uncommon (incidence 0.1 – 
0.9%) rare (incidence 0.01 – 0.09%) or very rare (incidence <0.01%),[197] and may not 
occur in a sample size such as ours. That said, our service has over ten years of 
experience of cardiac CT and now scans around 2000 patients per year, with similarly 
low rates of complication reported anecdotally. 
 
The use of intravenous beta-blockers has been demonstrated to be an effective 
measure for controlling heart rate prior to CT coronary angiography.[198] While some 
studies have suggested that injectable formulations may be less effective than oral 
administration, the protocols have generally been restricted to much lower doses than 
we describe here, and use in clinical practice.[54] This study provides data to answer 
previously unanswered questions about the safety of intravenous beta-blockers in this 
setting, at doses far higher than for more conventional indications. In combination 
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with improving temporal resolution in scanner hardware this should facilitate the 
inclusion of a wider range of previously difficult-to-image patients. 
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7. The patient experience as a factor in optimising cardiac imaging 
 
7.1 Introduction 
It is clear therefore that temporal resolution can be optimised by both pharmacological 
preparation of the patient and by careful attention to scanning technique, to include 
as many patients as possible. Nonetheless, this may be challenging to achieve in an 
anxious patient, where autonomic drive elevates the heart rate, and consequently 
additional radiation exposure is required to optimise the chances of diagnostic 
images.[199] Indeed, the efficacy of intravenous beta-blockade has been shown to 
decline with increasing dose – the concept of diminishing returns – with some patients 
remaining tachycardic despite significant doses of these drugs.[198] 
 
Poor patient selection and preparation have thus been shown to increase the radiation 
burden to the patient, as well as to increase the rate of non-diagnostic scans, leading 
to patients needing additional, alternative testing.[200] This can be distressing for 
patients and increases downstream costs for healthcare providers. Poor patient 
awareness is also known to increase the anxiety of attending for a test.[201] It is 
perhaps unsurprising therefore that observational evidence suggests that patients with 
higher levels of pre-CT anxiety ultimately have scans of lower image quality and that 
pre-procedural anxiety is higher in patients who have already undergone invasive 
angiography,[200] presumably because they anticipate a similar experience. 
Meanwhile, improved patient information and understanding has been shown to 
improve outcomes in a wide variety of hospital settings.[202–204] Evidence from 
cardiac catheter angiography suggests that the use of alternative information formats 
can reduce patient anxiety and improve patient satisfaction, as well as improving their 
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understanding of the technical requirements of a test.[205] The latter may also 
contribute to how well a patient prepares for a test – for example, patients who do not 
understand the requirements for cardiac CT, particularly the need for a slow heart 
rate, will often consume caffeine, stop their heart-slowing drugs, or even run or cycle 
to their appointment.  
 
Outside the cardiology setting, it is suggested that the addition of video information to 
written information significantly improves pre-procedural anxiety[204] and we 
therefore evaluated the impact of this method of conveying information to patients on 
how well they are prepared to undergo CT coronary angiography and the effect this 
might have on the outcome of their investigation. 
 
7.2 The study 
Materials and methods 
Ethics and consent 
The study was approved by our institutional research and development board, and by 
a committee of the UK National Research Ethics Service, and was prospectively 
registered as a clinical trial at clinicaltrials.gov (NCT 02156973). All participants 
provided informed, written consent to undertake an anxiety questionnaire and to 
allow their image sets and data to be included in the study, although to minimise 
reporting bias due to demand characteristics they were not specifically aware of the 
role of the information film. 
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Inclusion and exclusion criteria 
All adult patients attending for CT coronary angiography were screened. Patients were 
excluded if they were unable to provide informed, written consent for any reason, 
were attending for a non-coronary CT scan, had previously undergone cardiac CT, or 
were hospital inpatients. 
 
Sample size 
Previous similar work has identified a significant effect size when introducing videos 
before potentially stressful clinical procedures. One study identified a large effect size 
(>0.9) in a group of women attending for colposcopy.[204] Given that our investigation 
is less invasive, we have chosen a smaller effect size for our sample size calculation, in 
order to ensure we recruit sufficient patients (medium effect size, based on 
Cohen[206]). With an effect size of 0.5, for 80% power and with significance defined as 
p< 0.05, the sample size is 59 patients in each group. Allowing for a 10% non-return or 
withdrawal rate, our sample size will therefore be 130 patients. This calculation also 
assumes correction with asymptotic relative efficiency in the event of a non-normal 
distribution – this allows for the use of an appropriate, non-parametric test if 
necessary, by ensuring that the study power is not compromised in such an event. 
 
Procedures 
Patients attending for CT coronary angiography in our institution all receive an 
information leaflet with their appointment letter, which outlines the steps they need 
to take prior to coming to the scan (see Appendix 1). In addition they are given a brief 
verbal description of the scan by the radiographer immediately before it is undertaken, 
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as standard care. All patients attending during the study period were offered the 
opportunity to complete an abbreviated Speilberger State-Trait Anxiety Index (STAI) 
questionnaire, which has previously been validated for use in outpatient settings,[207] 
to gauge levels of pre-procedural anxiety. Participants subsequently underwent CT 
coronary angiography according to standard departmental protocols.  
 
Once the control group were recruited, and following a delay to ensure crossover did 
not occur, all subsequent patients were given the opportunity to view a short patient 
information film prior to their scan. This film was produced by a local university prior 
to commencement of the study, in collaboration with cardiologists and radiologists 
from our institution, having spoken to patients about their experiences of undergoing 
cardiac CT. The film demonstrates the pre-procedure preparation required, the scan 
room, scanner and anticipated patient experiences. The film is available on the 
hospital website and on YouTube with the URL provided to patients with their patient 
information leaflet (available at: tinyurl.com/derrifordheartct). Patients who did not 
access the internet were able to view the film in the waiting room prior to the scan. 
These patients were then invited to take the STAI questionnaire and underwent their 
CT coronary angiography in the usual way. 
 
The CT scans in both groups were completed using the same protocols in a 
standardised fashion. Scans were undertaken using a 64-MDCT scanner (Discovery 
CT750-HD, GE Healthcare, Milwaukee, USA). Patients with a heart rate greater than 60 
beats per minute received intravenous metoprolol, in 2.5 – 5 mg aliquots to a 
maximum of 60 mg,[178] to achieve a target heart rate of <60 beats per minute. 
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Calcium scoring was performed using prospective ECG gating in three or four sets of 
non-overlapping, axial slices with 4cm z-axis coverage, 100kV tube voltage and 100 
mAs tube current. CT angiography was then performed using prospective ECG gating, 
350 ms gantry rotation speed, and 64 x 0.625mm slice collimation. Standard or high-
definition mode[124] was used at the supervising doctor’s discretion based on the load 
and distribution of coronary artery calcium, or the presence of coronary stents. Fixed 
tube parameters adapted to the patient’s body mass index were used according to 
Table 17 with minimal radiation exposure time (zero padding) as a default. Patients 
with heart rate variability or a probable acquisition heart rate of greater than 65 beats 
per minute received up to 200 ms of padding to allow multi-phase data reconstruction.  
A dual-phase contrast injection protocol was used with 100 ml (125 ml for patients 
with coronary bypass grafts) of Optiray 350 (Ioversol, Mallinkrodt Inc, MO, USA) 
followed by a 70 ml saline flush using a standardised protocol. Raw CT data was 
reconstructed using a blend of 40% iterative reconstruction (Adaptive Statistical 
Iterative Reconstruction, GE Healthcare) and 60% Filtered Back Projection. 
 
Body mass index (kg/m2) kV mA mA HD 
<20 80 250 500 
20 – 22.4 100 270 600 
22.5 – 24.9 100 300 700 
25 – 27.4 100 360 800 
27.5 – 29.9 100 420 830 
30 – 34.9 120 390 830 
>35 120 480 N/A 
Table 17 
Scan parameters for patient information film study. kV – kilovoltage peak, mA – 
milliamperes, mA HD – milliamperes used when high definition mode selected (note 
this option is not available for patients with a body mass index of 35 kg/m2 or greater) 
 
 
The images were anonymised in a random fashion and reviewed, blinded, by two 
expert readers, each with more than 10 years experience of cardiac CT. Image quality 
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was recorded on a 5-point Likert scale for each coronary segment, thus: 5 – excellent 
image quality with minimal motion artefact, not affecting diagnosis, 4 – mild motion 
artefact but diagnostic confidence maintained, 3 – moderate artefact with little 
diagnostic doubt, 2 – significant motion artefact with diagnostic uncertainty, 
correlative imaging essential, 1 – study uninterpretable due to motion artefact. 
Segments graded 3 or greater were considered to be diagnostic for the purposes of the 
study. 
 
Outcome measures 
The primary outcome measure was the self-reported level of anxiety in patients 
attending for CT coronary angiography. 
 
The secondary outcome measures were the patient’s pre-scan heart rate, the 
requirement for intravenous beta-blockers, the required use of additional tube-on 
time (‘padding’), image quality and radiation dose (dose length product). 
 
Statistics 
Statistical analysis was performed using SPSS Statistics 21 (IBM Corp., New York). The 
distribution of data was assessed graphically. Continuous variables were analysed with 
an unmatched t-test or the independent samples Kruskal-Wallace test. Categorical 
variables were analysed using Chi-squares unless there were categories with an 
expected count of less than 5 results, where Fisher’s exact test was used. Image quality 
was analysed within each Likert category and as a binary variable (diagnostic or not 
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diagnostic), as was heart rate (more than 65 beats per minute, or not). Two-tailed P 
values of less than or equal to 0.05 were considered significant. 
 
Results 
Participants 
130 patients were recruited to the study, 11 patients having declined to participate. 
Two patients underwent non-coronary cardiac CT and were excluded. Three further 
patients were excluded as they had not answered all of the questions on the STAI 
questionnaire. Of the remaining 125 patients, 61 were in the control group and 64 in 
the intervention group. The baseline characteristics for the study participants are 
presented in Table 18. There were no significant differences between two groups. 
 
 Control Intervention p value 
Male 35 (57%) 31 (48%) 0.37 
High-definition mode 11 (18%) 18 (28%) 0.21 
Age (mean) 60 years 62 years 0.50 
BMI (mean) 28 kg/m2 28 kg/m2 0.88 
Table 18 
Baseline characteristics for patient information film study 
 
Outcomes 
The self-reported anxiety level, assessed using the Speilberger State-Trait Anxiety 
Index was significantly lower in the group who had seen the patient information film 
compared to those who had not (Table 19). There was no significant difference in pre- 
or intra- scan heart rate, required use of ‘padding’, required dose of intravenous beta 
blocker, image quality or radiation dose between the two groups. 
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 Control Intervention p value  
(95% confidence interval) 
STAI score1 33.20 31.25 0.04 (-7.36 – -0.11) 
Pre-scan heart rate1 
Scan heart rate1 
>65 bpm (n) 
73.3 
61.6 
14 (23%) 
71.3 
60.3 
12 (19%) 
0.39 (-6.47 – 2.53) 
0.49 (-4.90 – 2.35) 
0.66 
Beta-blocker dose2 10 mg (0 – 20) 10 mg (5 – 20) 0.15 
Use of padding (n) 9 (15%) 10 (16%) 1.00 
Image quality2 
Diagnostic (n) 
4 (3 – 4) 
54 (89%) 
4 (3 – 5) 
59 (92%) 
0.56 
0.77 
Dose length product2 151 (91 – 192) 151 (112 – 225)  0.40 
Table 19 
Outcome variables for patient information film study. 1mean and standard deviation, 
2median and interquartile range. 
 
 
7.3 Discussion 
This study suggests that the use of a patient information film may improve the anxiety 
experienced by patients attending for CT coronary angiography. Despite this, there 
was no significant impact on patient heart rate and as such the use of beta-blockers, 
the need for additional tube-on time and ultimately the radiation dose was therefore 
comparable. This suggests that while a patient information film may be useful in 
improving the patient experience of cardiac CT, it may not be effective at reducing 
heart rate significantly. 
 
There are however a number of factors which may be relevant which have not been 
explored in this study. The degree to which anxiety affects heart rate cannot be 
demonstrated and it is likely that this study is underpowered to identify subtle 
differences. Most patients (79%) underwent diagnostic scans with a heart rate within 
the target range and only 12 studies were not of diagnostic quality and, following on 
from the previous chapter, our centre utilises an aggressive approach to the use of 
intravenous beta-blockade, in all patients.[178,198] Given this high rate of diagnostic 
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imaging and widespread use of beta-blocker, it is perhaps unsurprising that a further 
improvement cannot be demonstrated with a small reduction in pre-scan anxiety. 
 
While a better understanding of an experience may improve a participant’s anxiety 
about what is to come[204,205], this finding is not universal. Some studies have 
demonstrated that despite improved knowledge and recall of information, anxiety has 
not been reduced.[208,209] There may be a number of different reasons for this fact, 
which may limit the applicability of this study. It is widely recognised that the causes 
and response to anxiety vary between different social and cultural 
environments[210,211] and it would be logical to assume that addressing anxiety 
would therefore need contextualisation to local cultures. This study was conducted in 
a single centre in a predominantly white, British population with a higher than average 
age demographic.[212] The information film was produced following consultation with 
patients who had experienced cardiac CT and therefore contained information 
pertinent to the anxieties of the local population. 
 
Future studies would be useful to explore which features of the information film 
patients found most beneficial, and to compare its usefulness at our centre with other 
environments. It would be useful to establish whether additional benefit can be found 
in patients with a resting heart rate above 65 beats per minute, or whether it is useful 
in patients who report no anxiety on arrival for the test. This may clarify whether it is 
of any benefit in helping to achieve diagnostic images in the difficult-to-image patient. 
Finally, a larger study may help determine if there is any measurable difference in 
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heart rate, beta-blocker use or radiation exposure, although given the apparent 
magnitude any impact is unlikely to have a useful clinical implication. 
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Section 4 – Additional information in the diagnosis of  
coronary artery disease 
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8. Ischaemia testing with cardiac CT 
8.1 Introduction 
There is an alternative strategy when faced with a patient in whom diagnostic, sub-
millimetre imaging is unlikely to be feasible. Rather than identifying coronary artery 
stenosis itself, the heart can be imaged in an attempt to identify the consequences of 
atherosclerotic disease. For patients presenting with chest pain this means generating 
information about the blood flow to the myocardium or the physiological effects of 
blood flow reduction. Such information is the target of all other non-invasive imaging 
modalities used for the investigation of coronary artery disease and considers either 
the flow of blood into and out of the myocardium, or the abnormal behaviour of the 
myocardium as a consequence of poor perfusion, or both. Stress echocardiography can 
identify regional abnormalities in myocardial wall motion during cardiac stress 
compared to rest. Cardiac magnetic resonance (CMR) imaging and radionuclide 
myocardial perfusion imaging (rMPI) also examine myocardial wall motion but in 
addition use contrast or radioactive tracer, respectively, to permit visualisation of 
blood as it passes into and out of the tissue. All of these modalities use a 
pharmacological agent to induce cardiac stress, simulating exercise, and some can also 
be performed with a patient using an exercise bicycle. 
 
It is also possible to use non-imaging tests to identify the ischaemic consequences of 
reduced myocardial blood flow. Exercise tolerance testing has been a mainstay of 
cardiology for decades[213] using electrocardiographic changes which occur due to the 
abnormal way in which ischaemic myocardium transmits electrical impulses. In the 
United Kingdom exercise tolerance testing has all but ceased as a primary diagnostic 
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test for the investigation of patients presenting for the first time with symptoms of 
potential myocardial ischaemia following guidelines from NICE in 2010.[82] The 
problem with the exercise ECG is that the electrical changes within myocardial tissue 
occur late on in the ischaemic process.[214] Modalities which identify the mechanical 
consequences of ischaemia – left ventricular dysfunction – are therefore more 
sensitive. Even before ischaemia leads to ventricular wall motion abnormality it is 
possible to identify the variation in blood supply to the myocardium with perfusion 
imaging, which may increase the sensitivity further.[215] The current reference 
standard is the measurement of fractional flow reserve at invasive angiography, which 
measures the drop in pressure which occurs as blood crosses a stenosis. 
 
Functional, or ischaemia, testing adds to anatomical data obtained with invasive, or CT, 
angiography. In patients with diffuse, or multi-vessel, coronary disease the correlation 
of symptoms and a demonstrable, regional reduction in blood flow can help to identify 
the ‘culprit’ lesion. It is also important to acknowledge that the anatomical degree of a 
stenosis is a poor predictor of its capability to cause ischaemia and undertaking 
revascularisation in this setting confers risk without benefit.[117] 
 
In comparison to CMR[216] or rMPI,[217] CT performance is limited for predicting 
ischaemia on the basis of stenosis alone. This is not altogether surprising and its 
accuracy compares to catheter angiography,[218] with well known limitations[117] in 
inferring blood flow from visual estimates of stenosis.[146] The desire to add 
physiological information to the highly accurate anatomical assessment which can be 
made with CT is therefore compelling. This is particularly useful if assessment can be 
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achieved without the need for such precise image quality. Because changes in blood 
flow or myocardial motion are larger than coronary lumen, techniques require far less 
stringent spatial resolution. Rudimentary blood flow imaging, simply observing 
myocardial density following contrast delivery, can be achieved with standard CT[106] 
and areas of hypoattenuation can often be seen in patients with significant CAD and 
does add to the accuracy of CT in patients with coronary atheroma,[219] particularly 
where this is calcified. However, this is not entirely straightforward as apparent 
hypoperfusion may be the result of beam-hardening, particularly in the basal segments 
where the proximity of highly attenuating, contrast-filled blood pools in the left heart 
and descending aorta can cause artefact. This is best refuted using multiphase 
examination, but this of course increases the radiation exposure to the patient. 
Nonetheless, CT assessment in this manner performs well compared to rMPI[220,221] 
and may be more sensitive.[106] It can be challenging to distinguish fixed from 
reversible perfusion defects with conventional CT, exacerbated by the proposition that 
iodinated contrast may act as a coronary vasodilator, eliciting a degree of coronary 
steal.[222] Because of this, ‘rest’ CTCA undertaken without a pharmacological stressor 
may identify perfusion defects seen at both rest and stress with rMPI.[223,224] 
 
Dual energy CT (DECT) may be useful in improving the accuracy of CT perfusion 
scanning, offering two potential advantages over single energy techniques. Firstly, 
particularly with the use of monochromatic images, beam hardening artefacts can be 
reduced, improving diagnostic confidence in the presence of hypoattenuating 
myocardium. Furthermore, DECT improves the assessment of iodine with the creation 
of colour maps, again increasing diagnostic accuracy.[225] These utilise the improved 
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contrast resolution of low kV scanning with the reduced noise and artefacts of higher 
kV images to improve the differentiation of normal and iodinated myocardium, which 
can help with the visualisation of hypoperfused regions.[226] 
 
This has been extensively explored by a number of studies,[226] and although there 
has been no direct comparison made between conventional and dual energy scanners, 
the novel technology does appear to offer improved performance[219,227] 
comparable to that of both rMPI and CMR. In one study examining patients with acute 
chest pain, the sensitivity, specificity, negative predictive value and positive predictive 
value were 93%, 99%, 92% and 96% respectively compared to CMR, and 94%, 98%, 
92% and 94% respectively compared to rMPI.[228] A more recent study compared a 
dual-energy CT angiography and perfusion protocol to FFR, finding 100% sensitivity, 
66% specificity, 100% NPV, 74% PPV, with 82% accuracy for a combination of a 
significant (>50%) stenosis and a territorial perfusion defect.[229] Such results are 
broadly comparable to a number of other studies in patients with symptoms or 
corroborative imaging findings, demonstrating again that DECT offers an exceptional 
ability to rule-out disease with rather more limited positive predictability, but 
comparable accuracy to conventional perfusion imaging.[224,230,231] 
 
The diagnostic performance of single-source, dual energy CT with rapid kV switching 
has not been evaluated to date. This has some theoretical advantages over the dual 
source systems which have undergone extensive investigation (see Chapter 1.4). We 
therefore undertook a preliminary investigation of the performance of a single source, 
dual energy CT scanner for the assessment of myocardial perfusion. 
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8.2 The study 
Materials and methods 
The study was performed in a prospective fashion, with prior approval by a committee 
of the UK National Research Ethics Service. It was registered as part of a larger clinical 
trial of the applications of single source, dual energy cardiac CT (NCT 01816750). All 
participants gave informed, written consent. All patients with a positive myocardial 
perfusion scan, having been imaged on standard clinical grounds, between March 2013 
and May 2014 were screened against the study criteria. 
 
The exclusion criteria were patients under 50 years old, body mass index >30kg/m2, 
allergy to iodinated contrast media, contraindication to intravenous beta-blockade, 
estimated glomerular filtration rate <30ml/min, or pregnancy. Patients requiring 
urgent revascularisation before CT scanning could take place were also excluded.  
 
This study was started during a transitional period for stress imaging at our centre. The 
growth of CT at our tertiary centre has taken a significant proportion of patients and 
the hospital has recently expanded its cardiac MRI service. NICE recommend the use of 
CMR, rMPI or stress echocardiography based on local expertise and service access and 
so the choice of a specific modality is somewhat variable between centres and 
referrers.[82] During the study period the CE-MARC trial, the largest examination of 
stress perfusion MRI in the assessment of coronary artery disease to date, was 
published. This study suggested superiority of CMR over rMPI,[232] which was further 
led to the expansion of our MRI service at the expense of nuclear medicine. Nuclear 
medicine remains particularly important for patients with renal dysfunction, 
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particularly as the use of gadolinium contrast media is contraindicated in renal failure 
due to the risk of nephrogenic systemic fibrosis. This means that a significant 
proportion of patients being referred for rMPI at our centre have renal dysfunction, 
which is an exclusion for our study due to the risk of contrast-induced nephropathy. 
This further limits the ability to recruit from this modality. As such, we revised our 
initial target of 20 patients to five-to-10, in order solely to assess the feasibility of the 
workflow and patient experience, with the subsequent intention of conducting a larger 
study comparing CT to cardiac MRI. The amendments to the study protocol were 
approved by the Research Ethics Committee. 
 
rMPI protocol 
The rMPI scans were undertaken over two attendances, one week apart, according to 
standard departmental protocol. A Millenium VG Hawkeye (GE Healthcare, Milwaukee) 
gamma camera was used. A weight-adjusted dose of technetium (99mTc) tetrofosmin 
(Myoview, GE Healthcare) was used on each occasion, with the stress acquisition 
undertaken at the first visit and the rest acquisition at the second. 
 
Following the scan the images were reported by one of two nuclear medicine 
consultants, each with more than 5 years experience of nuclear cardiology. 
 
CT protocol 
All patients underwent stress perfusion CT scanning between 1 day and 1 year after 
the MPI-SPECT, using the standardised Stress Perfusion CT protocol described below. 
CTCA was performed using a single source, dual energy scanner (Discovery CT750 HD, 
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GE Healthcare, Milwaukee, WI). Patients were weighed and measured and a body 
mass index (BMI) calculated.  Intravenous cannulae were inserted into both arms, to 
allow the administration of the pharmaceutical stressor and iodinated contrast 
medium separately. The patient’s baseline heart rate and blood pressure were 
recorded. 
 
An infusion of adenosine was commenced at the rate of 140 µg/kg/min. Patients were 
closely observed to ensure hyperaemia was achieved – where this did not occur, or 
where patients had consumed caffeine prior to the scan, the rate of adenosine was 
increased to 210 µg/kg/min, commensurate with recognised practice.[233] Blood 
pressure monitoring occurred at no less than 1 minute intervals throughout the 
administration of adenosine. Once hyperaemia was been achieved the stress CT was 
undertaken. Iodinated contrast (Optiray 350, Covidien, MA, USA) was administered as 
a 100 ml, multiphase bolus at an initial rate of 6.5 ml/s, followed by a 50 ml saline flush 
and the scan was triggered manually upon opacification of the ascending aorta, with a 
seven second scan delay. The scan was conducted using prospective ECG gating, 
without additional tube-on time, irrespective of heart rate. The following parameters 
were used: slice acquisition 64 × 0.625 mm, z-axis coverage 40 mm with an increment 
of 35 mm, gantry rotation time 350 ms, 80 – 140 kV fast switching tube voltage, with 
tube current according the manufacturer-specified settings (see Table 9, Chapter 3). 
The adenosine infusion was terminated immediately following the scan and the 
patient allowed to recover.  
 
164 
 
Fifteen minutes later the patient’s heart rate and blood pressure were assessed. 
Where the heart rate was below 65 beats per minute (bpm) no further medication was 
administered. For those patients with heart rates above 65 bpm, intravenous 
metoprolol (Betaloc, AstraZeneca, London, UK) was be administered slowly in boluses 
of 2.5 mg (up to a maximum of 40 mg) to obtain a heart rate  less than 65 bpm (as per 
standard clinical practice).[178,198] It is expected that occasionally the patient’s heart 
rate will not respond adequately to beta-blockade. A resting scan was then performed, 
using the same scan parameters as before. Where the patient’s heart rate control was 
inadequate despite beta-blockade up to 200 milliseconds of padding was utilised and 
the centre point was moved to 60% of the R-R interval, to acquire both systolic and 
diastolic phases.  
 
Following the scan both image sets were reconstructed using 50% iterative 
reconstruction (Adaptive Statistical Iterative Reconstruction, GE Healthcare), as 
recommended by previous studies,[147] and transferred to a workstation (Advantage 
Workstation 4.6, GE Healthcare).  
 
Results 
Seven patients were recruited for the study. All patients underwent both the rMPI and 
CT protocols. There were no adverse events. The group comprised five men and two 
women. The median age was 66 years (interquartile range 64 – 72.5 years) and the 
median body mass index was 26 kg/m2 (IQR 24.8 – 30 kg/m2).  
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The median CTDIvol was 30.9 mGy (IQR 25.75 – 33.5 mGy) and the dose length product 
was 372 mGy·cm (329.25 – 412 mGy·cm). 
 
There were 10 perfusion defects identified at rMPI. There was concordance with CT in 
five of these, with two ‘false positive’ and three ‘false negative’ results. When 
compared to the angiographic testing strategy there were eight concordant results 
with one false positive and two false negatives. 
 
The imaging of each patient is summarised below, with examples of the images 
obtained. Key: LMS – left main stem, LAD – left anterior descending artery, Cx – 
circumflex artery, RCA – right coronary artery, PCI – percutaneous coronary 
intervention 
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Patient 1 
 
Gender Male 
Age 72 years 
Body mass index 25 kg/m2 
Previous medical history Previous PCI to RCA 
Total dose (CTDIvol/DLP) 22 mGy / 403 mGy·cm 
rMPI diagnosis Inferior, mild reversible perfusion defect 
Fixed anterior perfusion defect but without regional wall 
motion abnormality – suggestive of artefact 
Perfusion CT findings Reversible inferior perfusion defect, fixed anteroseptal 
perfusion defect with reversibility in a larger, adjacent 
anterior territory 
Onward management Patient underwent PCI to the LAD, but the RCA was 
managed medically 
Comments This patient did not undergo functional testing during the 
invasive angiography. The LAD stenosis is clearly more 
severe, visually, and the operator elected to stent this 
vessel, although this does not match with the severity of 
the defects according to the perfusion study 
Table 20 
CT Perfusion Patient 1 Summary. 
 
 
 
Figure 21.1 
CT Perfusion Patient 1 – rMPI. A – LV outline at stress. B – basal cross-section through 
the left ventricle at rest. C – corresponding basal cross-section through the left ventricle 
at stress demonstrating modest anterior (arrowhead) and marked posterior (arrow) 
perfusion defects. 
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Figure 21.2 
CT Perfusion Patient 1 – CT. Left – rest image demonstrating hypoperfusion at the 
apical septum. Right – cross-section through the basal left ventricle comparable to the 
rMPI images in Figure X.1 demonstrating anterior (arrowheads) and posterior (arrow) 
perfusion defects. The anterior defect is unusual as it appears larger than the rMPI 
defect and does not follow a precisely subendocardial distribution, suggesting that it 
may partially be artefact. 
 
 
 
 
Figure 21.3 
CT Perfusion Patient 1 – invasive angiogram. The left anterior descending artery (left) 
and right coronary artery (right) lesions are indicated. 
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Patient 2 
 
Gender Male 
Age 74 years 
Body mass index 30 kg/m2 
Previous medical history Peripheral vascular disease, hypertension, former smoker 
Total dose (CTDIvol/DLP) 30 mGy / 424 mGy·cm 
rMPI diagnosis Moderately severe, fully reversible anteroseptal 
perfusion defect 
Perfusion CT findings Anteroseptal perfusion defect with severe proximal LAD 
stenosis 
Onward management Patient underwent PCI to the LAD 
Comments The rMPI and CT results appeared to show good 
concordance 
Table 21 
CT Perfusion Patient 2 – Summary. 
 
 
 
 
Figure 22.1 
CT Perfusion Patient 2 – Perfusion. rMPI (left) and CT (right) images demonstrating 
clear anteroseptal hypoperfusion. 
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Figure 22.2 
CT Perfusion Patient 2 – Iodine map. Rest and stress perfusion images reconstructed 
using iodine mapping. This demonstrates an apparent, relatively small perfusion in the 
basal anterior region with extension at stress, corresponding to the perfusion defect 
seen visually and by rMPI. The coronary arteries can be layered over the myocardial 
mapping. 
 
 
 
 
Figure 22.3 
CT Perfusion Patient 2 – Angiography. CT coronary angiography (left) from the ‘rest’ 
perfusion acquisition and invasive coronary angiography (right) demonstrating the 
proximal LAD stenosis responsible for the perfusion defect. 
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Patient 3 
 
Gender Male 
Age 65 years 
Body mass index 26 kg/m2 
Previous medical history Nil. Intermediate pre-test probability of coronary artery 
disease. 
Total dose (CTDIvol/DLP) 32 mGy / 344 mGy·cm 
rMPI diagnosis Mild, mid-basal anterior wall reversible perfusion defect. 
Fixed abnormality in the posterior territory suggestive of 
artefact. 
Perfusion CT findings No perfusion defects identified. Coronary artery 
atheroma in the LAD but no significant coronary 
obstruction. 
Onward management This patient underwent a CT coronary angiogram on 
clinical grounds which confirmed the absence of 
coronary obstruction and was therefore managed 
medically. 
Comments This case suggests highlights the benefits of simultaneous 
perfusion and angiography using CT 
Table 22 
CT Perfusion Patient 3 Summary. 
 
 
 
 
Figure 23.1 
CT Perfusion Patient 3 – rMPI. Rest (left) and stress (right) ‘bullseye’ reconstructions of 
left ventricular perfusion. This demonstrates an apparent perfusion defect anteriorly, 
with a posterior abnormality which was felt to be an artefact. 
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Figure 23.2 
CT Perfusion Patient 3 – CT. No obvious perfusion defect could be identified on the CT 
stress study (left) and the LAD appeared completely unobstructed (right) suggesting 
that the rMPI result was a false-positive. 
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Patient 4 
 
Gender Female 
Age 61 years 
Body mass index 24 kg/m2 
Previous medical history Type 1 diabetic with increasing angina, undergoing pre-
operative evaluation prior to pancreatic islet cell 
transplant 
Total dose (CTDIvol/DLP) 27 mGy / 273 mGy·cm 
rMPI diagnosis Limited severity, fully reversible perfusion defect 
involving the entire inferior wall 
Perfusion CT findings Extensive perfusion defect in the LAD territory. Subtotally 
occluded RCA with likely collateral filling from the LAD. 
Onward management The patient underwent correlative angiography (see 
below) and then coronary artery bypass grafting to the 
LAD and RCA. 
Comments The inferior wall perfusion defect was not obvious on the 
CT images. However, there was significant LAD territory 
perfusion deficit. Furthermore, the subtotally occluded 
RCA was evident, with LAD collateralisation, such that it 
was possible to explain the inferior perfusion defect on 
rMPI as a consequence of the LAD stenosis. 
Table 23 
CT Perfusion Patient 4 Summary. 
 
 
 
 
Figure 24.1 
CT Perfusion Patient 4 – rMPI. There is a large perfusion defect encompassing most of 
the inferior wall. 
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Figure 24.2 
CT Perfusion Patient 4 – CT. There are extensive regions of subendocardial 
hypoenhancement in the anterior (black arrowheads) and inferior (white arrowheads) 
on this stress perfusion acquisition, not evident on the rest study (left – axial four 
chamber slice, right – left ventricular short axis view). Note the step artefact due to 
heart rate variation in the right hand image. 
 
 
 
 
Figure 24.3 
CT Perfusion Patient 4 – Invasive angiogram. There is a short length of occlusion in the 
mid RCA (left, arrow) and a moderate stenosis in the mid LAD (right, arrow), with 
collateral filling from LAD to RCA (arrowheads), consistent with the CT findings. 
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Patient 5 
 
Gender Male 
Age 64 years 
Body mass index 31 kg/m2 
Previous medical history Previous coronary artery bypass grafts to LAD and RCA 
Total dose (CTDIvol/DLP) 60 mGy / 733 mGy·cm 
rMPI diagnosis Mild, fully reversible, apical inferoseptal perfusion 
defect, with a more significant basal to inferobasal fixed 
defect 
Perfusion CT findings Possible apical posteriolateral perfusion defect and clear 
inferobasal hypoperfusion or scar 
Onward management The patient underwent invasive angiography and the 
grafts were felt to be satisfactory. The patient was 
therefore managed medically 
Comments The inferobasal segment appears has the appearances of 
myocardial scar due to previous infarction on CT. There is 
an apparent posterolateral perfusion defect on the CT 
which does not fully correspond to the reversible defect 
on rMPI and it is unclear which of these is inaccurate. 
Table 24 
CT Perfusion Patient 5 Summary. 
 
 
 
 
Figure 25.1 
CT Perfusion Patient 5 – rMPI. Stress (left) and rest (right) images demonstrating a 
large inferobasal perfusion defect which is evidence on both, suggesting irreversibility, 
with reversibility evident more apically. 
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Figure 25.2 
CT Perfusion Patient 5 – CT. The fixed hypoenhancement in the inferobasal segment 
(left, arrow) is consistent with fibro-fatty infiltration which occurs following myocardial 
infarction. There also appears to be a perfusion defect in the lateral wall towards the 
apex, which extents posteriorly. The image on the right is a myocardial iodine mask, 
which can help to visualise perfusion defects.  
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Patient 6 
 
Gender Female 
Age 81 years 
Body mass index 22 kg/m2 
Previous medical history Previous PCI to LAD 
Total dose (CTDIvol/DLP) 33 mGy / 288 mGy·cm 
rMPI diagnosis Distal-mid anterior to anterolateral, moderately large, 
fully reversible perfusion defect. 
Perfusion CT findings Clear, corresponding perfusion defect. Suboptimal 
coronary artery imaging. 
Comments Patient underwent PCI to a severe Cx stenosis (see 
below). 
Table 25 
CT Perfusion Patient 6 Summary. 
 
 
Figure 26.1 
CT Perfusion Patient 6 – rMPI. Montage of rMPI images demonstrating a reversible 
anteriolateral perfusion defect. 
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Figure 26.2 
CT Perfusion Patient 6 – CT. Rest (left) and stress (right) images demonstrating a 
reversible anterolateral perfusion defect. 
 
 
 
 
Figure 26.3 
CT Perfusion Patient 6 – Invasive angiogram. The culprit lesion is a severe stenosis in 
the mid Cx which supplies an unusually anterior portion of the left ventricle due to a 
small calibre LAD.   
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Patient 7 
 
Gender Male 
Age 67 years 
Body mass index 30 kg/m2 
Previous medical history Known angina but no previous coronary imaging. Type 2 
diabetes mellitus 
Total dose (CTDIvol/DLP) 35 mGy / 401 mGy·cm 
rMPI diagnosis Mild, inferoseptal, inferior, and inferolateral perfusion 
defects. These are mainly reversible in the inferior and 
inferolateral territory but may represent scarring in the 
inferoseptal segment. 
Perfusion CT findings No perfusion defect identified. Moderate LAD stenosis. 
Onward management The patient underwent angiography demonstrating an 
unobstructed right coronary artery. The LAD had a 
moderate stenosis in the proximal course, consistent 
with the CT findings, which was stented on the basis of 
the patient’s symptoms. 
Comments The functional significance of the LAD stenosis is again 
uncertain – it was not identified on either the CT or the 
rMPI and was stented due to the patient having a 
convincing history of ischaemic-sounding pain. 
Table 26 
CT Perfusion Patient 7 Summary. 
 
 
 
 
Figure 27.1 
CT Perfusion Patient 7 – rMPI. Perfusion ‘bullseye’ demonstrating apparent basal  
inferior and inferoseptal perfusion defects (dark blue). 
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Figure 27.2 
CT Perfusion Patient 7 – CT. CT demonstrating apparently normal perfusion of the left 
ventricle at the basal level. 
 
 
 
 
Figure 27.3 
CT Perfusion Patient 7 – Invasive angiogram. Left (left image) and right (right image) 
coronary arteries demonstrating grossly normal calibre other than in the proximal LAD 
where a moderate stenosis is present. 
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8.3 Discussion 
This exploratory study of the usefulness of single source, dual energy CT for the 
assessment of perfusion has demonstrated the potential of CT to accurately assess 
myocardial blood flow during stress and at rest. It has identified 63% of the perfusion 
deficits seen at rMPI, but those which have been ‘missed’ appear to be false positives, 
based on angiographic correlation. Furthermore, CT seems to have identified two 
perfusion defects which were missed by rMPI. This suggests that this approach with CT 
might be able to offer superior accuracy over rMPI. This has also been identified with 
previous studies comparing CT with rMPI, which note the improved spatial resolution 
of CT which may identify perfusion defects missed by the nuclear medicine 
technique.[230] 
 
When compared to the angiographic testing strategy, CT correctly identified eight 
perfusion defects for which revascularisation was undertaken. The single false positive 
and two false negatives were all determined based on visual estimation of coronary 
stenosis rather than pressure wire study, which is a fallible strategy.[117] 
 
There are some apparent disadvantages to this CT perfusion algorithm, not least being 
the significant radiation dose. At a time when radiation doses from cardiac CT are 
falling markedly[19,34] the CT perfusion protocol used here resulted in a far greater 
dose. The selected scanner protocols used in this study (Table 9, Chapter 3) represent 
the highest tube settings available and this may be able to be reduced – further 
evaluation of the technique examining signal to noise ratios in a larger, clinical 
population will be required. Furthermore, the current protocol uses the same scan 
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acquisition parameters for both stress and rest images, to ensure optimal 
comparability. It is important to maintain the spatial resolution for the coronary 
imaging that slice thickness is maintained at 0.625 mm but for myocardial imaging this 
is not required. Indeed, optimal myocardial images require increased slice thickness 
and greater image smoothing than coronary imaging.[230] It is therefore likely that, at 
least for the stress acquisition, the slice thickness can be increased which will in turn 
reduce the radiation dose. 
 
The radiation dose also limits some of the data which can be obtained during a CT 
perfusion examination. The generation of functional information about left ventricular 
performance was routinely gathered when multiple phases of the cardiac cycle were 
always collected, with retrospective gating, and the accuracy of this data has ensured 
that quantifying ventricular function remains an appropriate use of cardiac CT.[99] 
However, the radiation exposure from this method is considered to be high, 
particularly in comparison to modern, prospective (or high-pitch retrospective) gating 
and this relegates CT to a second-line investigation for this indication. This means that 
whereas cardiac MRI is able to evaluate a combination of both myocardial blood flow 
and regional wall motion abnormality when assessing transcoronary perfusion, CT is 
generally limited to the former. Regional wall motion abnormalities can be identified 
using CT, with so-called ‘dynamic’ perfusion protocols, but at the expense of 
considerably high radiation exposure.[234] It is perhaps worth noting that there is 
some disagreement about whether single, static images can correctly be referred to as 
‘perfusion’ images.[235] 
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In addition to the above problems, some difficulties with the scanning process itself 
were identified. The image analysis was significantly hampered by the failure of the 
software to accurately delineate the myocardium (Figure 28). Particularly on stress 
imaging, the insufficient temporal resolution resulted in motion blur which impaired 
the accurate identification of the myocardial border and prevented the creation of a 
left ventricular perfusion map. This meant that image analysis had to be performed 
visually – given that the major purported advantage of dual energy CT is its improved 
iodine detection, this is clearly a major limitation. The hope going forward would be 
for improved software capability, to compensate for such artefact, or improved 
temporal resolution such that image quality would not be affected. Of course, the 
latter may also facilitate the improvement of coronary image quality, such that 
perfusion studies are not needed as a technique for improving diagnosis in the 
difficult-to-image patient. 
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Figure 28 
Myocardial border detection. This image demonstrates the limited ability of the post processing 
software to accurately delineate the myocardial border. The myocardial overlay (red and blue) 
does not conform to the myocardial borders. 
 
 
One further concern, beyond the technical ability of the scanner technology, is the 
ability of CT to identify defects in myocardial iodination at rest, which can only be 
identified on the stress study with rMPI. This may be due to the vasodilatory effects of 
iodinated contrast, acting as a pharmacological stressor and eliciting coronary steal, or 
the differences in distribution kinetics between radionuclide tracer and CT 
contrast.[235] One recent study found that 45% of reversible perfusion defects were 
misclassified as fixed due to this phenomenon.[236] This cannot be overcome by 
technological adjustments and the implications will need to be considered prior to 
adoption of this investigative process into routine clinical practice. 
 
The major limitation of this study is the small sample size. While it has been useful to 
evaluate the relative ease and initial usefulness of the technique, the sample size is too 
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small (and the number of apparently false positive rMPI studies is too high) to be able 
to draw firm conclusions as to its accuracy. As mentioned previously, this is in part due 
to a diminishing pool of patients with the increase in stress MRI being conducted at 
our institution, along with recent evidence suggesting that cardiac MRI may be 
superior to rMPI.[232] A study comparing this CT perfusion technique against what 
might now be considered as the current, non-invasive, gold standard of stress MRI is 
currently underway at our institution. 
 
Future studies may also consider exploiting the other potential benefits of dual energy 
CT imaging. The use of virtual monochromatic datasets may improve tissue 
characterisation, particularly at lower kVp energies, and might therefore help lower 
density, hypoperfused regions to become more conspicuous. In this study there were 
no true positive perfusion abnormalities which were not detected by CT. 
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9. Infarction and scar with cardiac CT 
9.1 Introduction 
Case 5 in the previous chapter demonstrates the relative ease with which fibrofatty 
replacement of the myocardium, occurring following myocardial infarction, can be 
observed.[237,238] This is facilitated by the tissue differentiation between relatively 
dense myocardium, particularly when it contains iodine, and low density fat. Following 
infarction, fatty replacement of the myocardium initially within fibrous scar[237,239] 
eventually leads to significant lipomatous metaplasia.[240] Although this is a relatively 
late feature, not described within the first 6 months following infarction,[237] it can 
ultimately be extensive and is evident in severely diseased hearts excised from 
patients receiving transplants.[239,241] On CT, fat in infarcted myocardium is usually, 
although not exclusively, subendocardially distributed[105] in a curvilinear pattern, 
within a coronary artery territory[240,242] (Figure 29). Transmural extension does not 
seem to occur.[243] It is easily visualised, even on non-enhanced images undertaken 
for calcium scoring,[244] and extremely common, with the prevalence of post-MI LV 
fat as high as 96% in some studies.[245] The frequency of infarct-related LV fat on CMR 
is reportedly lower, at around 68% – histological studies suggest the true prevalence to 
be somewhere in between.[239] 
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Figure 29 
A large, focal, fibrofatty lesion seen in C due to a circumflex territory infarction (black 
arrow) 
 
The prevalence, and relative ease of detection, of fibrofatty infiltration makes the 
identification of post-infarction scar an appealing objective for the identification of 
coronary artery disease, particularly if the coronary arteries themselves prove difficult 
to image, and the identification of previous infarction at CT has been explored.[246] 
Due to the previously described manner in which fibrofatty replacement occurs, it 
would also be necessary to identify scar prior to the development of low density 
lesions. The gold standard for the identification of myocardial scar is cardiac magnetic 
resonance imaging (MRI).[52] This exploits the difference in the way healthy and 
pathological myocytes process gadolinium, (altered clearance and volume of 
distribution)[247] to which cardiac MRI is highly sensitive. The operator is able to 
suppress or ‘null’ normal myocardium by setting a particular inversion time, such that 
healthy myocardium does not return a signal to the detector and thus appears black. 
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Regions of myocardium containing gadolinium display different magnetic properties 
and are therefore seen as bright white.[248] 
 
The purported improvement in iodine characterisation with dual energy CT[225] offers 
the possibility of improved identification of myocardial segments containing iodine 
against otherwise normal segments. This may allow improved detection of ‘delayed 
enhancement’ of the myocardium with CT, a concept which has been provisionally 
explored by a number of studies. These have generally been investigations in animal 
models,[249–251] or as part of a stress perfusion protocol,[230] where the combined 
accuracy of both stress perfusion and delayed enhancement has been used to identify 
coronary artery disease with comparators being invasive angiography or 
rMPI,[230,252] rather than as a direct test of the ability to identify delayed 
enhancement compared to cardiac MRI. 
 
This study therefore aimed to evaluate, for the first time in humans, the feasibility of 
single source, dual energy CT to identify delayed myocardial enhancement, in 
comparison to cardiac MRI. 
 
9.2 The study 
Materials and methods 
The study was performed in a prospective fashion, with prior approval by a committee 
of the UK National Research Ethics Service. It was registered as part of a larger clinical 
trial of the applications of single source, dual energy cardiac CT (NCT 01816750). All 
participants gave informed, written consent. All patients with an MRI scan 
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demonstrating myocardial late gadolinium enhancement, having been imaged on 
standard clinical grounds between March 2013 and May 2014, were screened against 
the study criteria. 
 
The exclusion criteria were patients under 50 years old, body mass index >30kg/m2, 
allergy to iodinated contrast media, estimated glomerular filtration rate <30ml/min, or 
pregnancy. Patients requiring urgent revascularisation before CT scanning could take 
place were also excluded.  
 
Cardiac MRI imaging protocol 
All patients underwent cardiac MRI assessment on a 1.5 Tesla system (Achieva 1.5 d-
stream conversion, Philips Medical Systems, Best, Netherlands) using dedicated 
cardiac phased array receiver coils for signal reception. Patients were weighed and an 
intravenous cannula was inserted. The standard cardiac MRI protocol included initial 
scout images in the axial, sagittal and coronal plains, followed by 2, 3 and 4-chamber 
cine images, and 4-chamber and left ventricular short axis cine volume stacks. The 
patients were then administered intravenous gadolinium (0.2 mmol/kg gadobutrolum, 
Gadovist, Bayer-Schering Pharma, Germany). Ten minutes after the injection of 
gadolinium, myocardial nulling was be assessed via a look-locker sequence. Individually 
optimised times (200-350 msec) determined from the look-locker sequence were then 
used to acquire inversion recovery gradient-echo 2 and 3-D images in the ventricular 
short axis and ventricular horizontal long axis, as well as a single vertical long axis. A 2D 
FFE multi-slice short axis inversion recovery sequence (TR/TE = 6/2.7; reconstructed 
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voxel-size 1 × 1 × 8 mm acquisition; SENSE-factor = 1.2; TI = 240 – 340 ms) was 
employed. 
 
CT imaging protocol 
Patients were weighed and measured and a body mass index (BMI) calculated, and an 
intravenous cannula was inserted. All patients underwent a prospectively gated, 
unenhanced scan (100 kV, 80 mA) with 2.5 mm slices, for calcium scoring and to assess 
for hypodense myocardium. Following this they underwent CTCA, performed using a 
single source, dual energy scanner (Discovery CT750 HD, GE Healthcare, Milwaukee, 
WI). Iodinated contrast (Optiray 350, Covidien, MA, USA) was administered as a 100 
ml, multiphase bolus at an initial rate of 6.5 ml/s, followed by a 50 ml saline flush and 
the scan was triggered manually upon opacification of the ascending aorta, with a 
seven second scan delay. The scan was conducted using prospective ECG gating, 
without additional tube-on time, irrespective of heart rate. The following parameters 
were used: slice acquisition 64 × 0.625 mm, z-axis coverage 40 mm with an increment 
of 35 mm, gantry rotation time 350 ms, 80 – 140 kV fast switching tube voltage, with 
tube current according the manufacturer-specified settings (see Table 9, Chapter 3).  
 
Immediately following the scan a further 50 ml iodinated contrast was administered as 
an intravenous bolus over one minute, using a hand injection. Ten minutes after this 
the patient underwent a delayed enhancement scan using the same settings. The 
images were reconstructed using a 50% blend of iterative reconstruction. 
 
Image interpretation 
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The image sets from both examinations were anonymised and transferred to remote 
workstations for interpretation. They were assessed by expert readers in each 
modality, each with more than 5 years experience, blinded to the results of the other 
test. All image sets were analysed using the American Heart Association 17-segment 
myocardial model.[253]  
 
Statistics 
Statistical analysis was performed using SPSS Statistics 21 (IBM Corp., New York). The 
distribution of data was assessed graphically and parametric or non-parametric tests 
selected accordingly. Continuous variables were assessed with an unmatched t-test or 
independent samples Kruskal-Wallace test. Test accuracy was estimated using 
descriptive statistics. 
 
Results 
Twenty patients were recruited to the study although two withdrew prior to 
completing the full image protocol. Therefore eighteen patients were included in the 
analysis, comprising 16 with prior myocardial infarction and two with hypertrophic 
cardiomyopathy. There were no adverse events. 
 
The baseline demographics of the study participants were as follows: median age 66.5 
years (interquartile range 56 – 72 years), body mass index 28 kg/m2 (IQR 25 – 29 
kg/m2), and 94% were male (n = 17). The median CTDIvol was 33.15 mGy (IQR 28.9 – 
36.8 mGy) and the median dose length product was 418 mGy·cm (IQR 365 – 420 
mGy·cm). 
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In total, 306 myocardial segments were analysed. Eighty four segments (27%) 
displayed late gadolinium enhancement at cardiac MRI. With CT, 60 segments (71%) 
containing late enhancement were correctly identified (true positive) and 216 (98%) 
were correctly classified as normal (true negative). There were 5 false positive and 25 
false negative segments. The overall accuracy of CT to identify delayed enhancement 
compared to cardiac MRI was therefore: sensitivity 0.71 (95% confidence interval 0.59 
– 0.80), specificity 0.98 (0.95 – 0.99), positive predictive value 0.92 (0.83 – 0.97) and 
negative predictive value 0.90 (0.85 – 0.93). 
 
9.3 Discussion 
This study suggests that, using a single source, dual energy technique, CT may offer 
good performance for the detection of myocardial scar with late iodine enhancement. 
This feature was identified with both focal (Figure 30) and coronary territory (Figure 
31) scar. The specificity is particularly impressive at 0.98, which is notable as the usual 
limitation of CT with coronary artery disease. Also of note, the false positive readings 
all occur in segments directly adjacent to true positives, suggesting that these may be 
due to differences in reader assignment of myocardial territory, rather than entirely 
spurious anomalies. 
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Figure 30 
Focal late contrast enhancement. Cardiac MRI images in the short axis (A) and 4 
chamber (B) views and corresponding CT images, also in the short axis (C) and 4 
chamber (D) views, demonstrating focal enhancement in the basal lateral wall. 
 
 
Figure 31 
Late iodine enhancement. Cardiac MRI image (A) demonstrating late gadolinium 
enhancement in the left anterior descending artery territory. While this scar is visible in 
the low keV image (B) the use of a myocardial iodine overlay (C) accentuates the 
abnormality further. 
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This finding has since been repeated by another group using a dual source, dual energy 
scanner in patients with only ischaemic scar.[254,255] One group has also achieved 
similar results using conventional 64-multidetector row CT technology rather than dual 
energy, with a sensitivity of just 53% but a specificity of 98%.[256] Although not 
directly comparable, these additional results would support the prospect of CT being 
able to offer delayed iodine enhancement imaging, with dual energy scanners 
potentially improving on the performance of conventional technology. 
 
CT scanners are narrower and generally have a wider bore than MRI scanners, which 
may improve patient tolerance. CT scanning is also much faster with a typical 
acquisition complete in a under a second, whereas MRI scanning takes tens of 
minutes. Furthermore, CT is able to combine delayed iodine enhancement imaging 
with the identification of fibro-fatty replacement, perfusion and delineation of the 
coronary anatomy in a single test (Figure 32). Finally, patients with pacemakers and 
other metallic implants can undergo CT without special devices or precautions being 
required, which is particularly relevant as patients with myocardial scar may well 
require complex cardiac devices, such as implantable defibrillators or cardiac 
resynchronisation therapy. 
 
194 
 
 
Figure 32 
Various contrast phases in a left anterior descending artery territory scar. A – cardiac 
MRI 4 chamber view demonstrating late gadolinium enhancement in the LAD territory. 
B – unenhanced CT image demonstrating small areas of low density material consistent 
with fibro-fatty replacement of the myocardium following infarction. This territory is 
smaller than in image A suggesting that only part of the scar has undergone 
replacement. The remainder is seen in C – with late iodine enhancement at the left 
ventricular apex. D demonstrates late gadolinium enhancement in a short axis view. 
Note the corresponding, dark, hypoperfused region during the contrast phase of the CT 
scan (E). 
 
One limitation of CT is the static nature of the imaging. As previously discussed the use 
of multi-phase cycles is costly in terms of radiation exposure. This limits imaging to the 
primary identification of delayed enhancement. At least for ischaemic scar, the 
presence of regional wall motion abnormality may also be useful to help identify 
pathological myocardium, but this was not available in this study. 
 
As with the perfusion imaging in chapter 8, one major difficulty is the current inability 
of the workstation software to accurately delineate the myocardium. It appears that 
the algorithm uses the high density blood pool within the left ventricle from which to 
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identify the myocardial border and the absence of contrast limits prohibits this (Figure 
33). Further improvement in performance may be achieved if myocardial masks were 
readily available to display iodine patterns. 
 
 
 
Figure 33 
The absence of a defined intra-ventricular blood pool of high (contrast) density 
prohibits the identification of the myocardial border. Instead the software appears to 
have selected the densest structure, in this case the spinal vertebra. 
 
 
 
 
 
 
One further consideration is the optimal timing of delayed enhancement images. Time 
is needed for the iodine to egress from healthy tissue, and to be taken up by diseased 
tissue,[251] but also to allow a reduction in iodine in the blood pool. Therefore, further 
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delay before the non-contrast acquisition may allow the myocardium, and any 
enhancement thereof, to be more conspicuous.[250] 
 
This study was conducted in a small number of patients to ensure its feasibility. It is 
tolerated well and there appears to be reasonable accuracy with the technique. Before 
widespread clinical introduction further study will be required, in unselected, all-comer 
populations to determine a more precise accuracy and further evaluate the limitations 
of CT for this application. 
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Section 5 – Discussion 
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The opportunities to improve the investigation of the difficult-to-image patient 
comprise a diverse range of approaches and this thesis therefore explores a number of 
novel contributions to the knowledge base. The examination of calcified vessels is 
crucial to modern CT practice; firstly for improving the positive predictive value in 
patients with a high coronary calcium burden. This is important not only because it 
may reduce the need for downstream, invasive testing, improving the patient 
experience and potentially reducing costs, but also because coronary calcium is one of 
the few variables which cannot be predicted or ameliorated prior to a patient’s 
attendance for a scan. This has a further implication, in that CT has been considered as 
inappropriate in patients deemed as being at high pre-test risk of coronary artery 
disease, partly because of the associated risk of calcified coronary arteries. Hence, 
removing coronary calcification as a barrier to successful CT coronary angiography 
would bring the opportunities of non-invasive coronary imaging to patients at higher 
risk, particularly in the United Kingdom where this is currently limited to those at low 
clinical risk (10 – 20% pre-test likelihood).[82] 
 
The studies outlined here exploring calcified coronary disease are not directly 
comparable but, superficially at least, high definition imaging seems to offer much a 
greater improvement in image quality than dual energy, calcium subtraction 
techniques. Further research will be needed in a larger, diverse population and 
incorporating multiple sites, but HD scanning appears to offer a highly accurate 
solution to this major imaging limitation.  There is a curious dichotomy in the NICE 
Diagnostics Guidance 3, whereby CT is recommended for patients at low pre-test 
probability and also those with known coronary disease who have previously 
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undergone revascularisation[98] and HD CT certainly appears capable of dealing with 
the latter. The rationale for limiting CT to the lower risk groups is predominantly the 
association with high calcium levels resulting in imaging difficulties, which might be 
removed with the introduction of HD scanning.  
 
The positive predictive value of CT in this context must of course be considered, 
influenced as it is by the pre-test likelihood. The use of CT for higher risk patients also 
has important implications for the risk-benefit ratio of this investigative modality. The 
risks of radiation exposure, discussed in Chapter 1.3, are a necessary consideration for 
referring clinicians and CT operators but the relative risk of ionising radiation is less if 
the likelihood of identifying a serious pathology, with implications for mortality and 
morbidity, is higher.  
 
Even without new generation technology, progress might be made in improving image 
quality in the face of calcified coronary arteries. While the findings need examining in 
vivo, it seems that careful consideration of the reconstruction methods used may help 
to improve the accuracy of imaging of high density structures. This might include 
stents as well as calcified atheromatous lesions. The benefits of novel methods of 
image reconstruction extend not only to this challenging patient group, but to all 
patients undergoing cardiac CT who may benefit from significant reductions in 
radiation exposure as a consequence. These methods exist in all CT systems and the 
variability in image quality and, crucially also, diagnostic accuracy which has been 
demonstrated should lead all those who use CT to question the methods being utilised 
to answer each clinical question.  
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The use of simple interventions to reduce the difficulty with which patients are imaged 
is an appealing one. The use of a more aggressive beta-blocker strategy is another 
relatively simple amendment which may improve imaging quality with important 
implications for radiation exposure. The use of intravenous beta-blockers minimises 
the impact on the clinical work flow, although referring clinicians might also be 
encouraged to prescribe oral agents for the days leading up to the scan. 
 
The combination of aggressive beta-blocker use and further simple adjustments in 
acquisition methodology also facilitates the imaging of patients with atrial fibrillation. 
The association of AF with coronary ischaemia makes the ability to successfully image 
patients with this arrhythmia of real clinical importance. Again, the findings presented 
here suggest that this is readily achievable with conventional 64-MDCT technology. 
 
The other, emerging applications of cardiac CT of perfusion and delayed enhancement 
imaging also show promise. While these may be useful as surrogate markers of 
coronary artery disease and its sequelae in patients who are difficult to image, they 
may also have applications of their own. Not all patients are suitable for cardiac MRI, 
due to claustrophobia or the presence of metallic foreign bodies or implants, for 
example, and an alternative imaging modality would be beneficial here. Furthermore, 
there is the suggestion that the combined CT perfusion and angiography might even be 
superior to rMPI, which has been established for many years. 
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If imaging can be improved in patients conventionally considered to be challenging 
then a range of additional potential uses for CT emerge. There is growing interest in 
assessing the functional significance of a coronary stenosis using fractional flow 
reserve estimations; applying principles of computational fluid dynamics to the CT 
images to infer functional significance. In addition, the identification of ‘vulnerable’ 
plaque, which is at high risk of rupture leading to acute coronary occlusion, is currently 
a key research topic across a number of imaging modalities, including with CT. Both of 
these techniques require excellent CT image quality, which becomes more likely if the 
challenges of imaging are diminished. 
 
These novel applications neglect the strength of CT for the assessment of coronary 
artery disease (CAD). If obstructive CAD can be confidently excluded across all patient 
groups, this would permit the consideration of CT as a genuine alternative to invasive 
angiography. There is already evidence that decision making about onward 
management is the same regardless of whether the patient was imaged with invasive 
angiography or high quality CT scanning[257]. Moreover, clear differences in mortality 
have been demonstrated between patients with non-obstructive coronary atheroma 
and patients with completely normal coronary arteries,[258] which can be a 
challenging distinction in the face of reduced image quality. 
 
Limitations 
There are a number of limitations to the evidence presented here. Most of these have 
been considered in each chapter, as relevant, but there are some key, overarching 
themes. 
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The studies have been performed in a single centre with considerable expertise in, and 
experience of, cardiac CT and the expert readers were highly experienced. Most 
evidence in cardiac CT has been developed from similar environments and this limits 
the wider clinical applicability of the findings.[7] Furthermore, the sample sizes are 
very small in a number of the studies. This makes the drawing of firm conclusions 
about the benefits of the technologies challenging and potentially dangerous. 
 
Finally, the benefits of dual energy CT over conventional technology need to be 
explored. While it appears that these techniques are useful, particularly for myocardial 
evaluation, there are some theoretical benefits to dual energy scanning, including 
differentiation of low contrast tissue densities and the reduction of artefacts, which 
have not been thoroughly explored. With the small sample sizes the populations 
contain insufficient examples of these phenomena to ensure that they are overcome 
by dual energy techniques. 
 
Future developments 
Incredibly, some commentators believe that CT has reached the limits of technological 
developments and will never be able to truly compete with angiography as a coronary 
diagnostic modality.[259] In reality, in some ways the findings from the studies 
presented here are already out of date. Technology is moving on at an incredible pace 
and it seems we are entering a revolutionary phase in the development of cardiac CT. 
With the increasing availability of wide detector scanners, which provide whole-heart 
coverage, allowing acquisition of the entire cardiac volume, the ‘slice war’, with 
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manufacturers competing to deliver scanners with ever more detector rows, may be 
reaching its limit. This by no means suggests that the development of CT technology 
has peaked otherwise. Increasing miniaturisation (Figure 34), improved spatial, 
temporal and contrast resolution, the use of dual-energy and progressive 
reconstruction methods are all driving CT forward. 
 
 
Figure 34 
Detectors in ‘new-generation’ and ‘next-generation’ CT scanners. On the left is the 
detector module from a modern scanner (in the region of 25 cm length), evaluated in 
the NICE review of ‘new-generation’ technology[98] and on the right is the equivalent 
component in the newest scanner to market (3 – 4 cm length). 
 
 
The latest wide detector, cardiac-capable scanner to reach the market claims a 
temporal resolution of 0.14 seconds, approaching that of fluoroscopy, with high-
definition scanning to achieve a spatial resolution of 18 line pairs per centimetre. Such 
developments make the prospect of single-heartbeat imaging, irrespective of heart 
rate or breath-hold, in patients with coronary calcification or stents, and with modern 
iterative reconstruction brings sub-milliSievert scanning into the routine, with 
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radiation doses well below that of fluoroscopy and even competing with plain film x-
ray.[166] If artefact and concern about radiation doses reduce this significantly then it 
also offers the possibility of using CT in other ways, with longer, perhaps multi-cycle 
acquisition, or to facilitate cardiac procedures in the same way that fluoroscopy 
facilitates percutaneous coronary intervention and CT already permits precise biopsy 
of stationary structures. Dynamic, whole cycle perfusion studies at peak stress could 
be conducted to identify perfusion defects and wall motion abnormality, with 
simultaneous coronary delineation. As far as coronary imaging is concerned it may well 
be, in the very near future, that no patient will be ‘difficult-to-image’ at all. 
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Appendix 1 
Information film available at: tinyurl.com/derrifordheartct 
 
 
Cardiac CT Scan 
 
Patient Information Sheet 
 
It has been requested by your doctor that you have a CT scan of your heart.  
This is a scan which can assess your heart and the arteries that supply it, to 
help your doctor make a diagnosis of your symptoms.   The scan uses x-rays 
to take pictures of your heart. 
 
1. Why am I having this scan? 
Based on your symptoms, your doctor has decided to investigate your heart 
and the blood vessels that supply it. 
 
2. Do I need to take any medication for the scan? 
No - you do not need to take any medication before the scan.   
You should continue to take all the routine medication your doctor has 
prescribed. 
 
If you have diabetes and take Metformin you should stop taking this 
medication on the day of the scan.  You will be advised after your scan when 
you can restart your Metformin. 
 
3. Can I eat and drink normally before the scan? 
Yes you can – in fact we advise you to be well hydrated (drink lots of water) 
before the scan.  Please try and avoid coffee, tea and chocolate on the day of 
the scan as these increase your heart rate, which will result in a poorer quality 
scan.  
 
4. Do I need to tell the staff what tablets I take? 
Yes – it is very important to tell the doctor or staff in the department what 
medication you take, before you have the scan. It is often useful to bring your 
repeat prescription on the day of the scan. 
 
5. Will I be given any medications during the scan? 
In order to get a good quality scan, your heart rate needs to be slow. Some 
people may have a slightly faster heart rate than others. If your heart rate is 
slightly fast a doctor will give you an injection to slow it down (a beta 
blocker).  This is standard practice and there is nothing to worry about.  The 
drug will slow your heart rate gently; it does not have major side effects. It 
acts for about 20 minutes.  
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6. Does the doctor need to know any other information about me before 
giving the drug? 
Yes – the doctor will check if you take any medication or have any allergies.  
It is important to say if you have any allergies, if you have taken Beta blockers 
before and if you had any problems with them.  You should also mention if 
you suffer from asthma. 
 
7. What happens during the scan? 
You will be given a dye (contrast) through a small needle (venflon) in your 
arm. This helps to show arteries in your heart better. It may produce a hot 
flush and a feeling that you are passing water.  This only lasts for a short time 
and symptoms pass quickly.    
 
You will be asked to hold your breath for approximately 20 seconds during 
the scan. It is important that you are able to hold your breath, as this will 
affect the quality of the scan. You could practice holding your breath at home 
so you are familiar with this when asked to do so during your scan.    
 
If you cannot hold your breath please tell the staff in the scanner who will be 
able to help you. 
 
8. How long will the scan take? 
The actual scan will only take a minute or two but preparing you for the scan 
might take a little longer.  We also ask you to wait in the department for 20 
minutes after your scan to monitor you. You should estimate to spend an 
hour in the department.  
 
You can normally drive home but we advise you to try and arrange for 
someone to pick you up. 
 
 
 
If you have any concerns or need further information about your scan please 
contact the department on  
01752 437182 
 
 
You can now see a short film about having a heart CT scan at Derriford. 
Please visit our YouTube page by typing this address into your internet 
browser: 
tinyurl.com/derrifordheartct 
 
If you are unable to access the internet and would like to borrow a DVD, 
please contact us on the number above. 
